PLK2
Normalized values from positional scanning peptide array
Phospho-serine (pS) is a duplicate of phospho-tyrosine (pT) in PSPA
Position-wise Probabilities
Log-Odds: Probabilities / STY Background
Sites with acceptor types representing >8% and count ≥10 are included
S Sites Probabilities
T Sites Probabilities
Log-Odds: S Sites / S Background
Log-Odds: T Sites / T Background
Sites with acceptor types representing >8% and count ≥10 are included
Motif clusters with count ≥ 10 are shown
Download
| substrate_uniprot | site | source | substrate_genes | site_seq |
|---|---|---|---|---|
| O15350 | S48 | EPSD|PSP | TP73 P73 | yFDLPQSSRGNNEVVGGTDssMDVFHLEGMTTSVMAQFNLL |
| O43719 | S702 | Sugiyama | HTATSF1 | EDADGKEVEDADEKLFEDDDsNEKLFDEEEDssEKLFDDsD |
| O43852 | S44 | EPSD|PSP|Sugiyama | CALU | KKDRVHHEPQLsDKVHNDAQsFDyDHDAFLGAEEAKtFDQL |
| O43852 | T196 | EPSD|PSP|Sugiyama | CALU | FtAFLHPEEyDyMKDIVVQEtMEDIDKNADGFIDLEEyIGD |
| O43852 | T60 | EPSD|PSP | CALU | NDAQsFDyDHDAFLGAEEAKtFDQLtPEEsKERLGKIVSKI |
| O60220 | S94 | Sugiyama | TIMM8A DDP DDP1 TIM8A | SQFILNRLEQTQKSKPVFSEsLsD_________________ |
| O60814 | S39 | Sugiyama | H2BC12 H2BFT HIRIP1 HIST1H2BK | VTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKA |
| O60841 | S66 | Sugiyama | EIF5B IF2 KIAA0741 | KEKKKQDFDEDDILKELEELsLEAQGIKADREtVAVKPTEN |
| O95218 | S165 | Sugiyama | ZRANB2 ZIS ZNF265 | LKEVEDKEsEGEEEDEDEDLsKyKLDEDEDEDDADLsKyNL |
| O95218 | S181 | Sugiyama | ZRANB2 ZIS ZNF265 | DEDLsKyKLDEDEDEDDADLsKyNLDAsEEEDsNKKKSNRR |
| P02511 | S19 | PSP | CRYAB CRYA2 HSPB5 | __MDIAIHHPWIRRPFFPFHsPsRLFDQFFGEHLLESDLFP |
| P04406 | T237 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | VGKVIPELNGKLtGMAFRVPtANVsVVDLtCRLEKPAKyDD |
| P04792 | S82 | Sugiyama | HSPB1 HSP27 HSP28 | AIEsPAVAAPAYsRALsRQLssGVsEIRHtADRWRVsLDVN |
| P05386 | S104 | Sugiyama | RPLP1 RRP1 | tAAAPAEEKKVEAKKEEsEEsDDDMGFGLFD__________ |
| P05387 | S105 | Sugiyama | RPLP2 D11S2243E RPP2 | GsAPAAAEEKKDEKKEEsEEsDDDMGFGLFD__________ |
| P06733 | T205 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | GAEVyHNLKNVIKEKyGKDAtNVGDEGGFAPNILENKEGLE |
| P06748 | S4 | GPS6|SIGNOR|EPSD|PSP | NPM1 NPM | _________________MEDsMDMDMsPLRPQNyLFGCELK |
| P07195 | T323 | Sugiyama | LDHB | sVINQKLKDDEVAQLKKsADtLWDIQKDLKDL_________ |
| P07900 | S50 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | MSLIINtFySNKEIFLRELIsNssDALDKIRyEsLtDPsKL |
| P08238 | S45 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | MSLIINTFYSNKEIFLRELIsNAsDALDKIRyEsLtDPsKL |
| P08238 | S468 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | RRRLsELLRyHtsQsGDEMtsLsEyVsRMKEtQKsIyyItG |
| P08238 | S48 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | IINTFYSNKEIFLRELIsNAsDALDKIRyEsLtDPsKLDsG |
| P08238 | T297 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | IDQEELNKtKPIWtRNPDDItQEEyGEFyKsLtNDWEDHLA |
| P13639 | T5 | Sugiyama | EEF2 EF2 | ________________MVNFtVDQIRAIMDKKANIRNMsVI |
| P14625 | S106 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | MKLIINSLYKNKEIFLRELIsNAsDALDKIRLISLTDENAL |
| P14625 | S109 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | IINSLYKNKEIFLRELIsNAsDALDKIRLISLTDENALSGN |
| P23434 | S160 | Sugiyama | GCSH | EDGWLIKMtLsNPsELDELMsEEAyEKYIKSIEE_______ |
| P25705 | S53 | Sugiyama | ATP5F1A ATP5A ATP5A1 ATP5AL2 ATPM | ARNFHASNTHLQKtGtAEMssILEERILGADtsVDLEETGR |
| P26038 | S576 | Sugiyama | MSN | YKtLRQIRQGNTKQRIDEFEsM___________________ |
| P26373 | S77 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | PIVRCPTVRYHTKVRAGRGFsLEELRVAGIHKKVARTIGIs |
| P30050 | S157 | Sugiyama | RPL12 | QsVGCNVDGRHPHDIIDDINsGAVECPAs____________ |
| P31943 | S63 | Sugiyama | HNRNPH1 HNRPH HNRPH1 | IRFIYTREGRPsGEAFVELEsEDEVKLALKKDRETMGHRyV |
| P37840 | S129 | SIGNOR|EPSD|PSP | SNCA NACP PARK1 | QEGILEDMPVDPDNEAyEMPsEEGyQDyEPEA_________ |
| P40855 | S147 | Sugiyama | PEX19 HK33 PXF OK/SW-cl.22 | SCLKETLSGLAKNATDLQNssMsEEELTKAMEGLGMDEGDG |
| P52597 | S63 | Sugiyama | HNRNPF HNRPF | VHFIYTREGRQsGEAFVELGsEDDVKMALKKDRESMGHRyI |
| P53350 | S137 | EPSD|PSP | PLK1 PLK | HGFFEDNDFVFVVLELCRRRsLLELHKRRKALTEPEARYYL |
| P55060 | S366 | Sugiyama | CSE1L CAS XPO2 | KVIVPNMEFRAADEEAFEDNsEEyIRRDLEGsDIDTRRRAA |
| P57053 | S39 | Sugiyama | H2BC12L H2BFS H2BS1 | VTKAQKKDGRKRKRSRKEsysVyVyKVLKQVHPDTGIssKA |
| P58876 | S39 | Sugiyama | H2BC5 H2BFB HIRIP2 HIST1H2BD | VTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKA |
| P62258 | T208 | EPSD|PSP|Sugiyama | YWHAE | PDRACRLAKAAFDDAIAELDtLsEEsyKDstLIMQLLRDNL |
| P62807 | S39 | Sugiyama | H2BC4 H2BFL HIST1H2BC; H2BC6 H2BFH HIST1H2BE; H2BC7 H2BFG HIST1H2BF; H2BC8 H2BFA HIST1H2BG; H2BC10 H2BFK HIST1H2BI | VTKAQKKDGKKRKRsRKEsysVyVyKVLKQVHPDTGIssKA |
| P67936 | T241 | Sugiyama | TPM4 | EEKLAQAKEENVGLHQtLDQtLNELNCI_____________ |
| P68363 | S439 | Sugiyama | TUBA1B | SEAREDMAALEKDyEEVGVDsVEGEGEEEGEEy________ |
| P68363 | T73 | Sugiyama | TUBA1B | FsEtGAGKHVPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLI |
| P68363 | T80 | Sugiyama | TUBA1B | KHVPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAA |
| P68363 | Y432 | Sugiyama | TUBA1B | GMEEGEFSEAREDMAALEKDyEEVGVDsVEGEGEEEGEEy_ |
| P68363 | Y83 | Sugiyama | TUBA1B | PRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAANNy |
| P84098 | T29 | Sugiyama | RPL19 | RLAssVLRCGKKKVWLDPNEtNEIANANsRQQIRKLIKDGL |
| Q01105 | S133 | Sugiyama | SET | DEEALHYLTRVEVtEFEDIKsGyRIDFyFDENPyFENKVLS |
| Q07021 | S210 | Sugiyama | C1QBP GC1QBP HABP1 SF2P32 | EDEVGQEDEAEsDIFsIREVsFQstGESEWKDTNYTLNTDS |
| Q13435 | S289 | Sugiyama | SF3B2 SAP145 | IPQALEKILQLKESRQEEMNsQQEEEEMETDARssLGQsAs |
| Q14568 | S50 | Sugiyama | HSP90AA2P HSP90AA2 HSPC2 HSPCAL3 | MSLIINTFYSNKEIFLRELIsNssDALDKIWYESLTDPSKL |
| Q14978 | S637 | Sugiyama | NOLC1 KIAA0035 NS5ATP13 | GEKRAssPFRRVREEEIEVDsRVADNsFDAKRGAAGDWGER |
| Q14978 | S643 | Sugiyama | NOLC1 KIAA0035 NS5ATP13 | sPFRRVREEEIEVDsRVADNsFDAKRGAAGDWGERANQVLK |
| Q14C86 | S740 | Sugiyama | GAPVD1 GAPEX5 KIAA1521 RAP6 | LPSDSEAPDLKQEERLQELEsCsGLGstSDDTDVREVSSRP |
| Q15056 | T100 | Sugiyama | EIF4H KIAA0038 WBSCR1 WSCR1 | KFKGFCyVEFDEVDsLKEALtyDGALLGDRsLRVDIAEGRK |
| Q15084 | S169 | Sugiyama | PDIA6 ERP5 P5 TXNDC7 | GKQGRSDsSSKKDVIELtDDsFDKNVLDSEDVWMVEFYAPW |
| Q15185 | S113 | Sugiyama | PTGES3 P23 TEBP | RAKLNWLsVDFNNWKDWEDDsDEDMsNFDRFSEMMNNMGGD |
| Q15293 | S80 | Sugiyama | RCN1 RCN | HEAFLGKEDsKtFDQLtPDEsKERLGKIVDRIDNDGDGFVt |
| Q15293 | T211 | Sugiyama | RCN1 RCN | FTAFLHPEEFEHMKEIVVLEtLEDIDKNGDGFVDQDEyIAD |
| Q16143 | S118 | SIGNOR|EPSD|PSP | SNCB | VAQEAAEEPLIEPLMEPEGEsYEDPPQEEyQEYEPEA____ |
| Q5H9R7 | S579 | Sugiyama | PPP6R3 C11orf23 KIAA1558 PP6R3 SAPL SAPS3 | IDQFGFNDEKFADQDDIGNVsFDRVSDINFTLNTNESGNIA |
| Q5QNW6 | S39 | Sugiyama | H2BC18 HIST2H2BF | VTKVQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKA |
| Q71U36 | S439 | Sugiyama | TUBA1A TUBA3 | SEAREDMAALEKDyEEVGVDsVEGEGEEEGEEy________ |
| Q71U36 | T73 | Sugiyama | TUBA1A TUBA3 | FsEtGAGKHVPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLI |
| Q71U36 | T80 | Sugiyama | TUBA1A TUBA3 | KHVPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAA |
| Q71U36 | Y432 | Sugiyama | TUBA1A TUBA3 | GMEEGEFSEAREDMAALEKDyEEVGVDsVEGEGEEEGEEy_ |
| Q71U36 | Y83 | Sugiyama | TUBA1A TUBA3 | PRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAANNy |
| Q86V81 | S239 | Sugiyama | ALYREF ALY BEF THOC4 | tRGGARGRGRGAGRNSKQQLsAEELDAQLDAyNARMDts__ |
| Q8TAM6 | S280 | Sugiyama | ERMN KIAA1189 | TISYRKIRKGNTKQRIDEFEsMMHL________________ |
| Q93079 | S39 | Sugiyama | H2BC9 H2BFJ HIST1H2BH | VTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKA |
| Q969H0 | S176 | SIGNOR|EPSD|PSP | FBXW7 FBW7 FBX30 SEL10 | QLSSPFYTKTTKMKRKLDHGsEVRSFSLGKKPCKVSEYTST |
| Q969H0 | S25 | EPSD|PSP | FBXW7 FBW7 FBX30 SEL10 | LLSVGsKRRRTGGsLRGNPSssQVDEEQMNRVVEEEQQQQL |
| Q969H0 | S349 | EPSD|PSP | FBXW7 FBW7 FBX30 SEL10 | GIDEPLHIKRRKVIKPGFIHsPWKSAYIRQHRIDTNWRRGE |
| Q96A49 | S313 | Sugiyama | SYAP1 PRO3113 | EMEQLVLDKKQEEtAVLEEDsADWEKELQQELQEyEVVtES |
| Q99877 | S39 | Sugiyama | H2BC15 H2BFD HIST1H2BN | VTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKA |
| Q99879 | S39 | Sugiyama | H2BC14 H2BFE HIST1H2BM | INKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKA |
| Q99880 | S39 | Sugiyama | H2BC13 H2BFC HIST1H2BL | VTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKA |
| Q9BQE3 | S439 | Sugiyama | TUBA1C TUBA6 | SEAREDMAALEKDyEEVGADsADGEDEGEEy__________ |
| Q9BQE3 | T73 | Sugiyama | TUBA1C TUBA6 | FsEtGAGKHVPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLI |
| Q9BQE3 | T80 | Sugiyama | TUBA1C TUBA6 | KHVPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAA |
| Q9BQE3 | Y83 | Sugiyama | TUBA1C TUBA6 | PRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAANNy |
| Q9H1E3 | S132 | Sugiyama | NUCKS1 NUCKS JC7 | GsEEEQEEEDEAPFQEKDsGsDEDFLMEDDDDsDyGSsKKK |
| Q9HC77 | S589 | GPS6|SIGNOR|EPSD|PSP | CPAP CENPJ LAP LIP1 | EKENLELDEFLFLEQAADEIsFSSNSsFVLKILERDQQICK |
| Q9HC77 | S595 | GPS6|SIGNOR|EPSD|PSP | CPAP CENPJ LAP LIP1 | LDEFLFLEQAADEIsFSSNSsFVLKILERDQQICKGHRMSS |
| Q9NYY3 | S248 | Sugiyama | PLK2 SNK | ARLEPLEHRRRtICGtPNyLsPEVLNKQGHGCESDIWALGC |
| Q9NYY3 | T103 | Sugiyama | PLK2 SNK | CRGKVLGKGGFAKCYEMTDLtNNKVYAAKIIPHSRVAKPHQ |
| Q9NYY3 | T239 | Sugiyama | PLK2 SNK | LKVGDFGLAARLEPLEHRRRtICGtPNyLsPEVLNKQGHGC |
| Q9NYY3 | T243 | Sugiyama | PLK2 SNK | DFGLAARLEPLEHRRRtICGtPNyLsPEVLNKQGHGCESDI |
| Q9NYY3 | T424 | Sugiyama | PLK2 SNK | KTSITQQPSKHRTDEELQPPtTTVARSGtPAVENKQQIGDA |
| Q9NYY3 | T432 | Sugiyama | PLK2 SNK | SKHRTDEELQPPtTTVARSGtPAVENKQQIGDAIRMIVRGT |
| Q9NYY3 | Y246 | Sugiyama | PLK2 SNK | LAARLEPLEHRRRtICGtPNyLsPEVLNKQGHGCESDIWAL |
Site Promiscuity
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Cell Cycle | R-HSA-1640170 | 2.220446e-16 | 15.654 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 1.587619e-14 | 13.799 | 0 | 0 |
| M Phase | R-HSA-68886 | 3.175238e-13 | 12.498 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 7.981971e-11 | 10.098 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 1.330227e-10 | 9.876 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 1.279234e-09 | 8.893 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 2.194980e-09 | 8.659 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 2.770573e-09 | 8.557 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 1.768596e-08 | 7.752 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 3.466925e-08 | 7.460 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 3.930873e-08 | 7.406 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 3.687223e-08 | 7.433 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 4.203761e-08 | 7.376 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 6.342488e-08 | 7.198 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 7.396351e-08 | 7.131 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 6.939725e-08 | 7.159 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 6.369309e-08 | 7.196 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 6.939725e-08 | 7.159 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 5.845346e-08 | 7.233 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 8.528254e-08 | 7.069 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 8.573118e-08 | 7.067 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 1.152560e-07 | 6.938 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 1.111770e-07 | 6.954 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 1.288769e-07 | 6.890 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 1.554463e-07 | 6.808 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 1.519612e-07 | 6.818 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 1.508392e-07 | 6.821 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 1.902389e-07 | 6.721 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 3.363918e-07 | 6.473 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 4.104394e-07 | 6.387 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 4.861693e-07 | 6.313 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 6.013015e-07 | 6.221 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 6.013015e-07 | 6.221 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 5.923486e-07 | 6.227 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 6.072460e-07 | 6.217 | 0 | 0 |
| Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | R-HSA-190840 | 6.994368e-07 | 6.155 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 7.742449e-07 | 6.111 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 8.904593e-07 | 6.050 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 1.090575e-06 | 5.962 | 0 | 0 |
| Transport of connexons to the plasma membrane | R-HSA-190872 | 1.200920e-06 | 5.920 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 1.283309e-06 | 5.892 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 1.323070e-06 | 5.878 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 1.718110e-06 | 5.765 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 2.039170e-06 | 5.691 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 2.289893e-06 | 5.640 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 2.740715e-06 | 5.562 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 2.956475e-06 | 5.529 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 2.929103e-06 | 5.533 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 3.174853e-06 | 5.498 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 3.298124e-06 | 5.482 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 3.545962e-06 | 5.450 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 3.497809e-06 | 5.456 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 3.607409e-06 | 5.443 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 3.834293e-06 | 5.416 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 4.361944e-06 | 5.360 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 6.596095e-06 | 5.181 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 7.711876e-06 | 5.113 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 9.060190e-06 | 5.043 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 9.224312e-06 | 5.035 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 1.023308e-05 | 4.990 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 1.146244e-05 | 4.941 | 0 | 0 |
| Post-chaperonin tubulin folding pathway | R-HSA-389977 | 1.457726e-05 | 4.836 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 1.680250e-05 | 4.775 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 1.843569e-05 | 4.734 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 1.939938e-05 | 4.712 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 2.142199e-05 | 4.669 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 2.162043e-05 | 4.665 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 2.282110e-05 | 4.642 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 2.394283e-05 | 4.621 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 2.394283e-05 | 4.621 | 0 | 0 |
| Downregulation of ERBB4 signaling | R-HSA-1253288 | 2.870795e-05 | 4.542 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 2.947412e-05 | 4.531 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 2.947412e-05 | 4.531 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 3.141666e-05 | 4.503 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 3.313928e-05 | 4.480 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 3.515134e-05 | 4.454 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 4.056601e-05 | 4.392 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 4.056601e-05 | 4.392 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 4.408272e-05 | 4.356 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 4.484230e-05 | 4.348 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 5.036065e-05 | 4.298 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 5.126743e-05 | 4.290 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 5.446465e-05 | 4.264 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 5.827039e-05 | 4.235 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 5.970004e-05 | 4.224 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 6.111091e-05 | 4.214 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 7.524273e-05 | 4.124 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 7.635522e-05 | 4.117 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 8.014981e-05 | 4.096 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 8.967208e-05 | 4.047 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 8.967208e-05 | 4.047 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 9.074331e-05 | 4.042 | 0 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 1.001923e-04 | 3.999 | 0 | 0 |
| Josephin domain DUBs | R-HSA-5689877 | 1.013610e-04 | 3.994 | 0 | 0 |
| Kinesins | R-HSA-983189 | 1.074700e-04 | 3.969 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 1.098155e-04 | 3.959 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 1.186308e-04 | 3.926 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 1.271935e-04 | 3.896 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 1.333231e-04 | 3.875 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 1.333714e-04 | 3.875 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 1.496668e-04 | 3.825 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 1.512114e-04 | 3.820 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 1.646529e-04 | 3.783 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 1.621778e-04 | 3.790 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 1.728675e-04 | 3.762 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 1.750040e-04 | 3.757 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 1.833882e-04 | 3.737 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 2.104283e-04 | 3.677 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 2.206559e-04 | 3.656 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 2.286043e-04 | 3.641 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 2.342826e-04 | 3.630 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 2.460566e-04 | 3.609 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 2.589615e-04 | 3.587 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 2.634458e-04 | 3.579 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 3.099416e-04 | 3.509 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 3.144302e-04 | 3.502 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 3.224028e-04 | 3.492 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 3.237117e-04 | 3.490 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 3.736027e-04 | 3.428 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 3.742225e-04 | 3.427 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 3.733185e-04 | 3.428 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 3.780812e-04 | 3.422 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 3.974393e-04 | 3.401 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 4.379187e-04 | 3.359 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 4.444144e-04 | 3.352 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 4.444144e-04 | 3.352 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 4.589452e-04 | 3.338 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 4.749812e-04 | 3.323 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 4.749812e-04 | 3.323 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 5.248366e-04 | 3.280 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 5.208111e-04 | 3.283 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 5.321227e-04 | 3.274 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 5.495050e-04 | 3.260 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 5.495050e-04 | 3.260 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 5.512446e-04 | 3.259 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 5.735774e-04 | 3.241 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 5.930467e-04 | 3.227 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 6.098820e-04 | 3.215 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 6.098820e-04 | 3.215 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 6.342780e-04 | 3.198 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 6.696173e-04 | 3.174 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 6.342780e-04 | 3.198 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 7.002287e-04 | 3.155 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 7.144844e-04 | 3.146 | 0 | 0 |
| Gap junction assembly | R-HSA-190861 | 7.334486e-04 | 3.135 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 8.199307e-04 | 3.086 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 8.271821e-04 | 3.082 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 8.364165e-04 | 3.078 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 8.364165e-04 | 3.078 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 8.624058e-04 | 3.064 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 8.414899e-04 | 3.075 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 9.216997e-04 | 3.035 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 9.002998e-04 | 3.046 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 9.515575e-04 | 3.022 | 0 | 0 |
| Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation | R-HSA-9828211 | 9.525438e-04 | 3.021 | 0 | 0 |
| PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | R-HSA-8849469 | 9.525438e-04 | 3.021 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 9.625055e-04 | 3.017 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 1.047819e-03 | 2.980 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 1.134006e-03 | 2.945 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 1.134006e-03 | 2.945 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 1.140426e-03 | 2.943 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 1.145923e-03 | 2.941 | 0 | 0 |
| S Phase | R-HSA-69242 | 1.156891e-03 | 2.937 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 1.214212e-03 | 2.916 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 1.250147e-03 | 2.903 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 1.308787e-03 | 2.883 | 0 | 0 |
| TICAM1, RIP1-mediated IKK complex recruitment | R-HSA-168927 | 1.499392e-03 | 2.824 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 1.404821e-03 | 2.852 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 1.512622e-03 | 2.820 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 1.499392e-03 | 2.824 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 1.459460e-03 | 2.836 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 1.523940e-03 | 2.817 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 1.556719e-03 | 2.808 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 1.556719e-03 | 2.808 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 1.576449e-03 | 2.802 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 1.576449e-03 | 2.802 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 1.576449e-03 | 2.802 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 1.576449e-03 | 2.802 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 1.615404e-03 | 2.792 | 1 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 1.751575e-03 | 2.757 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 1.812811e-03 | 2.742 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 1.940456e-03 | 2.712 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 2.048835e-03 | 2.688 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 2.048835e-03 | 2.688 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 2.098225e-03 | 2.678 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 2.098225e-03 | 2.678 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 2.132163e-03 | 2.671 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 2.141844e-03 | 2.669 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 2.440499e-03 | 2.613 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 2.440499e-03 | 2.613 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 2.440499e-03 | 2.613 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 2.440499e-03 | 2.613 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 2.440499e-03 | 2.613 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 2.440499e-03 | 2.613 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 2.440499e-03 | 2.613 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 2.440499e-03 | 2.613 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 2.440499e-03 | 2.613 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 2.440499e-03 | 2.613 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 2.440499e-03 | 2.613 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 2.214644e-03 | 2.655 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 2.384579e-03 | 2.623 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 2.492020e-03 | 2.603 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 2.492020e-03 | 2.603 | 0 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 2.492020e-03 | 2.603 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 2.513105e-03 | 2.600 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 2.548338e-03 | 2.594 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 2.694482e-03 | 2.570 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 2.701595e-03 | 2.568 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 2.795352e-03 | 2.554 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 2.852135e-03 | 2.545 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 2.852135e-03 | 2.545 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 2.881862e-03 | 2.540 | 1 | 0 |
| FLT3 signaling by CBL mutants | R-HSA-9706377 | 3.077196e-03 | 2.512 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 3.088559e-03 | 2.510 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 3.273702e-03 | 2.485 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 3.430707e-03 | 2.465 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 3.281472e-03 | 2.484 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 3.077109e-03 | 2.512 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 3.335084e-03 | 2.477 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 3.184281e-03 | 2.497 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 3.273702e-03 | 2.485 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 3.395350e-03 | 2.469 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 3.471226e-03 | 2.460 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 3.509802e-03 | 2.455 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 3.632988e-03 | 2.440 | 0 | 0 |
| ChREBP activates metabolic gene expression | R-HSA-163765 | 3.632988e-03 | 2.440 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 3.738352e-03 | 2.427 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 3.743809e-03 | 2.427 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 3.922216e-03 | 2.406 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 3.922216e-03 | 2.406 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 3.925410e-03 | 2.406 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 3.967159e-03 | 2.402 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 4.044805e-03 | 2.393 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 4.044805e-03 | 2.393 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 4.448247e-03 | 2.352 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence | R-HSA-9825895 | 4.566838e-03 | 2.340 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 4.770832e-03 | 2.321 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 4.805272e-03 | 2.318 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 4.843000e-03 | 2.315 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 4.843000e-03 | 2.315 | 0 | 0 |
| Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7 | R-HSA-9824878 | 5.244112e-03 | 2.280 | 0 | 0 |
| TICAM1-dependent activation of IRF3/IRF7 | R-HSA-9013973 | 5.244112e-03 | 2.280 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 5.244112e-03 | 2.280 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 5.244112e-03 | 2.280 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 5.379047e-03 | 2.269 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 5.379047e-03 | 2.269 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 5.379047e-03 | 2.269 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 5.419868e-03 | 2.266 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 5.540199e-03 | 2.256 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 5.543917e-03 | 2.256 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 5.627807e-03 | 2.250 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 6.138298e-03 | 2.212 | 0 | 0 |
| Regulation of NF-kappa B signaling | R-HSA-9758274 | 7.211108e-03 | 2.142 | 0 | 0 |
| IKK complex recruitment mediated by RIP1 | R-HSA-937041 | 6.768773e-03 | 2.169 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 6.638722e-03 | 2.178 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 7.074942e-03 | 2.150 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 7.119739e-03 | 2.148 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 7.211108e-03 | 2.142 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 7.339568e-03 | 2.134 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 7.339568e-03 | 2.134 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 7.372769e-03 | 2.132 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 7.660412e-03 | 2.116 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 8.661664e-03 | 2.062 | 0 | 0 |
| Small interfering RNA (siRNA) biogenesis | R-HSA-426486 | 8.661664e-03 | 2.062 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 8.763362e-03 | 2.057 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 8.920483e-03 | 2.050 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 8.920483e-03 | 2.050 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 8.987410e-03 | 2.046 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 9.142925e-03 | 2.039 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 9.144158e-03 | 2.039 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 9.451621e-03 | 2.024 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 9.478032e-03 | 2.023 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 9.499662e-03 | 2.022 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 9.615281e-03 | 2.017 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 9.703158e-03 | 2.013 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 9.917803e-03 | 2.004 | 0 | 0 |
| MECP2 regulates transcription of neuronal ligands | R-HSA-9022702 | 9.917803e-03 | 2.004 | 0 | 0 |
| TICAM1,TRAF6-dependent induction of TAK1 complex | R-HSA-9014325 | 9.917803e-03 | 2.004 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 9.917803e-03 | 2.004 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 1.035247e-02 | 1.985 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 1.035247e-02 | 1.985 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 1.071011e-02 | 1.970 | 0 | 0 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 1.064827e-02 | 1.973 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 1.039593e-02 | 1.983 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 1.039593e-02 | 1.983 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 1.197340e-02 | 1.922 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 1.195572e-02 | 1.922 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 1.195572e-02 | 1.922 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 1.110424e-02 | 1.955 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 1.234181e-02 | 1.909 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 1.195572e-02 | 1.922 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 1.035247e-02 | 1.985 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 1.234181e-02 | 1.909 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 1.107739e-02 | 1.956 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 1.107739e-02 | 1.956 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 1.276492e-02 | 1.894 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 1.276492e-02 | 1.894 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 1.276492e-02 | 1.894 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 1.277946e-02 | 1.893 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 1.277946e-02 | 1.893 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 1.289454e-02 | 1.890 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 1.317533e-02 | 1.880 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 1.317533e-02 | 1.880 | 0 | 0 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 1.329659e-02 | 1.876 | 0 | 0 |
| Regulation of CDH1 mRNA translation by microRNAs | R-HSA-9764562 | 1.329659e-02 | 1.876 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 1.370791e-02 | 1.863 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 1.370791e-02 | 1.863 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 1.370791e-02 | 1.863 | 0 | 0 |
| Alpha-protein kinase 1 signaling pathway | R-HSA-9645460 | 1.382016e-02 | 1.859 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 1.389718e-02 | 1.857 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 1.413967e-02 | 1.850 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 1.423842e-02 | 1.847 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 1.458183e-02 | 1.836 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 1.466369e-02 | 1.834 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 1.510843e-02 | 1.821 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 1.521564e-02 | 1.818 | 0 | 0 |
| Post-transcriptional silencing by small RNAs | R-HSA-426496 | 1.662245e-02 | 1.779 | 0 | 0 |
| Regulation of NPAS4 mRNA translation | R-HSA-9768778 | 1.896080e-02 | 1.722 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 1.554348e-02 | 1.808 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 1.776416e-02 | 1.750 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 1.776416e-02 | 1.750 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 1.909324e-02 | 1.719 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 1.554348e-02 | 1.808 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 1.743754e-02 | 1.759 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 1.554348e-02 | 1.808 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 1.726563e-02 | 1.763 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 1.595618e-02 | 1.797 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 1.909324e-02 | 1.719 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 1.697365e-02 | 1.770 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 1.698385e-02 | 1.770 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 1.680196e-02 | 1.775 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 1.849046e-02 | 1.733 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 1.873701e-02 | 1.727 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 1.849046e-02 | 1.733 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 1.849046e-02 | 1.733 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 1.731086e-02 | 1.762 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 1.743754e-02 | 1.759 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 1.601554e-02 | 1.795 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 1.785055e-02 | 1.748 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 1.604384e-02 | 1.795 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 1.761576e-02 | 1.754 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 1.945273e-02 | 1.711 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 2.005175e-02 | 1.698 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 2.020006e-02 | 1.695 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 2.030936e-02 | 1.692 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 2.061612e-02 | 1.686 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 2.068260e-02 | 1.684 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 2.068964e-02 | 1.684 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 2.068964e-02 | 1.684 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 2.075544e-02 | 1.683 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 2.075544e-02 | 1.683 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 2.075544e-02 | 1.683 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 2.108779e-02 | 1.676 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 2.108779e-02 | 1.676 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 2.129833e-02 | 1.672 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 2.187086e-02 | 1.660 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 2.226495e-02 | 1.652 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 2.232406e-02 | 1.651 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 2.327790e-02 | 1.633 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 2.327790e-02 | 1.633 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 2.398301e-02 | 1.620 | 0 | 0 |
| Depurination | R-HSA-73927 | 2.410510e-02 | 1.618 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 2.452153e-02 | 1.610 | 0 | 0 |
| VLDLR internalisation and degradation | R-HSA-8866427 | 2.460056e-02 | 1.609 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 2.460056e-02 | 1.609 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 2.487980e-02 | 1.604 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 2.487980e-02 | 1.604 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 2.504031e-02 | 1.601 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 2.504031e-02 | 1.601 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 2.533036e-02 | 1.596 | 0 | 0 |
| Loss of MECP2 binding ability to the NCoR/SMRT complex | R-HSA-9022537 | 2.551810e-02 | 1.593 | 0 | 0 |
| RUNX1 regulates expression of components of tight junctions | R-HSA-8935964 | 2.551810e-02 | 1.593 | 0 | 0 |
| Maturation of protein E | R-HSA-9694493 | 2.551810e-02 | 1.593 | 0 | 0 |
| Maturation of protein E | R-HSA-9683683 | 2.551810e-02 | 1.593 | 0 | 0 |
| Inactivation of CDC42 and RAC1 | R-HSA-428543 | 2.626368e-02 | 1.581 | 0 | 0 |
| AKT phosphorylates targets in the nucleus | R-HSA-198693 | 2.626368e-02 | 1.581 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex | R-HSA-937042 | 2.626368e-02 | 1.581 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 2.626368e-02 | 1.581 | 0 | 0 |
| Unwinding of DNA | R-HSA-176974 | 2.626368e-02 | 1.581 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 2.669026e-02 | 1.574 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 2.689042e-02 | 1.570 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 2.729968e-02 | 1.564 | 0 | 0 |
| Formation of editosomes by ADAR proteins | R-HSA-77042 | 3.140233e-02 | 1.503 | 0 | 0 |
| Loss of MECP2 binding ability to 5hmC-DNA | R-HSA-9022534 | 3.140233e-02 | 1.503 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by DVL-interacting proteins | R-HSA-5368598 | 3.242410e-02 | 1.489 | 0 | 0 |
| Loss of MECP2 binding ability to 5mC-DNA | R-HSA-9022538 | 3.242410e-02 | 1.489 | 0 | 0 |
| CREB phosphorylation | R-HSA-199920 | 3.680459e-02 | 1.434 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 2.776086e-02 | 1.557 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 2.949412e-02 | 1.530 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 3.448125e-02 | 1.462 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 3.448125e-02 | 1.462 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 3.448125e-02 | 1.462 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 3.334482e-02 | 1.477 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 2.888196e-02 | 1.539 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 3.652083e-02 | 1.437 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 3.196720e-02 | 1.495 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 2.776086e-02 | 1.557 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 2.783529e-02 | 1.555 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 2.888196e-02 | 1.539 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 3.515042e-02 | 1.454 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 3.433218e-02 | 1.464 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 2.924630e-02 | 1.534 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 3.594432e-02 | 1.444 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 2.880668e-02 | 1.541 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 2.774531e-02 | 1.557 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 2.907645e-02 | 1.536 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 3.196720e-02 | 1.495 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 3.194630e-02 | 1.496 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 3.175625e-02 | 1.498 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 3.652083e-02 | 1.437 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 3.348720e-02 | 1.475 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 3.196720e-02 | 1.495 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 3.225583e-02 | 1.491 | 0 | 0 |
| Pexophagy | R-HSA-9664873 | 3.515042e-02 | 1.454 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 3.810664e-02 | 1.419 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 3.833701e-02 | 1.416 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 3.836635e-02 | 1.416 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 3.911596e-02 | 1.408 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 3.911596e-02 | 1.408 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 3.942039e-02 | 1.404 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 3.942039e-02 | 1.404 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 3.982842e-02 | 1.400 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | R-HSA-975163 | 3.990547e-02 | 1.399 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 3.990547e-02 | 1.399 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 3.990547e-02 | 1.399 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 3.993001e-02 | 1.399 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 4.002795e-02 | 1.398 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 4.151480e-02 | 1.382 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 4.208248e-02 | 1.376 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 4.208248e-02 | 1.376 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 4.208248e-02 | 1.376 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 4.208248e-02 | 1.376 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 4.241437e-02 | 1.372 | 1 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 4.344768e-02 | 1.362 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 4.389204e-02 | 1.358 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 4.389204e-02 | 1.358 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 4.404308e-02 | 1.356 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 4.524885e-02 | 1.344 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 4.569107e-02 | 1.340 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 4.569107e-02 | 1.340 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 4.601826e-02 | 1.337 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 4.605197e-02 | 1.337 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 4.605197e-02 | 1.337 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 4.605197e-02 | 1.337 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 4.615117e-02 | 1.336 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 4.615761e-02 | 1.336 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 4.651156e-02 | 1.332 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 4.696608e-02 | 1.328 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 4.696608e-02 | 1.328 | 0 | 0 |
| Protein folding | R-HSA-391251 | 4.714564e-02 | 1.327 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 4.875381e-02 | 1.312 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 4.940533e-02 | 1.306 | 0 | 0 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | R-HSA-937072 | 4.940533e-02 | 1.306 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 4.940533e-02 | 1.306 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 4.940533e-02 | 1.306 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 4.940533e-02 | 1.306 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 4.994043e-02 | 1.302 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 4.994043e-02 | 1.302 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 4.995450e-02 | 1.301 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 4.995450e-02 | 1.301 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 5.032549e-02 | 1.298 | 0 | 0 |
| Translesion Synthesis by POLH | R-HSA-110320 | 5.032549e-02 | 1.298 | 0 | 0 |
| MECP2 regulates transcription factors | R-HSA-9022707 | 5.054044e-02 | 1.296 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 5.054044e-02 | 1.296 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 5.054044e-02 | 1.296 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 5.054044e-02 | 1.296 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 5.054044e-02 | 1.296 | 0 | 0 |
| p75NTR negatively regulates cell cycle via SC1 | R-HSA-193670 | 5.076519e-02 | 1.294 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 5.076519e-02 | 1.294 | 0 | 0 |
| NFE2L2 regulating ER-stress associated genes | R-HSA-9818035 | 5.076519e-02 | 1.294 | 0 | 0 |
| Inhibition of TSC complex formation by PKB | R-HSA-165181 | 5.076519e-02 | 1.294 | 0 | 0 |
| NADE modulates death signalling | R-HSA-205025 | 5.076519e-02 | 1.294 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 5.238350e-02 | 1.281 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 5.238813e-02 | 1.281 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 5.288986e-02 | 1.277 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 5.288986e-02 | 1.277 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 5.289045e-02 | 1.277 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 5.359036e-02 | 1.271 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 5.409640e-02 | 1.267 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 5.453594e-02 | 1.263 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 5.453594e-02 | 1.263 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 7.184607e-02 | 1.144 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 7.184607e-02 | 1.144 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 7.184607e-02 | 1.144 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 7.184607e-02 | 1.144 | 0 | 0 |
| Regulation of BACH1 activity | R-HSA-9708530 | 6.018264e-02 | 1.221 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 6.018264e-02 | 1.221 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 5.984211e-02 | 1.223 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 5.984211e-02 | 1.223 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 5.984211e-02 | 1.223 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 5.984211e-02 | 1.223 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 7.039145e-02 | 1.152 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 8.197811e-02 | 1.086 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 5.569022e-02 | 1.254 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 5.569022e-02 | 1.254 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 6.393503e-02 | 1.194 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 6.393503e-02 | 1.194 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 6.024325e-02 | 1.220 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 6.366681e-02 | 1.196 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 5.688364e-02 | 1.245 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 7.361750e-02 | 1.133 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 7.361750e-02 | 1.133 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 7.361750e-02 | 1.133 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 7.361750e-02 | 1.133 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 6.290054e-02 | 1.201 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 6.290054e-02 | 1.201 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 8.154139e-02 | 1.089 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 7.517137e-02 | 1.124 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 7.691382e-02 | 1.114 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 7.052297e-02 | 1.152 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 7.291381e-02 | 1.137 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 7.480401e-02 | 1.126 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 7.697154e-02 | 1.114 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 8.263330e-02 | 1.083 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 6.620563e-02 | 1.179 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 5.984211e-02 | 1.223 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 6.024325e-02 | 1.220 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 8.077018e-02 | 1.093 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 6.138642e-02 | 1.212 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 6.366681e-02 | 1.196 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 6.138642e-02 | 1.212 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 5.792228e-02 | 1.237 | 0 | 0 |
| Nectin/Necl trans heterodimerization | R-HSA-420597 | 7.309815e-02 | 1.136 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in BCR signaling | R-HSA-8939245 | 7.309815e-02 | 1.136 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 7.517137e-02 | 1.124 | 0 | 0 |
| Repression of WNT target genes | R-HSA-4641265 | 7.184607e-02 | 1.144 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 7.695035e-02 | 1.114 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 6.465720e-02 | 1.189 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 7.016711e-02 | 1.154 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 7.925957e-02 | 1.101 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 5.964487e-02 | 1.224 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 5.905243e-02 | 1.229 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 7.758321e-02 | 1.110 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 6.620563e-02 | 1.179 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperone genes | R-HSA-381183 | 5.792185e-02 | 1.237 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 7.480401e-02 | 1.126 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 6.018264e-02 | 1.221 | 0 | 0 |
| Inactivation of CSF3 (G-CSF) signaling | R-HSA-9705462 | 8.197811e-02 | 1.086 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 6.620563e-02 | 1.179 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 6.620563e-02 | 1.179 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 7.758321e-02 | 1.110 | 0 | 0 |
| Myoclonic epilepsy of Lafora | R-HSA-3785653 | 6.670925e-02 | 1.176 | 0 | 0 |
| IRAK1 recruits IKK complex | R-HSA-937039 | 7.184607e-02 | 1.144 | 0 | 0 |
| IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation | R-HSA-975144 | 7.184607e-02 | 1.144 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 5.812844e-02 | 1.236 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 7.291381e-02 | 1.137 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 7.136869e-02 | 1.146 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 8.276114e-02 | 1.082 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 6.397073e-02 | 1.194 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 7.934114e-02 | 1.101 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 7.674879e-02 | 1.115 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 6.660832e-02 | 1.176 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 7.697154e-02 | 1.114 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in apoptosis | R-HSA-9824594 | 7.039145e-02 | 1.152 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 6.006082e-02 | 1.221 | 0 | 0 |
| Modulation by Mtb of host immune system | R-HSA-9637628 | 6.670925e-02 | 1.176 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 8.365980e-02 | 1.077 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 8.365980e-02 | 1.077 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 8.380318e-02 | 1.077 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 8.522981e-02 | 1.069 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 8.522981e-02 | 1.069 | 0 | 0 |
| Activation of the AP-1 family of transcription factors | R-HSA-450341 | 8.522981e-02 | 1.069 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 8.559990e-02 | 1.068 | 0 | 0 |
| Regulation of NPAS4 gene expression | R-HSA-9768759 | 8.559990e-02 | 1.068 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 8.613291e-02 | 1.065 | 0 | 0 |
| Membrane binding and targetting of GAG proteins | R-HSA-174490 | 8.743624e-02 | 1.058 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperones | R-HSA-381033 | 8.743624e-02 | 1.058 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 8.743624e-02 | 1.058 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 8.860821e-02 | 1.053 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 8.860821e-02 | 1.053 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 9.071218e-02 | 1.042 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 9.081881e-02 | 1.042 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 9.081881e-02 | 1.042 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 9.101680e-02 | 1.041 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 9.114968e-02 | 1.040 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 9.114968e-02 | 1.040 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 9.114968e-02 | 1.040 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 9.114968e-02 | 1.040 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 9.114968e-02 | 1.040 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 9.309485e-02 | 1.031 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 9.309485e-02 | 1.031 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 9.459573e-02 | 1.024 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 9.624166e-02 | 1.017 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 9.791005e-02 | 1.009 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 9.893875e-02 | 1.005 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 9.893875e-02 | 1.005 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 9.902268e-02 | 1.004 | 0 | 0 |
| IkBA variant leads to EDA-ID | R-HSA-5603029 | 9.902268e-02 | 1.004 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 9.902268e-02 | 1.004 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 9.902268e-02 | 1.004 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 1.002118e-01 | 0.999 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 1.004937e-01 | 0.998 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 1.009351e-01 | 0.996 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 1.046368e-01 | 0.980 | 0 | 0 |
| Synthesis And Processing Of GAG, GAGPOL Polyproteins | R-HSA-174495 | 1.046368e-01 | 0.980 | 0 | 0 |
| MAP3K8 (TPL2)-dependent MAPK1/3 activation | R-HSA-5684264 | 1.046368e-01 | 0.980 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 1.046369e-01 | 0.980 | 0 | 0 |
| mRNA Editing: A to I Conversion | R-HSA-75064 | 1.053033e-01 | 0.978 | 0 | 0 |
| Regulation of TP53 Expression | R-HSA-6804754 | 1.053033e-01 | 0.978 | 0 | 0 |
| C6 deamination of adenosine | R-HSA-75102 | 1.053033e-01 | 0.978 | 0 | 0 |
| TGFBR1 LBD Mutants in Cancer | R-HSA-3656535 | 1.053033e-01 | 0.978 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 1.059166e-01 | 0.975 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 1.059672e-01 | 0.975 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 1.059672e-01 | 0.975 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 1.059672e-01 | 0.975 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 1.066277e-01 | 0.972 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 1.066277e-01 | 0.972 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 1.066277e-01 | 0.972 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 1.078380e-01 | 0.967 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 1.084127e-01 | 0.965 | 0 | 0 |
| Endosomal Sorting Complex Required For Transport (ESCRT) | R-HSA-917729 | 1.132270e-01 | 0.946 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 1.132270e-01 | 0.946 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 1.132270e-01 | 0.946 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 1.162226e-01 | 0.935 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 1.168251e-01 | 0.932 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 1.178371e-01 | 0.929 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 1.178371e-01 | 0.929 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 1.184725e-01 | 0.926 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 1.233676e-01 | 0.909 | 0 | 0 |
| Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | R-HSA-9673767 | 1.233676e-01 | 0.909 | 0 | 0 |
| Signaling by PDGFRA extracellular domain mutants | R-HSA-9673770 | 1.233676e-01 | 0.909 | 0 | 0 |
| p38MAPK events | R-HSA-171007 | 1.233676e-01 | 0.909 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 1.233676e-01 | 0.909 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 1.233676e-01 | 0.909 | 0 | 0 |
| Translesion synthesis by REV1 | R-HSA-110312 | 1.233676e-01 | 0.909 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 1.233676e-01 | 0.909 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 1.233676e-01 | 0.909 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 1.245003e-01 | 0.905 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 1.267885e-01 | 0.897 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 1.267885e-01 | 0.897 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 1.267885e-01 | 0.897 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 1.277311e-01 | 0.894 | 0 | 0 |
| Signaling by LTK in cancer | R-HSA-9842640 | 1.280572e-01 | 0.893 | 0 | 0 |
| Nef and signal transduction | R-HSA-164944 | 1.280572e-01 | 0.893 | 0 | 0 |
| Drug resistance of PDGFR mutants | R-HSA-9674415 | 1.281899e-01 | 0.892 | 0 | 0 |
| PDGFR mutants bind TKIs | R-HSA-9674428 | 1.281899e-01 | 0.892 | 0 | 0 |
| Imatinib-resistant PDGFR mutants | R-HSA-9674396 | 1.281899e-01 | 0.892 | 0 | 0 |
| Sorafenib-resistant PDGFR mutants | R-HSA-9674404 | 1.281899e-01 | 0.892 | 0 | 0 |
| Regorafenib-resistant PDGFR mutants | R-HSA-9674403 | 1.281899e-01 | 0.892 | 0 | 0 |
| APC truncation mutants are not K63 polyubiquitinated | R-HSA-5467333 | 1.281899e-01 | 0.892 | 0 | 0 |
| Deletions in the AMER1 gene destabilize the destruction complex | R-HSA-5467343 | 1.281899e-01 | 0.892 | 0 | 0 |
| Defective translocation of RB1 mutants to the nucleus | R-HSA-9661070 | 1.281899e-01 | 0.892 | 0 | 0 |
| Loss of function of TP53 in cancer due to loss of tetramerization ability | R-HSA-9723905 | 1.281899e-01 | 0.892 | 0 | 0 |
| Sunitinib-resistant PDGFR mutants | R-HSA-9674401 | 1.281899e-01 | 0.892 | 0 | 0 |
| Loss of Function of TP53 in Cancer | R-HSA-9723907 | 1.281899e-01 | 0.892 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 1.283069e-01 | 0.892 | 0 | 0 |
| Regulation of CDH11 mRNA translation by microRNAs | R-HSA-9759811 | 1.287444e-01 | 0.890 | 0 | 0 |
| CD163 mediating an anti-inflammatory response | R-HSA-9662834 | 1.287444e-01 | 0.890 | 1 | 1 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 1.288651e-01 | 0.890 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 1.288651e-01 | 0.890 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 1.288931e-01 | 0.890 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 1.296746e-01 | 0.887 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 1.296746e-01 | 0.887 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 1.330528e-01 | 0.876 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 1.359524e-01 | 0.867 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 1.384153e-01 | 0.859 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 1.384153e-01 | 0.859 | 0 | 0 |
| MicroRNA (miRNA) biogenesis | R-HSA-203927 | 1.384153e-01 | 0.859 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 1.387395e-01 | 0.858 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 1.411521e-01 | 0.850 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 1.411521e-01 | 0.850 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 1.421257e-01 | 0.847 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 1.422022e-01 | 0.847 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 1.422022e-01 | 0.847 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 1.422022e-01 | 0.847 | 0 | 0 |
| Translesion synthesis by POLI | R-HSA-5656121 | 1.435275e-01 | 0.843 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 1.435275e-01 | 0.843 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 2.399536e-01 | 0.620 | 0 | 0 |
| Regulation of PAK-2p34 activity by PS-GAP/RHG10 | R-HSA-211728 | 2.399536e-01 | 0.620 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 2.399536e-01 | 0.620 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 2.399536e-01 | 0.620 | 0 | 0 |
| TICAM1 deficiency - HSE | R-HSA-5602566 | 2.399536e-01 | 0.620 | 0 | 0 |
| Hereditary fructose intolerance | R-HSA-5657560 | 2.399536e-01 | 0.620 | 0 | 0 |
| UNC93B1 deficiency - HSE | R-HSA-5602415 | 2.399536e-01 | 0.620 | 0 | 0 |
| Defective DNA double strand break response due to BARD1 loss of function | R-HSA-9699150 | 2.399536e-01 | 0.620 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 2.399536e-01 | 0.620 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH6 | R-HSA-5632968 | 2.399536e-01 | 0.620 | 0 | 0 |
| Defective DNA double strand break response due to BRCA1 loss of function | R-HSA-9663199 | 2.399536e-01 | 0.620 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 2.399536e-01 | 0.620 | 0 | 0 |
| TRKA activation by NGF | R-HSA-187042 | 1.509009e-01 | 0.821 | 0 | 0 |
| PLC-gamma1 signalling | R-HSA-167021 | 1.509009e-01 | 0.821 | 0 | 0 |
| Signaling by cytosolic PDGFRA and PDGFRB fusion proteins | R-HSA-9673766 | 1.509009e-01 | 0.821 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 1.509009e-01 | 0.821 | 0 | 0 |
| Regulation of gap junction activity | R-HSA-191650 | 1.995139e-01 | 0.700 | 0 | 0 |
| MECP2 regulates transcription of genes involved in GABA signaling | R-HSA-9022927 | 1.995139e-01 | 0.700 | 0 | 0 |
| TLR3-mediated TICAM1-dependent programmed cell death | R-HSA-9013957 | 1.995139e-01 | 0.700 | 0 | 0 |
| RUNX2 regulates genes involved in differentiation of myeloid cells | R-HSA-8941333 | 1.995139e-01 | 0.700 | 0 | 0 |
| AKT-mediated inactivation of FOXO1A | R-HSA-211163 | 1.995139e-01 | 0.700 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 1.596812e-01 | 0.797 | 0 | 0 |
| NrCAM interactions | R-HSA-447038 | 2.496208e-01 | 0.603 | 0 | 0 |
| RUNX2 regulates chondrocyte maturation | R-HSA-8941284 | 2.496208e-01 | 0.603 | 0 | 0 |
| IRS activation | R-HSA-74713 | 2.496208e-01 | 0.603 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 2.496208e-01 | 0.603 | 0 | 0 |
| Loss of Function of TGFBR1 in Cancer | R-HSA-3656534 | 2.496208e-01 | 0.603 | 0 | 0 |
| Loss of phosphorylation of MECP2 at T308 | R-HSA-9022535 | 2.496208e-01 | 0.603 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 1.933668e-01 | 0.714 | 0 | 0 |
| Formyl peptide receptors bind formyl peptides and many other ligands | R-HSA-444473 | 1.933668e-01 | 0.714 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 1.933668e-01 | 0.714 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 1.533525e-01 | 0.814 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 1.795613e-01 | 0.746 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 1.795613e-01 | 0.746 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 2.286000e-01 | 0.641 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 2.286000e-01 | 0.641 | 0 | 0 |
| SHC1 events in ERBB4 signaling | R-HSA-1250347 | 1.649981e-01 | 0.783 | 0 | 0 |
| Translesion synthesis by POLK | R-HSA-5655862 | 1.649981e-01 | 0.783 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 1.649981e-01 | 0.783 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 1.511644e-01 | 0.821 | 0 | 0 |
| 2-LTR circle formation | R-HSA-164843 | 2.648964e-01 | 0.577 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 2.648964e-01 | 0.577 | 0 | 0 |
| Activation of PPARGC1A (PGC-1alpha) by phosphorylation | R-HSA-2151209 | 2.648964e-01 | 0.577 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 1.876478e-01 | 0.727 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 1.703056e-01 | 0.769 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 2.113352e-01 | 0.675 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 1.903913e-01 | 0.720 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 1.903913e-01 | 0.720 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 1.903913e-01 | 0.720 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 1.722184e-01 | 0.764 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 1.722184e-01 | 0.764 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 1.722184e-01 | 0.764 | 0 | 0 |
| Competing endogenous RNAs (ceRNAs) regulate PTEN translation | R-HSA-8948700 | 2.653428e-01 | 0.576 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 2.653428e-01 | 0.576 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 2.653428e-01 | 0.576 | 0 | 0 |
| Regulation of PTEN mRNA translation | R-HSA-8943723 | 2.113290e-01 | 0.675 | 0 | 0 |
| Response of EIF2AK1 (HRI) to heme deficiency | R-HSA-9648895 | 2.113290e-01 | 0.675 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 1.903405e-01 | 0.720 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 1.903405e-01 | 0.720 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 1.551720e-01 | 0.809 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 1.708599e-01 | 0.767 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 1.887028e-01 | 0.724 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 2.330206e-01 | 0.633 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 2.612286e-01 | 0.583 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 2.019529e-01 | 0.695 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 2.236798e-01 | 0.650 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 2.694089e-01 | 0.570 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 2.351807e-01 | 0.629 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 2.351807e-01 | 0.629 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 2.206406e-01 | 0.656 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 2.554156e-01 | 0.593 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 2.554156e-01 | 0.593 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 2.019529e-01 | 0.695 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 2.158741e-01 | 0.666 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 2.694089e-01 | 0.570 | 0 | 0 |
| Caspase activation via Dependence Receptors in the absence of ligand | R-HSA-418889 | 2.286000e-01 | 0.641 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 2.019529e-01 | 0.695 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 1.931553e-01 | 0.714 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 1.718931e-01 | 0.765 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 1.649981e-01 | 0.783 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 2.351807e-01 | 0.629 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 2.439779e-01 | 0.613 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 2.795092e-01 | 0.554 | 0 | 0 |
| Caspase activation via extrinsic apoptotic signalling pathway | R-HSA-5357769 | 2.782563e-01 | 0.556 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 1.649981e-01 | 0.783 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 2.496208e-01 | 0.603 | 0 | 0 |
| Regulation of commissural axon pathfinding by SLIT and ROBO | R-HSA-428542 | 2.286000e-01 | 0.641 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 2.113352e-01 | 0.675 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 1.721498e-01 | 0.764 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 1.861196e-01 | 0.730 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 1.931553e-01 | 0.714 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 1.912297e-01 | 0.718 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 2.083387e-01 | 0.681 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 2.169532e-01 | 0.664 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 2.058966e-01 | 0.686 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 1.817399e-01 | 0.741 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 2.566893e-01 | 0.591 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 1.995139e-01 | 0.700 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 2.488002e-01 | 0.604 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 2.206406e-01 | 0.656 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 2.641689e-01 | 0.578 | 1 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 2.782563e-01 | 0.556 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 2.648964e-01 | 0.577 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 1.641104e-01 | 0.785 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 2.500193e-01 | 0.602 | 0 | 0 |
| Pyrophosphate hydrolysis | R-HSA-71737 | 2.496208e-01 | 0.603 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 1.649981e-01 | 0.783 | 0 | 0 |
| Modulation of host responses by IFN-stimulated genes | R-HSA-9909505 | 1.876478e-01 | 0.727 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 1.721498e-01 | 0.764 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 1.562100e-01 | 0.806 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 2.236798e-01 | 0.650 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 2.183206e-01 | 0.661 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 2.183206e-01 | 0.661 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 2.093522e-01 | 0.679 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 2.330206e-01 | 0.633 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 1.562100e-01 | 0.806 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 1.830022e-01 | 0.738 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 1.596812e-01 | 0.797 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 2.782563e-01 | 0.556 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 2.266305e-01 | 0.645 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 2.058966e-01 | 0.686 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 1.873633e-01 | 0.727 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 2.782563e-01 | 0.556 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 1.452804e-01 | 0.838 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 1.687917e-01 | 0.773 | 0 | 0 |
| ERK/MAPK targets | R-HSA-198753 | 2.871325e-01 | 0.542 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 2.701991e-01 | 0.568 | 0 | 0 |
| Regulation of innate immune responses to cytosolic DNA | R-HSA-3134975 | 1.649981e-01 | 0.783 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 2.359124e-01 | 0.627 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 1.757282e-01 | 0.755 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 1.829598e-01 | 0.738 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 1.829598e-01 | 0.738 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 1.703056e-01 | 0.769 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 1.721498e-01 | 0.764 | 0 | 0 |
| SDK interactions | R-HSA-373756 | 2.399536e-01 | 0.620 | 0 | 0 |
| MTF1 activates gene expression | R-HSA-5660489 | 1.995139e-01 | 0.700 | 0 | 0 |
| FLT3 signaling through SRC family kinases | R-HSA-9706374 | 1.995139e-01 | 0.700 | 0 | 0 |
| Co-stimulation by ICOS | R-HSA-9927354 | 1.933668e-01 | 0.714 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 1.795613e-01 | 0.746 | 0 | 0 |
| Cellular response to mitochondrial stress | R-HSA-9840373 | 2.286000e-01 | 0.641 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 2.648964e-01 | 0.577 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 1.703056e-01 | 0.769 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 1.903405e-01 | 0.720 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 2.091918e-01 | 0.679 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 2.058966e-01 | 0.686 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 1.976485e-01 | 0.704 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 1.976485e-01 | 0.704 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 1.602046e-01 | 0.795 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 2.607937e-01 | 0.584 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 2.800085e-01 | 0.553 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 2.871325e-01 | 0.542 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 2.445191e-01 | 0.612 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 1.723549e-01 | 0.764 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 2.286000e-01 | 0.641 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 1.721498e-01 | 0.764 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 2.236798e-01 | 0.650 | 0 | 0 |
| Uptake and function of diphtheria toxin | R-HSA-5336415 | 1.596812e-01 | 0.797 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 1.887028e-01 | 0.724 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 2.058966e-01 | 0.686 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 2.609608e-01 | 0.583 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 2.071278e-01 | 0.684 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 2.612286e-01 | 0.583 | 0 | 0 |
| Calnexin/calreticulin cycle | R-HSA-901042 | 2.058966e-01 | 0.686 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 2.003120e-01 | 0.698 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 2.160757e-01 | 0.665 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 2.113352e-01 | 0.675 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 2.488002e-01 | 0.604 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 2.185678e-01 | 0.660 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD Domain Mutants | R-HSA-2691232 | 1.795613e-01 | 0.746 | 0 | 0 |
| Signaling by NOTCH1 HD Domain Mutants in Cancer | R-HSA-2691230 | 1.795613e-01 | 0.746 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 2.871325e-01 | 0.542 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 2.505884e-01 | 0.601 | 0 | 0 |
| Assembly Of The HIV Virion | R-HSA-175474 | 1.703056e-01 | 0.769 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 2.638846e-01 | 0.579 | 0 | 0 |
| NOTCH2 Activation and Transmission of Signal to the Nucleus | R-HSA-2979096 | 2.871325e-01 | 0.542 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 2.358038e-01 | 0.627 | 0 | 0 |
| PD-L1(CD274) glycosylation and translocation to plasma membrane | R-HSA-9931295 | 2.871325e-01 | 0.542 | 0 | 0 |
| Cation-coupled Chloride cotransporters | R-HSA-426117 | 1.596812e-01 | 0.797 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 2.586099e-01 | 0.587 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 1.649981e-01 | 0.783 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 2.128269e-01 | 0.672 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 1.661824e-01 | 0.779 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 2.800085e-01 | 0.553 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 1.619499e-01 | 0.791 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 2.553644e-01 | 0.593 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 1.513639e-01 | 0.820 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 2.882638e-01 | 0.540 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 2.882638e-01 | 0.540 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 2.890316e-01 | 0.539 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 2.890316e-01 | 0.539 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 2.904515e-01 | 0.537 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 2.904515e-01 | 0.537 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 2.904515e-01 | 0.537 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 2.904515e-01 | 0.537 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 2.921292e-01 | 0.534 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 2.933158e-01 | 0.533 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 2.948442e-01 | 0.530 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 2.948442e-01 | 0.530 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 2.955043e-01 | 0.529 | 0 | 0 |
| Class I peroxisomal membrane protein import | R-HSA-9603798 | 2.955043e-01 | 0.529 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 2.955043e-01 | 0.529 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 2.955043e-01 | 0.529 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 2.969298e-01 | 0.527 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 2.969372e-01 | 0.527 | 0 | 0 |
| SLIT2:ROBO1 increases RHOA activity | R-HSA-8985586 | 3.000404e-01 | 0.523 | 0 | 0 |
| SMAC, XIAP-regulated apoptotic response | R-HSA-111469 | 3.000404e-01 | 0.523 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 3.000404e-01 | 0.523 | 0 | 0 |
| Epithelial-Mesenchymal Transition (EMT) during gastrulation | R-HSA-9758919 | 3.000404e-01 | 0.523 | 0 | 0 |
| Sodium-coupled phosphate cotransporters | R-HSA-427652 | 3.000404e-01 | 0.523 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 3.006102e-01 | 0.522 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 3.015918e-01 | 0.521 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 3.015918e-01 | 0.521 | 0 | 0 |
| ER Quality Control Compartment (ERQC) | R-HSA-901032 | 3.015918e-01 | 0.521 | 0 | 0 |
| RUNX2 regulates genes involved in cell migration | R-HSA-8941332 | 3.018106e-01 | 0.520 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 3.018106e-01 | 0.520 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 3.023733e-01 | 0.519 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 3.045727e-01 | 0.516 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 3.045727e-01 | 0.516 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 3.066342e-01 | 0.513 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 3.112766e-01 | 0.507 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 3.118502e-01 | 0.506 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 3.122063e-01 | 0.506 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 3.123823e-01 | 0.505 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 3.133218e-01 | 0.504 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 3.134748e-01 | 0.504 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 3.252614e-01 | 0.488 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 3.252668e-01 | 0.488 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 3.252668e-01 | 0.488 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 3.252668e-01 | 0.488 | 0 | 0 |
| TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling | R-HSA-975110 | 3.260591e-01 | 0.487 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 3.297944e-01 | 0.482 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 3.309864e-01 | 0.480 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 3.309864e-01 | 0.480 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 3.335272e-01 | 0.477 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 3.335272e-01 | 0.477 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 3.335272e-01 | 0.477 | 0 | 0 |
| Signaling by TCF7L2 mutants | R-HSA-5339700 | 3.373952e-01 | 0.472 | 0 | 0 |
| PTEN Loss of Function in Cancer | R-HSA-5674404 | 3.373952e-01 | 0.472 | 0 | 0 |
| Defective TPMT causes TPMT deficiency | R-HSA-5578995 | 3.373952e-01 | 0.472 | 0 | 0 |
| Defective SLC4A4 causes renal tubular acidosis, proximal, with ocular abnormalities and mental retardation (pRTA-OA) | R-HSA-5619054 | 3.373952e-01 | 0.472 | 0 | 0 |
| Defective SLC17A5 causes Salla disease (SD) and ISSD | R-HSA-5619035 | 3.373952e-01 | 0.472 | 0 | 0 |
| TRAF3 deficiency - HSE | R-HSA-5602571 | 3.373952e-01 | 0.472 | 0 | 0 |
| Defective SLC20A2 causes idiopathic basal ganglia calcification 1 (IBGC1) | R-HSA-5619111 | 3.373952e-01 | 0.472 | 0 | 0 |
| IKBKG deficiency causes anhidrotic ectodermal dysplasia with immunodeficiency (EDA-ID) (via TLR) | R-HSA-5603027 | 3.373952e-01 | 0.472 | 0 | 0 |
| IKBKB deficiency causes SCID | R-HSA-5602636 | 3.373952e-01 | 0.472 | 0 | 0 |
| Defective SLC12A6 causes agenesis of the corpus callosum, with peripheral neuropathy (ACCPN) | R-HSA-5619039 | 3.373952e-01 | 0.472 | 0 | 0 |
| Defective SLC4A1 causes hereditary spherocytosis type 4 (HSP4), distal renal tubular acidosis (dRTA) and dRTA with hemolytic anemia (dRTA-HA) | R-HSA-5619050 | 3.373952e-01 | 0.472 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH2 | R-HSA-5632928 | 3.373952e-01 | 0.472 | 0 | 0 |
| Manipulation of host energy metabolism | R-HSA-9636667 | 3.373952e-01 | 0.472 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 3.389419e-01 | 0.470 | 0 | 0 |
| PI3K events in ERBB4 signaling | R-HSA-1250342 | 3.389419e-01 | 0.470 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 3.389419e-01 | 0.470 | 0 | 0 |
| Integration of provirus | R-HSA-162592 | 3.389419e-01 | 0.470 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 3.389419e-01 | 0.470 | 0 | 0 |
| Regulation of gene expression by Hypoxia-inducible Factor | R-HSA-1234158 | 3.389419e-01 | 0.470 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 3.395618e-01 | 0.469 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 3.395618e-01 | 0.469 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 3.401107e-01 | 0.468 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 3.491792e-01 | 0.457 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 3.498694e-01 | 0.456 | 0 | 0 |
| Autointegration results in viral DNA circles | R-HSA-177539 | 3.498694e-01 | 0.456 | 0 | 0 |
| RAS signaling downstream of NF1 loss-of-function variants | R-HSA-6802953 | 3.498694e-01 | 0.456 | 0 | 0 |
| Regulation of NFE2L2 gene expression | R-HSA-9818749 | 3.498694e-01 | 0.456 | 0 | 0 |
| Neurofascin interactions | R-HSA-447043 | 3.498694e-01 | 0.456 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex in Cancer | R-HSA-3304351 | 3.498694e-01 | 0.456 | 0 | 0 |
| Integration of viral DNA into host genomic DNA | R-HSA-175567 | 3.498694e-01 | 0.456 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 3.502579e-01 | 0.456 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 3.533724e-01 | 0.452 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 3.539971e-01 | 0.451 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 3.567916e-01 | 0.448 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 3.567916e-01 | 0.448 | 0 | 0 |
| Regulation of FZD by ubiquitination | R-HSA-4641263 | 3.567916e-01 | 0.448 | 0 | 0 |
| Glycogen storage diseases | R-HSA-3229121 | 3.567916e-01 | 0.448 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 3.570079e-01 | 0.447 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 3.581871e-01 | 0.446 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 3.598471e-01 | 0.444 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 3.598471e-01 | 0.444 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 3.630889e-01 | 0.440 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 3.633259e-01 | 0.440 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 3.669008e-01 | 0.435 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 3.669008e-01 | 0.435 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 3.669008e-01 | 0.435 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 3.669008e-01 | 0.435 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 3.669008e-01 | 0.435 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 3.706315e-01 | 0.431 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 3.732301e-01 | 0.428 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 3.732301e-01 | 0.428 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 3.732301e-01 | 0.428 | 0 | 0 |
| NOTCH2 intracellular domain regulates transcription | R-HSA-2197563 | 3.759365e-01 | 0.425 | 0 | 0 |
| SHC-related events triggered by IGF1R | R-HSA-2428933 | 3.759365e-01 | 0.425 | 0 | 0 |
| Polymerase switching | R-HSA-69091 | 3.759365e-01 | 0.425 | 0 | 0 |
| Role of second messengers in netrin-1 signaling | R-HSA-418890 | 3.759365e-01 | 0.425 | 0 | 0 |
| Leading Strand Synthesis | R-HSA-69109 | 3.759365e-01 | 0.425 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 3.759365e-01 | 0.425 | 0 | 0 |
| Activated NTRK2 signals through FRS2 and FRS3 | R-HSA-9028731 | 3.759365e-01 | 0.425 | 0 | 0 |
| MET activates RAS signaling | R-HSA-8851805 | 3.759365e-01 | 0.425 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 3.774113e-01 | 0.423 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 3.840869e-01 | 0.416 | 0 | 0 |
| FOXO-mediated transcription of cell death genes | R-HSA-9614657 | 3.875024e-01 | 0.412 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 3.875024e-01 | 0.412 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 3.875024e-01 | 0.412 | 0 | 0 |
| Tie2 Signaling | R-HSA-210993 | 3.875024e-01 | 0.412 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 3.937135e-01 | 0.405 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 3.954880e-01 | 0.403 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 3.963857e-01 | 0.402 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 3.973240e-01 | 0.401 | 0 | 0 |
| Activation of TRKA receptors | R-HSA-187015 | 3.984311e-01 | 0.400 | 0 | 0 |
| MET activates PI3K/AKT signaling | R-HSA-8851907 | 3.984311e-01 | 0.400 | 0 | 0 |
| IFNG signaling activates MAPKs | R-HSA-9732724 | 3.984311e-01 | 0.400 | 0 | 0 |
| TRIF-mediated programmed cell death | R-HSA-2562578 | 3.984311e-01 | 0.400 | 0 | 0 |
| Recycling of eIF2:GDP | R-HSA-72731 | 3.984311e-01 | 0.400 | 0 | 0 |
| Netrin mediated repulsion signals | R-HSA-418886 | 3.984311e-01 | 0.400 | 0 | 0 |
| TGFBR3 regulates TGF-beta signaling | R-HSA-9839389 | 3.984311e-01 | 0.400 | 0 | 0 |
| RUNX3 Regulates Immune Response and Cell Migration | R-HSA-8949275 | 3.984311e-01 | 0.400 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 3.988744e-01 | 0.399 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 4.008182e-01 | 0.397 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 4.012551e-01 | 0.397 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 4.013566e-01 | 0.396 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 4.015905e-01 | 0.396 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to lipogenesis | R-HSA-9029558 | 4.124883e-01 | 0.385 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 4.124883e-01 | 0.385 | 0 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 4.124883e-01 | 0.385 | 0 | 0 |
| PI5P Regulates TP53 Acetylation | R-HSA-6811555 | 4.124883e-01 | 0.385 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 4.180096e-01 | 0.379 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 4.196996e-01 | 0.377 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 4.205974e-01 | 0.376 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 4.211762e-01 | 0.376 | 0 | 0 |
| Regulation of cortical dendrite branching | R-HSA-8985801 | 4.223492e-01 | 0.374 | 0 | 0 |
| TGFBR2 Kinase Domain Mutants in Cancer | R-HSA-3645790 | 4.223492e-01 | 0.374 | 0 | 0 |
| Signaling by RAS GAP mutants | R-HSA-9753510 | 4.223492e-01 | 0.374 | 0 | 0 |
| Neurophilin interactions with VEGF and VEGFR | R-HSA-194306 | 4.223492e-01 | 0.374 | 0 | 0 |
| Loss of Function of TGFBR2 in Cancer | R-HSA-3642278 | 4.223492e-01 | 0.374 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 4.223492e-01 | 0.374 | 0 | 0 |
| DSCAM interactions | R-HSA-376172 | 4.223492e-01 | 0.374 | 0 | 0 |
| Stimulation of the cell death response by PAK-2p34 | R-HSA-211736 | 4.223492e-01 | 0.374 | 0 | 0 |
| ATF6B (ATF6-beta) activates chaperones | R-HSA-8874177 | 4.223492e-01 | 0.374 | 0 | 0 |
| Synthesis and processing of ENV and VPU | R-HSA-171286 | 4.223492e-01 | 0.374 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 4.377952e-01 | 0.359 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 4.377952e-01 | 0.359 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 4.415899e-01 | 0.355 | 0 | 0 |
| RAS processing | R-HSA-9648002 | 4.434721e-01 | 0.353 | 0 | 0 |
| EGFR interacts with phospholipase C-gamma | R-HSA-212718 | 4.452315e-01 | 0.351 | 0 | 0 |
| Activated NTRK2 signals through PI3K | R-HSA-9028335 | 4.452315e-01 | 0.351 | 0 | 0 |
| MET receptor recycling | R-HSA-8875656 | 4.452315e-01 | 0.351 | 0 | 0 |
| Regulation by c-FLIP | R-HSA-3371378 | 4.452315e-01 | 0.351 | 0 | 0 |
| Sodium/Proton exchangers | R-HSA-425986 | 4.452315e-01 | 0.351 | 0 | 0 |
| Dimerization of procaspase-8 | R-HSA-69416 | 4.452315e-01 | 0.351 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 4.452315e-01 | 0.351 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of myeloid cells | R-HSA-8939246 | 4.452315e-01 | 0.351 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 4.452844e-01 | 0.351 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 4.452844e-01 | 0.351 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 4.469226e-01 | 0.350 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 4.479855e-01 | 0.349 | 0 | 0 |
| Regulation of PD-L1(CD274) translation | R-HSA-9909620 | 4.481502e-01 | 0.349 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 4.481502e-01 | 0.349 | 0 | 0 |
| Glycogen synthesis | R-HSA-3322077 | 4.481502e-01 | 0.349 | 0 | 0 |
| TP53 Regulates Transcription of Death Receptors and Ligands | R-HSA-6803211 | 4.483375e-01 | 0.348 | 0 | 0 |
| YAP1- and WWTR1 (TAZ)-stimulated gene expression | R-HSA-2032785 | 4.483375e-01 | 0.348 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 4.552214e-01 | 0.342 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 4.552214e-01 | 0.342 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 4.619008e-01 | 0.335 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 4.652850e-01 | 0.332 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 4.652850e-01 | 0.332 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 4.652850e-01 | 0.332 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 4.652850e-01 | 0.332 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 4.701792e-01 | 0.328 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 4.715351e-01 | 0.326 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 4.731006e-01 | 0.325 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 4.747935e-01 | 0.323 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 4.766784e-01 | 0.322 | 0 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 4.777795e-01 | 0.321 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 4.777795e-01 | 0.321 | 0 | 0 |
| Prevention of phagosomal-lysosomal fusion | R-HSA-9636383 | 4.777795e-01 | 0.321 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 4.830857e-01 | 0.316 | 0 | 0 |
| Processive synthesis on the lagging strand | R-HSA-69183 | 4.832678e-01 | 0.316 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 4.832678e-01 | 0.316 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 4.832678e-01 | 0.316 | 0 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 4.832678e-01 | 0.316 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 4.870791e-01 | 0.312 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 4.899242e-01 | 0.310 | 0 | 0 |
| WNT mediated activation of DVL | R-HSA-201688 | 4.899242e-01 | 0.310 | 0 | 0 |
| AMPK inhibits chREBP transcriptional activation activity | R-HSA-163680 | 4.899242e-01 | 0.310 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 4.899242e-01 | 0.310 | 0 | 0 |
| CASP8 activity is inhibited | R-HSA-5218900 | 4.899242e-01 | 0.310 | 0 | 0 |
| mRNA Editing | R-HSA-75072 | 4.899242e-01 | 0.310 | 0 | 0 |
| Regulation of signaling by NODAL | R-HSA-1433617 | 4.899242e-01 | 0.310 | 0 | 0 |
| APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway | R-HSA-5649702 | 4.899242e-01 | 0.310 | 0 | 0 |
| Activation of the TFAP2 (AP-2) family of transcription factors | R-HSA-8866907 | 4.899242e-01 | 0.310 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 4.899242e-01 | 0.310 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 4.899242e-01 | 0.310 | 0 | 0 |
| Respiratory syncytial virus genome replication | R-HSA-9834752 | 4.899242e-01 | 0.310 | 0 | 0 |
| FasL/ CD95L signaling | R-HSA-75157 | 4.964154e-01 | 0.304 | 0 | 0 |
| Activated NTRK3 signals through PLCG1 | R-HSA-9034793 | 4.964154e-01 | 0.304 | 0 | 0 |
| Adrenaline signalling through Alpha-2 adrenergic receptor | R-HSA-392023 | 4.964154e-01 | 0.304 | 0 | 0 |
| MET activates PTPN11 | R-HSA-8865999 | 4.964154e-01 | 0.304 | 0 | 0 |
| Defective ABCC2 causes DJS | R-HSA-5679001 | 4.964154e-01 | 0.304 | 0 | 0 |
| Signalling to STAT3 | R-HSA-198745 | 4.964154e-01 | 0.304 | 0 | 0 |
| Diseases of Mismatch Repair (MMR) | R-HSA-5423599 | 4.964154e-01 | 0.304 | 0 | 0 |
| CASP5-mediated substrate cleavage | R-HSA-9960525 | 4.964154e-01 | 0.304 | 0 | 0 |
| CASP4-mediated substrate cleavage | R-HSA-9960519 | 4.964154e-01 | 0.304 | 0 | 0 |
| Expression and Processing of Neurotrophins | R-HSA-9036866 | 4.964154e-01 | 0.304 | 0 | 0 |
| NGF processing | R-HSA-167060 | 4.964154e-01 | 0.304 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 4.965453e-01 | 0.304 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 4.992546e-01 | 0.302 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 5.067720e-01 | 0.295 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 5.082387e-01 | 0.294 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 5.082387e-01 | 0.294 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 5.082387e-01 | 0.294 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 5.151671e-01 | 0.288 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 5.154645e-01 | 0.288 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 5.154645e-01 | 0.288 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 5.154645e-01 | 0.288 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 5.164817e-01 | 0.287 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 5.171039e-01 | 0.286 | 0 | 0 |
| WNT5:FZD7-mediated leishmania damping | R-HSA-9673324 | 5.171039e-01 | 0.286 | 0 | 0 |
| Killing mechanisms | R-HSA-9664420 | 5.171039e-01 | 0.286 | 0 | 0 |
| Caspase activation via Death Receptors in the presence of ligand | R-HSA-140534 | 5.171039e-01 | 0.286 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 5.203955e-01 | 0.284 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 5.241327e-01 | 0.281 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 5.268286e-01 | 0.278 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 5.289610e-01 | 0.277 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 5.292736e-01 | 0.276 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 5.322803e-01 | 0.274 | 0 | 0 |
| Receptor Mediated Mitophagy | R-HSA-8934903 | 5.322803e-01 | 0.274 | 0 | 0 |
| Defective RIPK1-mediated regulated necrosis | R-HSA-9693928 | 5.322803e-01 | 0.274 | 0 | 0 |
| Ion influx/efflux at host-pathogen interface | R-HSA-6803544 | 5.322803e-01 | 0.274 | 0 | 0 |
| Assembly and release of respiratory syncytial virus (RSV) virions | R-HSA-9820962 | 5.322803e-01 | 0.274 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 5.322803e-01 | 0.274 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 5.350199e-01 | 0.272 | 1 | 1 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 5.350199e-01 | 0.272 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 5.350199e-01 | 0.272 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 5.381136e-01 | 0.269 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 5.381136e-01 | 0.269 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 5.381136e-01 | 0.269 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 5.381136e-01 | 0.269 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 5.403517e-01 | 0.267 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 5.411798e-01 | 0.267 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 5.488291e-01 | 0.261 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 5.495739e-01 | 0.260 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 5.495739e-01 | 0.260 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 5.495739e-01 | 0.260 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 5.497075e-01 | 0.260 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 5.497075e-01 | 0.260 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 5.499507e-01 | 0.260 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 5.521831e-01 | 0.258 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 5.557520e-01 | 0.255 | 0 | 0 |
| Activated NTRK2 signals through PLCG1 | R-HSA-9026527 | 5.609886e-01 | 0.251 | 0 | 0 |
| Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes | R-HSA-69200 | 5.609886e-01 | 0.251 | 0 | 0 |
| TGFBR1 KD Mutants in Cancer | R-HSA-3656532 | 5.609886e-01 | 0.251 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 5.609886e-01 | 0.251 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of cell cycle factors | R-HSA-8866911 | 5.609886e-01 | 0.251 | 0 | 0 |
| TNFR1-mediated ceramide production | R-HSA-5626978 | 5.609886e-01 | 0.251 | 0 | 0 |
| SARS-CoV-1-mediated effects on programmed cell death | R-HSA-9692913 | 5.609886e-01 | 0.251 | 0 | 0 |
| Transcriptional activation of cell cycle inhibitor p21 | R-HSA-69895 | 5.609886e-01 | 0.251 | 0 | 0 |
| Transcriptional activation of p53 responsive genes | R-HSA-69560 | 5.609886e-01 | 0.251 | 0 | 0 |
| Activation of NOXA and translocation to mitochondria | R-HSA-111448 | 5.609886e-01 | 0.251 | 0 | 0 |
| Regulation of HMOX1 expression and activity | R-HSA-9707587 | 5.609886e-01 | 0.251 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 5.624331e-01 | 0.250 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 5.624331e-01 | 0.250 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 5.655140e-01 | 0.248 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 5.702280e-01 | 0.244 | 0 | 0 |
| NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | R-HSA-933543 | 5.721643e-01 | 0.242 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 5.721643e-01 | 0.242 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 5.721643e-01 | 0.242 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 5.721643e-01 | 0.242 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 5.721643e-01 | 0.242 | 0 | 0 |
| Dissolution of Fibrin Clot | R-HSA-75205 | 5.721643e-01 | 0.242 | 0 | 0 |
| Formation of the posterior neural plate | R-HSA-9832991 | 5.721643e-01 | 0.242 | 0 | 0 |
| Synthesis of PI | R-HSA-1483226 | 5.721643e-01 | 0.242 | 0 | 0 |
| Activated NTRK3 signals through RAS | R-HSA-9034864 | 5.721643e-01 | 0.242 | 0 | 0 |
| Interleukin-2 signaling | R-HSA-9020558 | 5.721643e-01 | 0.242 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 5.728906e-01 | 0.242 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 5.739511e-01 | 0.241 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 5.790713e-01 | 0.237 | 1 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 5.790713e-01 | 0.237 | 0 | 0 |
| Removal of the Flap Intermediate from the C-strand | R-HSA-174437 | 5.809737e-01 | 0.236 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | R-HSA-5358606 | 5.809737e-01 | 0.236 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 1 | R-HSA-418592 | 5.889379e-01 | 0.230 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 5.889379e-01 | 0.230 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 5.889379e-01 | 0.230 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 5.900683e-01 | 0.229 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 5.900683e-01 | 0.229 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 6.030678e-01 | 0.220 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 6.043062e-01 | 0.219 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 6.094385e-01 | 0.215 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis | R-HSA-9623433 | 6.095138e-01 | 0.215 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 6.095138e-01 | 0.215 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 6.095138e-01 | 0.215 | 0 | 0 |
| Sensing of DNA Double Strand Breaks | R-HSA-5693548 | 6.095138e-01 | 0.215 | 0 | 0 |
| POLB-Dependent Long Patch Base Excision Repair | R-HSA-110362 | 6.095138e-01 | 0.215 | 0 | 0 |
| Activated NTRK2 signals through RAS | R-HSA-9026519 | 6.095138e-01 | 0.215 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 6.095138e-01 | 0.215 | 0 | 0 |
| APOBEC3G mediated resistance to HIV-1 infection | R-HSA-180689 | 6.095138e-01 | 0.215 | 0 | 0 |
| Cytochrome c-mediated apoptotic response | R-HSA-111461 | 6.095138e-01 | 0.215 | 0 | 0 |
| Cytosolic iron-sulfur cluster assembly | R-HSA-2564830 | 6.108276e-01 | 0.214 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 6.108276e-01 | 0.214 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 6.108276e-01 | 0.214 | 0 | 0 |
| Apoptotic factor-mediated response | R-HSA-111471 | 6.108276e-01 | 0.214 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 6.119255e-01 | 0.213 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 6.144759e-01 | 0.211 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 6.144759e-01 | 0.211 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 6.144759e-01 | 0.211 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 6.144759e-01 | 0.211 | 0 | 0 |
| Reelin signalling pathway | R-HSA-8866376 | 6.172850e-01 | 0.210 | 0 | 0 |
| NFE2L2 regulating inflammation associated genes | R-HSA-9818026 | 6.172850e-01 | 0.210 | 0 | 0 |
| SMAD2/3 Phosphorylation Motif Mutants in Cancer | R-HSA-3304356 | 6.172850e-01 | 0.210 | 0 | 0 |
| Resolution of AP sites via the single-nucleotide replacement pathway | R-HSA-110381 | 6.172850e-01 | 0.210 | 0 | 0 |
| Activation of AKT2 | R-HSA-165158 | 6.172850e-01 | 0.210 | 0 | 0 |
| PTK6 Down-Regulation | R-HSA-8849472 | 6.172850e-01 | 0.210 | 0 | 0 |
| Muscarinic acetylcholine receptors | R-HSA-390648 | 6.172850e-01 | 0.210 | 0 | 0 |
| SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes | R-HSA-111464 | 6.172850e-01 | 0.210 | 0 | 0 |
| SMAC (DIABLO) binds to IAPs | R-HSA-111463 | 6.172850e-01 | 0.210 | 0 | 0 |
| DEx/H-box helicases activate type I IFN and inflammatory cytokines production | R-HSA-3134963 | 6.172850e-01 | 0.210 | 0 | 0 |
| Assembly of Viral Components at the Budding Site | R-HSA-168316 | 6.172850e-01 | 0.210 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 6.211270e-01 | 0.207 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 6.235827e-01 | 0.205 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 6.294309e-01 | 0.201 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 6.317028e-01 | 0.199 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 6.390028e-01 | 0.194 | 0 | 0 |
| Suppression of phagosomal maturation | R-HSA-9637687 | 6.390028e-01 | 0.194 | 0 | 0 |
| PI-3K cascade:FGFR3 | R-HSA-5654710 | 6.392201e-01 | 0.194 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 6.392201e-01 | 0.194 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 6.392201e-01 | 0.194 | 0 | 0 |
| Other interleukin signaling | R-HSA-449836 | 6.392201e-01 | 0.194 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 6.407695e-01 | 0.193 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 6.407695e-01 | 0.193 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 6.414073e-01 | 0.193 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 6.443229e-01 | 0.191 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 6.443229e-01 | 0.191 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 6.443229e-01 | 0.191 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 6.443229e-01 | 0.191 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 6.443229e-01 | 0.191 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 6.443229e-01 | 0.191 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 6.443229e-01 | 0.191 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 6.443229e-01 | 0.191 | 0 | 0 |
| Trafficking and processing of endosomal TLR | R-HSA-1679131 | 6.443229e-01 | 0.191 | 0 | 0 |
| Regulation of IFNG signaling | R-HSA-877312 | 6.443229e-01 | 0.191 | 0 | 0 |
| Interleukin-15 signaling | R-HSA-8983432 | 6.443229e-01 | 0.191 | 0 | 0 |
| Reversal of alkylation damage by DNA dioxygenases | R-HSA-73943 | 6.443229e-01 | 0.191 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 6.500876e-01 | 0.187 | 0 | 0 |
| Phosphorylation of CD3 and TCR zeta chains | R-HSA-202427 | 6.624875e-01 | 0.179 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 6.624875e-01 | 0.179 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 6.627214e-01 | 0.179 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 6.627214e-01 | 0.179 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 6.646445e-01 | 0.177 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 6.661248e-01 | 0.176 | 0 | 0 |
| PI-3K cascade:FGFR4 | R-HSA-5654720 | 6.661248e-01 | 0.176 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 6.661248e-01 | 0.176 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 6.661248e-01 | 0.176 | 0 | 0 |
| Signaling by NODAL | R-HSA-1181150 | 6.661248e-01 | 0.176 | 0 | 0 |
| Common Pathway of Fibrin Clot Formation | R-HSA-140875 | 6.661248e-01 | 0.176 | 0 | 0 |
| TYSND1 cleaves peroxisomal proteins | R-HSA-9033500 | 6.663651e-01 | 0.176 | 0 | 0 |
| NGF-independant TRKA activation | R-HSA-187024 | 6.663651e-01 | 0.176 | 0 | 0 |
| Signalling to p38 via RIT and RIN | R-HSA-187706 | 6.663651e-01 | 0.176 | 0 | 0 |
| Cam-PDE 1 activation | R-HSA-111957 | 6.663651e-01 | 0.176 | 0 | 0 |
| Phosphorylation of Emi1 | R-HSA-176417 | 6.663651e-01 | 0.176 | 0 | 0 |
| Inhibition of Signaling by Overexpressed EGFR | R-HSA-5638303 | 6.663651e-01 | 0.176 | 0 | 0 |
| Signaling by Overexpressed Wild-Type EGFR in Cancer | R-HSA-5638302 | 6.663651e-01 | 0.176 | 0 | 0 |
| Loss-of-function mutations in DBT cause MSUD2 | R-HSA-9865113 | 6.663651e-01 | 0.176 | 0 | 0 |
| Loss-of-function mutations in DLD cause MSUD3/DLDD | R-HSA-9907570 | 6.663651e-01 | 0.176 | 0 | 0 |
| PDE3B signalling | R-HSA-165160 | 6.663651e-01 | 0.176 | 0 | 0 |
| Noncanonical activation of NOTCH3 | R-HSA-9017802 | 6.663651e-01 | 0.176 | 0 | 0 |
| PKB-mediated events | R-HSA-109703 | 6.663651e-01 | 0.176 | 0 | 0 |
| Loss of Function of SMAD2/3 in Cancer | R-HSA-3304349 | 6.663651e-01 | 0.176 | 0 | 0 |
| Synthesis of PS | R-HSA-1483101 | 6.663651e-01 | 0.176 | 0 | 0 |
| CDC6 association with the ORC:origin complex | R-HSA-68689 | 6.663651e-01 | 0.176 | 0 | 0 |
| Activation of caspases through apoptosome-mediated cleavage | R-HSA-111459 | 6.663651e-01 | 0.176 | 0 | 0 |
| VEGF binds to VEGFR leading to receptor dimerization | R-HSA-195399 | 6.663651e-01 | 0.176 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 6.663651e-01 | 0.176 | 0 | 0 |
| Relaxin receptors | R-HSA-444821 | 6.663651e-01 | 0.176 | 0 | 0 |
| Release of apoptotic factors from the mitochondria | R-HSA-111457 | 6.663651e-01 | 0.176 | 0 | 0 |
| VEGF ligand-receptor interactions | R-HSA-194313 | 6.663651e-01 | 0.176 | 0 | 0 |
| SLC15A4:TASL-dependent IRF5 activation | R-HSA-9860276 | 6.663651e-01 | 0.176 | 0 | 0 |
| RUNX3 regulates CDKN1A transcription | R-HSA-8941855 | 6.663651e-01 | 0.176 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 6.667152e-01 | 0.176 | 1 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 6.675161e-01 | 0.176 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 6.677417e-01 | 0.175 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 6.720358e-01 | 0.173 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 6.749132e-01 | 0.171 | 0 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 6.766289e-01 | 0.170 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 6.766289e-01 | 0.170 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 6.766289e-01 | 0.170 | 0 | 0 |
| Reversible hydration of carbon dioxide | R-HSA-1475029 | 6.766289e-01 | 0.170 | 0 | 0 |
| TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway | R-HSA-5676594 | 6.766289e-01 | 0.170 | 0 | 0 |
| Platelet Adhesion to exposed collagen | R-HSA-75892 | 6.766289e-01 | 0.170 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 6.782545e-01 | 0.169 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 6.847331e-01 | 0.164 | 0 | 0 |
| ATF4 activates genes in response to endoplasmic reticulum stress | R-HSA-380994 | 6.849101e-01 | 0.164 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 6.849101e-01 | 0.164 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 6.876990e-01 | 0.163 | 0 | 0 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 6.915345e-01 | 0.160 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 6.915345e-01 | 0.160 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 6.974251e-01 | 0.157 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 7.020033e-01 | 0.154 | 0 | 0 |
| Removal of the Flap Intermediate | R-HSA-69166 | 7.065012e-01 | 0.151 | 0 | 0 |
| PTK6 promotes HIF1A stabilization | R-HSA-8857538 | 7.091535e-01 | 0.149 | 0 | 0 |
| STAT5 Activation | R-HSA-9645135 | 7.091535e-01 | 0.149 | 0 | 0 |
| Defective CHST3 causes SEDCJD | R-HSA-3595172 | 7.091535e-01 | 0.149 | 0 | 0 |
| H139Hfs13* PPM1K causes a mild variant of MSUD | R-HSA-9912529 | 7.091535e-01 | 0.149 | 0 | 0 |
| Loss-of-function mutations in BCKDHA or BCKDHB cause MSUD | R-HSA-9865125 | 7.091535e-01 | 0.149 | 0 | 0 |
| E2F-enabled inhibition of pre-replication complex formation | R-HSA-113507 | 7.091535e-01 | 0.149 | 0 | 0 |
| Defective CHST14 causes EDS, musculocontractural type | R-HSA-3595174 | 7.091535e-01 | 0.149 | 0 | 0 |
| Defective SLC16A1 causes symptomatic deficiency in lactate transport (SDLT) | R-HSA-5619070 | 7.091535e-01 | 0.149 | 0 | 0 |
| Branched-chain ketoacid dehydrogenase kinase deficiency | R-HSA-9912481 | 7.091535e-01 | 0.149 | 0 | 0 |
| G2/M DNA replication checkpoint | R-HSA-69478 | 7.091535e-01 | 0.149 | 0 | 0 |
| Intracellular metabolism of fatty acids regulates insulin secretion | R-HSA-434313 | 7.091535e-01 | 0.149 | 0 | 0 |
| RUNX3 regulates YAP1-mediated transcription | R-HSA-8951671 | 7.091535e-01 | 0.149 | 0 | 0 |
| Activation of NIMA Kinases NEK9, NEK6, NEK7 | R-HSA-2980767 | 7.091535e-01 | 0.149 | 0 | 0 |
| Lipid particle organization | R-HSA-8964572 | 7.091535e-01 | 0.149 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 7.119821e-01 | 0.148 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 7.119821e-01 | 0.148 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 7.136063e-01 | 0.147 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 7.138287e-01 | 0.146 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 7.154583e-01 | 0.145 | 0 | 0 |
| FRS-mediated FGFR3 signaling | R-HSA-5654706 | 7.154583e-01 | 0.145 | 0 | 0 |
| Attachment and Entry | R-HSA-9694614 | 7.154583e-01 | 0.145 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 7.154615e-01 | 0.145 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 7.164187e-01 | 0.145 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 7.173164e-01 | 0.144 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 7.192063e-01 | 0.143 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 7.265408e-01 | 0.139 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 7.274882e-01 | 0.138 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 7.276544e-01 | 0.138 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 7.282838e-01 | 0.138 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 7.317482e-01 | 0.136 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 7.332054e-01 | 0.135 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 7.340327e-01 | 0.134 | 0 | 0 |
| RNA Polymerase III Chain Elongation | R-HSA-73780 | 7.340327e-01 | 0.134 | 0 | 0 |
| Biotin transport and metabolism | R-HSA-196780 | 7.340327e-01 | 0.134 | 0 | 0 |
| Formation of the anterior neural plate | R-HSA-9823739 | 7.340327e-01 | 0.134 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 7.340327e-01 | 0.134 | 0 | 0 |
| DNA Damage Reversal | R-HSA-73942 | 7.340327e-01 | 0.134 | 0 | 0 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 7.379188e-01 | 0.132 | 0 | 0 |
| Regulation of IFNA/IFNB signaling | R-HSA-912694 | 7.379188e-01 | 0.132 | 0 | 0 |
| FRS-mediated FGFR4 signaling | R-HSA-5654712 | 7.379188e-01 | 0.132 | 0 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 7.379188e-01 | 0.132 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 7.406193e-01 | 0.130 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 7.447014e-01 | 0.128 | 0 | 0 |
| Removal of aminoterminal propeptides from gamma-carboxylated proteins | R-HSA-159782 | 7.464566e-01 | 0.127 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to triglyceride lipolysis in adipose | R-HSA-9031528 | 7.464566e-01 | 0.127 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to limit cholesterol uptake | R-HSA-9031525 | 7.464566e-01 | 0.127 | 0 | 0 |
| Defective CHSY1 causes TPBS | R-HSA-3595177 | 7.464566e-01 | 0.127 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 7.464566e-01 | 0.127 | 0 | 0 |
| Insulin effects increased synthesis of Xylulose-5-Phosphate | R-HSA-163754 | 7.464566e-01 | 0.127 | 0 | 0 |
| PTK6 Expression | R-HSA-8849473 | 7.464566e-01 | 0.127 | 0 | 0 |
| Activated NTRK2 signals through CDK5 | R-HSA-9032845 | 7.464566e-01 | 0.127 | 0 | 0 |
| Disinhibition of SNARE formation | R-HSA-114516 | 7.464566e-01 | 0.127 | 0 | 0 |
| Microbial modulation of RIPK1-mediated regulated necrosis | R-HSA-9686347 | 7.464566e-01 | 0.127 | 0 | 0 |
| Activation of PUMA and translocation to mitochondria | R-HSA-139915 | 7.464566e-01 | 0.127 | 0 | 0 |
| VLDL clearance | R-HSA-8964046 | 7.464566e-01 | 0.127 | 0 | 0 |
| Defective HLCS causes multiple carboxylase deficiency | R-HSA-3371599 | 7.464566e-01 | 0.127 | 0 | 0 |
| Nef Mediated CD4 Down-regulation | R-HSA-167590 | 7.464566e-01 | 0.127 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 7.547265e-01 | 0.122 | 0 | 0 |
| Defective GALNT12 causes CRCS1 | R-HSA-5083636 | 7.593322e-01 | 0.120 | 0 | 0 |
| Defective GALNT3 causes HFTC | R-HSA-5083625 | 7.593322e-01 | 0.120 | 0 | 0 |
| TP53 Regulates Transcription of Caspase Activators and Caspases | R-HSA-6803207 | 7.593322e-01 | 0.120 | 0 | 0 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | R-HSA-210744 | 7.593322e-01 | 0.120 | 0 | 0 |
| Activation of SMO | R-HSA-5635838 | 7.593322e-01 | 0.120 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 7.623534e-01 | 0.118 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 7.623720e-01 | 0.118 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 7.639032e-01 | 0.117 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 7.639231e-01 | 0.117 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 7.639231e-01 | 0.117 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 7.707984e-01 | 0.113 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 7.707984e-01 | 0.113 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 7.707984e-01 | 0.113 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 7.729298e-01 | 0.112 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 7.778644e-01 | 0.109 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 7.783536e-01 | 0.109 | 0 | 0 |
| Translocation of ZAP-70 to Immunological synapse | R-HSA-202430 | 7.785928e-01 | 0.109 | 0 | 0 |
| phospho-PLA2 pathway | R-HSA-111995 | 7.789771e-01 | 0.108 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 7.789771e-01 | 0.108 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 7.789771e-01 | 0.108 | 0 | 0 |
| Nef mediated downregulation of MHC class I complex cell surface expression | R-HSA-164940 | 7.789771e-01 | 0.108 | 0 | 0 |
| Axonal growth inhibition (RHOA activation) | R-HSA-193634 | 7.789771e-01 | 0.108 | 0 | 0 |
| Activation of RAS in B cells | R-HSA-1169092 | 7.789771e-01 | 0.108 | 0 | 0 |
| TGFBR3 PTM regulation | R-HSA-9839383 | 7.789771e-01 | 0.108 | 0 | 0 |
| Adrenoceptors | R-HSA-390696 | 7.789771e-01 | 0.108 | 0 | 0 |
| Negative regulation of activity of TFAP2 (AP-2) family transcription factors | R-HSA-8866904 | 7.789771e-01 | 0.108 | 0 | 0 |
| Activated NTRK2 signals through FYN | R-HSA-9032500 | 7.789771e-01 | 0.108 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 7.810611e-01 | 0.107 | 0 | 0 |
| Antigen processing: Ub, ATP-independent proteasomal degradation | R-HSA-9912633 | 7.825194e-01 | 0.107 | 0 | 0 |
| Defective B3GALT6 causes EDSP2 and SEMDJL1 | R-HSA-4420332 | 7.825194e-01 | 0.107 | 0 | 0 |
| Defective B4GALT7 causes EDS, progeroid type | R-HSA-3560783 | 7.825194e-01 | 0.107 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 7.825194e-01 | 0.107 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation | R-HSA-2892247 | 7.825194e-01 | 0.107 | 0 | 0 |
| Response to metal ions | R-HSA-5660526 | 7.825194e-01 | 0.107 | 0 | 0 |
| PI-3K cascade:FGFR2 | R-HSA-5654695 | 7.968978e-01 | 0.099 | 0 | 0 |
| FRS-mediated FGFR1 signaling | R-HSA-5654693 | 7.968978e-01 | 0.099 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 7.968978e-01 | 0.099 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 7.968978e-01 | 0.099 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 7.971958e-01 | 0.098 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 7.971958e-01 | 0.098 | 0 | 0 |
| Defective B3GAT3 causes JDSSDHD | R-HSA-3560801 | 8.037198e-01 | 0.095 | 0 | 0 |
| Defective C1GALT1C1 causes TNPS | R-HSA-5083632 | 8.037198e-01 | 0.095 | 0 | 0 |
| Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | R-HSA-164938 | 8.037198e-01 | 0.095 | 0 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 8.037198e-01 | 0.095 | 0 | 0 |
| Specification of primordial germ cells | R-HSA-9827857 | 8.037198e-01 | 0.095 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 8.052795e-01 | 0.094 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 8.072308e-01 | 0.093 | 0 | 0 |
| NFE2L2 regulating MDR associated enzymes | R-HSA-9818032 | 8.073281e-01 | 0.093 | 0 | 0 |
| MASTL Facilitates Mitotic Progression | R-HSA-2465910 | 8.073281e-01 | 0.093 | 0 | 0 |
| Hypusine synthesis from eIF5A-lysine | R-HSA-204626 | 8.073281e-01 | 0.093 | 0 | 0 |
| Estrogen-stimulated signaling through PRKCZ | R-HSA-9634635 | 8.073281e-01 | 0.093 | 0 | 0 |
| p75NTR regulates axonogenesis | R-HSA-193697 | 8.073281e-01 | 0.093 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 8.073281e-01 | 0.093 | 0 | 0 |
| Regulation of NPAS4 gene transcription | R-HSA-9768777 | 8.073281e-01 | 0.093 | 0 | 0 |
| Interleukin-1 processing | R-HSA-448706 | 8.073281e-01 | 0.093 | 0 | 0 |
| Regulated proteolysis of p75NTR | R-HSA-193692 | 8.073281e-01 | 0.093 | 0 | 0 |
| Zinc influx into cells by the SLC39 gene family | R-HSA-442380 | 8.073281e-01 | 0.093 | 0 | 0 |
| Defects in biotin (Btn) metabolism | R-HSA-3323169 | 8.073281e-01 | 0.093 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 8.106371e-01 | 0.091 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 8.123567e-01 | 0.090 | 0 | 0 |
| Antigen Presentation: Folding, assembly and peptide loading of class I MHC | R-HSA-983170 | 8.123567e-01 | 0.090 | 0 | 0 |
| Signal amplification | R-HSA-392518 | 8.123567e-01 | 0.090 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 8.123567e-01 | 0.090 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 8.139190e-01 | 0.089 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 8.139190e-01 | 0.089 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 8.141800e-01 | 0.089 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 8.145721e-01 | 0.089 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 8.220743e-01 | 0.085 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 8.221355e-01 | 0.085 | 0 | 0 |
| Synaptic adhesion-like molecules | R-HSA-8849932 | 8.230616e-01 | 0.085 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9679504 | 8.230616e-01 | 0.085 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 8.246499e-01 | 0.084 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 8.270909e-01 | 0.082 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 8.319576e-01 | 0.080 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 8.320439e-01 | 0.080 | 0 | 0 |
| Binding and entry of HIV virion | R-HSA-173107 | 8.320439e-01 | 0.080 | 0 | 0 |
| DNA replication initiation | R-HSA-68952 | 8.320439e-01 | 0.080 | 0 | 0 |
| Formation of intermediate mesoderm | R-HSA-9761174 | 8.320439e-01 | 0.080 | 0 | 0 |
| Formation of apoptosome | R-HSA-111458 | 8.320439e-01 | 0.080 | 0 | 0 |
| Regulation of the apoptosome activity | R-HSA-9627069 | 8.320439e-01 | 0.080 | 0 | 0 |
| Interleukin-27 signaling | R-HSA-9020956 | 8.320439e-01 | 0.080 | 0 | 0 |
| Maturation of spike protein | R-HSA-9683686 | 8.320439e-01 | 0.080 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 8.398899e-01 | 0.076 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 8.406725e-01 | 0.075 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 8.406725e-01 | 0.075 | 0 | 0 |
| Pre-NOTCH Processing in Golgi | R-HSA-1912420 | 8.406725e-01 | 0.075 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 8.406725e-01 | 0.075 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 8.413538e-01 | 0.075 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 8.433181e-01 | 0.074 | 0 | 0 |
| FRS-mediated FGFR2 signaling | R-HSA-5654700 | 8.443444e-01 | 0.073 | 0 | 0 |
| Insulin receptor recycling | R-HSA-77387 | 8.443444e-01 | 0.073 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 8.443444e-01 | 0.073 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 8.504124e-01 | 0.070 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 8.507235e-01 | 0.070 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 8.512949e-01 | 0.070 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 8.523343e-01 | 0.069 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 8.530244e-01 | 0.069 | 0 | 0 |
| vRNP Assembly | R-HSA-192905 | 8.535904e-01 | 0.069 | 0 | 0 |
| RHOBTB3 ATPase cycle | R-HSA-9706019 | 8.535904e-01 | 0.069 | 0 | 0 |
| SARS-CoV-2 modulates autophagy | R-HSA-9754560 | 8.535904e-01 | 0.069 | 0 | 0 |
| Prostanoid ligand receptors | R-HSA-391908 | 8.535904e-01 | 0.069 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 8.578706e-01 | 0.067 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 8.583110e-01 | 0.066 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 8.614960e-01 | 0.065 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 8.623927e-01 | 0.064 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 8.639477e-01 | 0.064 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 8.658768e-01 | 0.063 | 0 | 0 |
| Thrombin signalling through proteinase activated receptors (PARs) | R-HSA-456926 | 8.703553e-01 | 0.060 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 8.703553e-01 | 0.060 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 8.705193e-01 | 0.060 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 8.707501e-01 | 0.060 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 8.712009e-01 | 0.060 | 0 | 0 |
| SHC-mediated cascade:FGFR3 | R-HSA-5654704 | 8.712009e-01 | 0.060 | 0 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 8.712009e-01 | 0.060 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 8.712009e-01 | 0.060 | 0 | 0 |
| DS-GAG biosynthesis | R-HSA-2022923 | 8.723739e-01 | 0.059 | 0 | 0 |
| Synthesis of diphthamide-EEF2 | R-HSA-5358493 | 8.723739e-01 | 0.059 | 0 | 0 |
| Proton-coupled monocarboxylate transport | R-HSA-433692 | 8.723739e-01 | 0.059 | 0 | 0 |
| Inhibition of replication initiation of damaged DNA by RB1/E2F1 | R-HSA-113501 | 8.723739e-01 | 0.059 | 0 | 0 |
| ERKs are inactivated | R-HSA-202670 | 8.723739e-01 | 0.059 | 0 | 0 |
| Sema4D mediated inhibition of cell attachment and migration | R-HSA-416550 | 8.723739e-01 | 0.059 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 8.747691e-01 | 0.058 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 8.796743e-01 | 0.056 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 8.810880e-01 | 0.055 | 0 | 0 |
| Molecules associated with elastic fibres | R-HSA-2129379 | 8.818602e-01 | 0.055 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 8.843574e-01 | 0.053 | 0 | 0 |
| SHC-mediated cascade:FGFR4 | R-HSA-5654719 | 8.843574e-01 | 0.053 | 0 | 0 |
| Mitochondrial calcium ion transport | R-HSA-8949215 | 8.843574e-01 | 0.053 | 0 | 0 |
| Serine metabolism | R-HSA-977347 | 8.843574e-01 | 0.053 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 8.846066e-01 | 0.053 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 8.880332e-01 | 0.052 | 0 | 0 |
| Maple Syrup Urine Disease | R-HSA-9865114 | 8.887485e-01 | 0.051 | 0 | 0 |
| Defective EXT1 causes exostoses 1, TRPS2 and CHDS | R-HSA-3656253 | 8.887485e-01 | 0.051 | 0 | 0 |
| Defective EXT2 causes exostoses 2 | R-HSA-3656237 | 8.887485e-01 | 0.051 | 0 | 0 |
| Scavenging by Class F Receptors | R-HSA-3000484 | 8.887485e-01 | 0.051 | 0 | 0 |
| Serotonin clearance from the synaptic cleft | R-HSA-380615 | 8.887485e-01 | 0.051 | 0 | 0 |
| Advanced glycosylation endproduct receptor signaling | R-HSA-879415 | 8.887485e-01 | 0.051 | 0 | 0 |
| Gamma-carboxylation, transport, and amino-terminal cleavage of proteins | R-HSA-159854 | 8.887485e-01 | 0.051 | 0 | 0 |
| Erythrocytes take up oxygen and release carbon dioxide | R-HSA-1247673 | 8.887485e-01 | 0.051 | 0 | 0 |
| Interleukin-35 Signalling | R-HSA-8984722 | 8.887485e-01 | 0.051 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 8.887485e-01 | 0.051 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 8.909874e-01 | 0.050 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 8.941931e-01 | 0.049 | 0 | 0 |
| Amino acid transport across the plasma membrane | R-HSA-352230 | 8.959130e-01 | 0.048 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 8.960040e-01 | 0.048 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9694676 | 8.962592e-01 | 0.048 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 9.018747e-01 | 0.045 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 9.028739e-01 | 0.044 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 9.028739e-01 | 0.044 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 9.030230e-01 | 0.044 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 9.030230e-01 | 0.044 | 0 | 0 |
| Processing of SMDT1 | R-HSA-8949664 | 9.030230e-01 | 0.044 | 0 | 0 |
| IL-6-type cytokine receptor ligand interactions | R-HSA-6788467 | 9.030230e-01 | 0.044 | 0 | 0 |
| CREB1 phosphorylation through the activation of Adenylate Cyclase | R-HSA-442720 | 9.030230e-01 | 0.044 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9683610 | 9.030230e-01 | 0.044 | 0 | 0 |
| Interleukin-6 signaling | R-HSA-1059683 | 9.030230e-01 | 0.044 | 0 | 0 |
| Replication of the SARS-CoV-1 genome | R-HSA-9682706 | 9.030230e-01 | 0.044 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 9.033136e-01 | 0.044 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 9.047273e-01 | 0.043 | 0 | 0 |
| Termination of O-glycan biosynthesis | R-HSA-977068 | 9.070115e-01 | 0.042 | 0 | 0 |
| Free fatty acids regulate insulin secretion | R-HSA-400451 | 9.070115e-01 | 0.042 | 0 | 0 |
| Formation of the ureteric bud | R-HSA-9830674 | 9.070115e-01 | 0.042 | 0 | 0 |
| ABC transporters in lipid homeostasis | R-HSA-1369062 | 9.070115e-01 | 0.042 | 0 | 0 |
| Carnitine shuttle | R-HSA-200425 | 9.070115e-01 | 0.042 | 0 | 0 |
| Synthesis of pyrophosphates in the cytosol | R-HSA-1855167 | 9.070115e-01 | 0.042 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 9.096421e-01 | 0.041 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 9.096421e-01 | 0.041 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 9.096421e-01 | 0.041 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 9.102565e-01 | 0.041 | 0 | 0 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 9.110977e-01 | 0.040 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 9.132407e-01 | 0.039 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 9.140991e-01 | 0.039 | 0 | 0 |
| Retrograde neurotrophin signalling | R-HSA-177504 | 9.154668e-01 | 0.038 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR3 | R-HSA-5654227 | 9.154668e-01 | 0.038 | 0 | 0 |
| BCKDH synthesizes BCAA-CoA from KIC, KMVA, KIV | R-HSA-9859138 | 9.154668e-01 | 0.038 | 0 | 0 |
| Synthesis of IPs in the nucleus | R-HSA-1855191 | 9.154668e-01 | 0.038 | 0 | 0 |
| Hydrolysis of LPC | R-HSA-1483115 | 9.154668e-01 | 0.038 | 0 | 0 |
| CLEC7A (Dectin-1) induces NFAT activation | R-HSA-5607763 | 9.154668e-01 | 0.038 | 0 | 0 |
| CRMPs in Sema3A signaling | R-HSA-399956 | 9.154668e-01 | 0.038 | 0 | 0 |
| Physiological factors | R-HSA-5578768 | 9.154668e-01 | 0.038 | 0 | 0 |
| Respiratory syncytial virus genome transcription | R-HSA-9828642 | 9.154668e-01 | 0.038 | 0 | 0 |
| Non-canonical inflammasome activation | R-HSA-9686114 | 9.154668e-01 | 0.038 | 0 | 0 |
| Acyl chain remodeling of CL | R-HSA-1482798 | 9.154668e-01 | 0.038 | 0 | 0 |
| Zinc transporters | R-HSA-435354 | 9.154668e-01 | 0.038 | 0 | 0 |
| P2Y receptors | R-HSA-417957 | 9.154668e-01 | 0.038 | 0 | 0 |
| SARS-CoV-1 Genome Replication and Transcription | R-HSA-9679514 | 9.154668e-01 | 0.038 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 9.162568e-01 | 0.038 | 0 | 0 |
| SHC-mediated cascade:FGFR1 | R-HSA-5654688 | 9.167134e-01 | 0.038 | 0 | 0 |
| Mitochondrial RNA degradation | R-HSA-9836573 | 9.167134e-01 | 0.038 | 0 | 0 |
| Assembly of active LPL and LIPC lipase complexes | R-HSA-8963889 | 9.167134e-01 | 0.038 | 0 | 0 |
| Interleukin-6 family signaling | R-HSA-6783589 | 9.167134e-01 | 0.038 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 9.183704e-01 | 0.037 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 9.192762e-01 | 0.037 | 1 | 1 |
| Hyaluronan degradation | R-HSA-2160916 | 9.254574e-01 | 0.034 | 0 | 0 |
| Protein lipoylation | R-HSA-9857492 | 9.263144e-01 | 0.033 | 0 | 0 |
| G beta:gamma signalling through BTK | R-HSA-8964315 | 9.263144e-01 | 0.033 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR4 | R-HSA-5654228 | 9.263144e-01 | 0.033 | 0 | 0 |
| Telomere C-strand synthesis initiation | R-HSA-174430 | 9.263144e-01 | 0.033 | 0 | 0 |
| Signaling by Activin | R-HSA-1502540 | 9.263144e-01 | 0.033 | 0 | 0 |
| Lysosphingolipid and LPA receptors | R-HSA-419408 | 9.263144e-01 | 0.033 | 0 | 0 |
| Other semaphorin interactions | R-HSA-416700 | 9.263144e-01 | 0.033 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 9.294341e-01 | 0.032 | 0 | 0 |
| Translation | R-HSA-72766 | 9.299026e-01 | 0.032 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 9.301351e-01 | 0.031 | 0 | 0 |
| Sphingolipid catabolism | R-HSA-9845614 | 9.333294e-01 | 0.030 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 9.333294e-01 | 0.030 | 0 | 0 |
| Synthesis of IP2, IP, and Ins in the cytosol | R-HSA-1855183 | 9.333294e-01 | 0.030 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 9.336049e-01 | 0.030 | 0 | 0 |
| Formation of Fibrin Clot (Clotting Cascade) | R-HSA-140877 | 9.336049e-01 | 0.030 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 9.336049e-01 | 0.030 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 9.339909e-01 | 0.030 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 9.357705e-01 | 0.029 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 9.357705e-01 | 0.029 | 0 | 0 |
| Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion | R-HSA-434316 | 9.357705e-01 | 0.029 | 0 | 0 |
| Induction of Cell-Cell Fusion | R-HSA-9733458 | 9.357705e-01 | 0.029 | 0 | 0 |
| Fructose catabolism | R-HSA-70350 | 9.357705e-01 | 0.029 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 9.357705e-01 | 0.029 | 0 | 0 |
| Attachment and Entry | R-HSA-9678110 | 9.357705e-01 | 0.029 | 0 | 0 |
| Atorvastatin ADME | R-HSA-9754706 | 9.357705e-01 | 0.029 | 0 | 0 |
| Virus Assembly and Release | R-HSA-168268 | 9.357705e-01 | 0.029 | 0 | 0 |
| Iron uptake and transport | R-HSA-917937 | 9.363910e-01 | 0.029 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 9.374674e-01 | 0.028 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 9.374674e-01 | 0.028 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 9.384616e-01 | 0.028 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 9.388402e-01 | 0.027 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 9.404092e-01 | 0.027 | 0 | 0 |
| SHC-mediated cascade:FGFR2 | R-HSA-5654699 | 9.404092e-01 | 0.027 | 0 | 0 |
| Triglyceride biosynthesis | R-HSA-75109 | 9.404092e-01 | 0.027 | 0 | 0 |
| Insulin processing | R-HSA-264876 | 9.404092e-01 | 0.027 | 0 | 0 |
| Synthesis of PE | R-HSA-1483213 | 9.404092e-01 | 0.027 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 9.434486e-01 | 0.025 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 9.434726e-01 | 0.025 | 0 | 0 |
| G beta:gamma signalling through CDC42 | R-HSA-8964616 | 9.440137e-01 | 0.025 | 0 | 0 |
| Glycine degradation | R-HSA-6783984 | 9.440137e-01 | 0.025 | 0 | 0 |
| STAT5 activation downstream of FLT3 ITD mutants | R-HSA-9702518 | 9.440137e-01 | 0.025 | 0 | 0 |
| Acetylcholine regulates insulin secretion | R-HSA-399997 | 9.440137e-01 | 0.025 | 0 | 0 |
| tRNA modification in the mitochondrion | R-HSA-6787450 | 9.440137e-01 | 0.025 | 0 | 0 |
| Synthesis of PG | R-HSA-1483148 | 9.440137e-01 | 0.025 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 9.467705e-01 | 0.024 | 0 | 0 |
| Pyroptosis | R-HSA-5620971 | 9.467705e-01 | 0.024 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 9.507486e-01 | 0.022 | 0 | 0 |
| Phospholipase C-mediated cascade: FGFR1 | R-HSA-5654219 | 9.511993e-01 | 0.022 | 0 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 9.511993e-01 | 0.022 | 0 | 0 |
| Replication of the SARS-CoV-2 genome | R-HSA-9694686 | 9.511993e-01 | 0.022 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 9.514762e-01 | 0.022 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 9.522473e-01 | 0.021 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 9.524810e-01 | 0.021 | 0 | 0 |
| Activation of Matrix Metalloproteinases | R-HSA-1592389 | 9.524810e-01 | 0.021 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 9.531308e-01 | 0.021 | 0 | 0 |
| Trafficking of GluR2-containing AMPA receptors | R-HSA-416993 | 9.574630e-01 | 0.019 | 0 | 0 |
| G beta:gamma signalling through PLC beta | R-HSA-418217 | 9.574630e-01 | 0.019 | 0 | 0 |
| Presynaptic function of Kainate receptors | R-HSA-500657 | 9.574630e-01 | 0.019 | 0 | 0 |
| PKA activation | R-HSA-163615 | 9.574630e-01 | 0.019 | 0 | 0 |
| Organic anion transport by SLC5/17/25 transporters | R-HSA-428643 | 9.574630e-01 | 0.019 | 0 | 0 |
| Nucleotide-like (purinergic) receptors | R-HSA-418038 | 9.574630e-01 | 0.019 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 9.576029e-01 | 0.019 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 9.595812e-01 | 0.018 | 0 | 0 |
| Cargo concentration in the ER | R-HSA-5694530 | 9.621933e-01 | 0.017 | 0 | 0 |
| Strand-asynchronous mitochondrial DNA replication | R-HSA-9913635 | 9.629231e-01 | 0.016 | 0 | 0 |
| Pyrimidine biosynthesis | R-HSA-500753 | 9.629231e-01 | 0.016 | 0 | 0 |
| Germ layer formation at gastrulation | R-HSA-9754189 | 9.629231e-01 | 0.016 | 0 | 0 |
| mRNA decay by 3' to 5' exoribonuclease | R-HSA-429958 | 9.629231e-01 | 0.016 | 0 | 0 |
| O2/CO2 exchange in erythrocytes | R-HSA-1480926 | 9.629231e-01 | 0.016 | 0 | 0 |
| Specification of the neural plate border | R-HSA-9834899 | 9.629231e-01 | 0.016 | 0 | 0 |
| Erythrocytes take up carbon dioxide and release oxygen | R-HSA-1237044 | 9.629231e-01 | 0.016 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 9.629231e-01 | 0.016 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9694631 | 9.629231e-01 | 0.016 | 0 | 0 |
| SARS-CoV-2 Genome Replication and Transcription | R-HSA-9694682 | 9.629231e-01 | 0.016 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 9.636412e-01 | 0.016 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 9.652884e-01 | 0.015 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 9.663042e-01 | 0.015 | 0 | 0 |
| Formation of ATP by chemiosmotic coupling | R-HSA-163210 | 9.676826e-01 | 0.014 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR2 | R-HSA-5654221 | 9.676826e-01 | 0.014 | 0 | 0 |
| BBSome-mediated cargo-targeting to cilium | R-HSA-5620922 | 9.676826e-01 | 0.014 | 0 | 0 |
| Acyl chain remodelling of PI | R-HSA-1482922 | 9.676826e-01 | 0.014 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 9.676826e-01 | 0.014 | 0 | 0 |
| Eicosanoid ligand-binding receptors | R-HSA-391903 | 9.676826e-01 | 0.014 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 9.686324e-01 | 0.014 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 9.704188e-01 | 0.013 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 9.705705e-01 | 0.013 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 9.709317e-01 | 0.013 | 0 | 0 |
| Matriglycan biosynthesis on DAG1 | R-HSA-9939291 | 9.718314e-01 | 0.012 | 0 | 0 |
| Abacavir metabolism | R-HSA-2161541 | 9.718314e-01 | 0.012 | 0 | 0 |
| Vitamin C (ascorbate) metabolism | R-HSA-196836 | 9.718314e-01 | 0.012 | 0 | 0 |
| Acyl chain remodelling of PG | R-HSA-1482925 | 9.718314e-01 | 0.012 | 0 | 0 |
| Acyl chain remodelling of PC | R-HSA-1482788 | 9.732727e-01 | 0.012 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 9.744281e-01 | 0.011 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 9.744281e-01 | 0.011 | 0 | 0 |
| CS-GAG biosynthesis | R-HSA-2022870 | 9.754478e-01 | 0.011 | 0 | 0 |
| Ribavirin ADME | R-HSA-9755088 | 9.754478e-01 | 0.011 | 0 | 0 |
| Glutathione synthesis and recycling | R-HSA-174403 | 9.754478e-01 | 0.011 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 9.754502e-01 | 0.011 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 9.758146e-01 | 0.011 | 0 | 0 |
| Glycosaminoglycan-protein linkage region biosynthesis | R-HSA-1971475 | 9.762129e-01 | 0.010 | 0 | 0 |
| Hyaluronan metabolism | R-HSA-2142845 | 9.762129e-01 | 0.010 | 0 | 0 |
| Immune System | R-HSA-168256 | 9.784231e-01 | 0.009 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 9.786000e-01 | 0.009 | 0 | 0 |
| Fructose metabolism | R-HSA-5652084 | 9.786000e-01 | 0.009 | 0 | 0 |
| Acyl chain remodelling of PE | R-HSA-1482839 | 9.788388e-01 | 0.009 | 0 | 0 |
| Transferrin endocytosis and recycling | R-HSA-917977 | 9.788388e-01 | 0.009 | 0 | 0 |
| Synthesis of PC | R-HSA-1483191 | 9.805722e-01 | 0.009 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 9.807250e-01 | 0.008 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 9.807903e-01 | 0.008 | 0 | 0 |
| G beta:gamma signalling through PI3Kgamma | R-HSA-392451 | 9.813478e-01 | 0.008 | 0 | 0 |
| Mitochondrial mRNA modification | R-HSA-9937008 | 9.813478e-01 | 0.008 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 9.813987e-01 | 0.008 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 9.816805e-01 | 0.008 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 9.833074e-01 | 0.007 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 9.833511e-01 | 0.007 | 0 | 0 |
| Complex III assembly | R-HSA-9865881 | 9.837428e-01 | 0.007 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 9.851384e-01 | 0.007 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 9.856745e-01 | 0.006 | 0 | 0 |
| Synthesis of PIPs at the early endosome membrane | R-HSA-1660516 | 9.858305e-01 | 0.006 | 0 | 0 |
| Glycogen breakdown (glycogenolysis) | R-HSA-70221 | 9.858305e-01 | 0.006 | 0 | 0 |
| Diseases of carbohydrate metabolism | R-HSA-5663084 | 9.861616e-01 | 0.006 | 0 | 0 |
| Diseases of branched-chain amino acid catabolism | R-HSA-9865118 | 9.876501e-01 | 0.005 | 0 | 0 |
| Adrenaline,noradrenaline inhibits insulin secretion | R-HSA-400042 | 9.876501e-01 | 0.005 | 0 | 0 |
| Urea cycle | R-HSA-70635 | 9.876501e-01 | 0.005 | 0 | 0 |
| Abacavir ADME | R-HSA-2161522 | 9.876501e-01 | 0.005 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 9.878220e-01 | 0.005 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 9.881135e-01 | 0.005 | 0 | 0 |
| Mitochondrial tRNA aminoacylation | R-HSA-379726 | 9.882800e-01 | 0.005 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 9.886437e-01 | 0.005 | 1 | 0 |
| Leishmania infection | R-HSA-9658195 | 9.886437e-01 | 0.005 | 1 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 9.892362e-01 | 0.005 | 0 | 0 |
| Signaling by BMP | R-HSA-201451 | 9.892362e-01 | 0.005 | 0 | 0 |
| Maturation of hRSV A proteins | R-HSA-9828806 | 9.892362e-01 | 0.005 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 9.897933e-01 | 0.004 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 9.906186e-01 | 0.004 | 0 | 0 |
| Iron assimilation using enterobactin | R-HSA-9638334 | 9.906186e-01 | 0.004 | 0 | 0 |
| Pyrimidine salvage | R-HSA-73614 | 9.906186e-01 | 0.004 | 0 | 0 |
| SLC-mediated transport of neurotransmitters | R-HSA-442660 | 9.907704e-01 | 0.004 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 9.910118e-01 | 0.004 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.917569e-01 | 0.004 | 0 | 0 |
| Paracetamol ADME | R-HSA-9753281 | 9.917932e-01 | 0.004 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 9.918236e-01 | 0.004 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 9.928041e-01 | 0.003 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 9.928739e-01 | 0.003 | 0 | 0 |
| Neurotransmitter clearance | R-HSA-112311 | 9.928739e-01 | 0.003 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 9.934117e-01 | 0.003 | 0 | 0 |
| Surfactant metabolism | R-HSA-5683826 | 9.935654e-01 | 0.003 | 0 | 0 |
| Methylation | R-HSA-156581 | 9.935654e-01 | 0.003 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 9.935654e-01 | 0.003 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 9.935795e-01 | 0.003 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 9.939281e-01 | 0.003 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 9.939281e-01 | 0.003 | 0 | 0 |
| Diseases associated with glycosaminoglycan metabolism | R-HSA-3560782 | 9.942978e-01 | 0.002 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 9.945236e-01 | 0.002 | 0 | 0 |
| HS-GAG degradation | R-HSA-2024096 | 9.945871e-01 | 0.002 | 0 | 0 |
| DAG1 glycosylations | R-HSA-8931838 | 9.945871e-01 | 0.002 | 0 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 9.947191e-01 | 0.002 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 9.947191e-01 | 0.002 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 9.947298e-01 | 0.002 | 0 | 0 |
| Defective B3GALTL causes PpS | R-HSA-5083635 | 9.952825e-01 | 0.002 | 0 | 0 |
| CS/DS degradation | R-HSA-2024101 | 9.958886e-01 | 0.002 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 9.958886e-01 | 0.002 | 0 | 0 |
| Vitamin B5 (pantothenate) metabolism | R-HSA-199220 | 9.958886e-01 | 0.002 | 0 | 0 |
| Heme degradation | R-HSA-189483 | 9.958886e-01 | 0.002 | 0 | 0 |
| Plasma lipoprotein remodeling | R-HSA-8963899 | 9.960384e-01 | 0.002 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 9.962204e-01 | 0.002 | 0 | 0 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | R-HSA-6814122 | 9.964169e-01 | 0.002 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 9.964169e-01 | 0.002 | 0 | 0 |
| Regulation of TLR by endogenous ligand | R-HSA-5686938 | 9.964169e-01 | 0.002 | 0 | 0 |
| Phosphate bond hydrolysis by NUDT proteins | R-HSA-2393930 | 9.964169e-01 | 0.002 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 9.964290e-01 | 0.002 | 0 | 0 |
| Glyoxylate metabolism and glycine degradation | R-HSA-389661 | 9.964931e-01 | 0.002 | 0 | 0 |
| Chemokine receptors bind chemokines | R-HSA-380108 | 9.964931e-01 | 0.002 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 9.965896e-01 | 0.001 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 9.967543e-01 | 0.001 | 0 | 0 |
| Defects in vitamin and cofactor metabolism | R-HSA-3296482 | 9.968773e-01 | 0.001 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 9.968964e-01 | 0.001 | 0 | 0 |
| HS-GAG biosynthesis | R-HSA-2022928 | 9.972786e-01 | 0.001 | 0 | 0 |
| Triglyceride catabolism | R-HSA-163560 | 9.972786e-01 | 0.001 | 0 | 0 |
| O-glycosylation of TSR domain-containing proteins | R-HSA-5173214 | 9.976283e-01 | 0.001 | 0 | 0 |
| Metabolism of folate and pterines | R-HSA-196757 | 9.976283e-01 | 0.001 | 0 | 0 |
| tRNA processing in the mitochondrion | R-HSA-6785470 | 9.979331e-01 | 0.001 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 9.979331e-01 | 0.001 | 0 | 0 |
| Purine salvage | R-HSA-74217 | 9.979331e-01 | 0.001 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 9.979396e-01 | 0.001 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 9.981316e-01 | 0.001 | 0 | 0 |
| Pentose phosphate pathway | R-HSA-71336 | 9.981988e-01 | 0.001 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | R-HSA-381771 | 9.981988e-01 | 0.001 | 0 | 0 |
| rRNA processing in the mitochondrion | R-HSA-8868766 | 9.984303e-01 | 0.001 | 0 | 0 |
| Tryptophan catabolism | R-HSA-71240 | 9.984303e-01 | 0.001 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 9.985161e-01 | 0.001 | 0 | 0 |
| Aflatoxin activation and detoxification | R-HSA-5423646 | 9.986321e-01 | 0.001 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 9.986380e-01 | 0.001 | 0 | 0 |
| Scavenging by Class A Receptors | R-HSA-3000480 | 9.988079e-01 | 0.001 | 0 | 0 |
| Incretin synthesis, secretion, and inactivation | R-HSA-400508 | 9.989612e-01 | 0.000 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 9.989996e-01 | 0.000 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 9.990219e-01 | 0.000 | 0 | 0 |
| Synthesis of very long-chain fatty acyl-CoAs | R-HSA-75876 | 9.990947e-01 | 0.000 | 0 | 0 |
| Synthesis of Leukotrienes (LT) and Eoxins (EX) | R-HSA-2142691 | 9.992111e-01 | 0.000 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 9.993125e-01 | 0.000 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 9.993313e-01 | 0.000 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 9.994009e-01 | 0.000 | 0 | 0 |
| CD22 mediated BCR regulation | R-HSA-5690714 | 9.994515e-01 | 0.000 | 0 | 0 |
| Mitochondrial ribosome-associated quality control | R-HSA-9937383 | 9.994884e-01 | 0.000 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 9.995451e-01 | 0.000 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 9.995847e-01 | 0.000 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 9.996234e-01 | 0.000 | 0 | 0 |
| Nicotinate metabolism | R-HSA-196807 | 9.996234e-01 | 0.000 | 0 | 0 |
| Synthesis of Prostaglandins (PG) and Thromboxanes (TX) | R-HSA-2162123 | 9.996546e-01 | 0.000 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 9.996566e-01 | 0.000 | 0 | 0 |
| O-linked glycosylation of mucins | R-HSA-913709 | 9.996679e-01 | 0.000 | 0 | 0 |
| Branched-chain amino acid catabolism | R-HSA-70895 | 9.996990e-01 | 0.000 | 0 | 0 |
| Complex IV assembly | R-HSA-9864848 | 9.996990e-01 | 0.000 | 0 | 0 |
| Cytosolic sulfonation of small molecules | R-HSA-156584 | 9.996990e-01 | 0.000 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 9.996990e-01 | 0.000 | 0 | 0 |
| Nucleotide biosynthesis | R-HSA-8956320 | 9.997715e-01 | 0.000 | 0 | 0 |
| Retinoid metabolism and transport | R-HSA-975634 | 9.997724e-01 | 0.000 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 9.997868e-01 | 0.000 | 0 | 0 |
| Purine catabolism | R-HSA-74259 | 9.997994e-01 | 0.000 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 9.997994e-01 | 0.000 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.998044e-01 | 0.000 | 0 | 0 |
| Aspirin ADME | R-HSA-9749641 | 9.998233e-01 | 0.000 | 0 | 0 |
| Chondroitin sulfate/dermatan sulfate metabolism | R-HSA-1793185 | 9.998265e-01 | 0.000 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 9.998265e-01 | 0.000 | 0 | 0 |
| ROS and RNS production in phagocytes | R-HSA-1222556 | 9.998443e-01 | 0.000 | 0 | 0 |
| Synthesis of PA | R-HSA-1483166 | 9.998683e-01 | 0.000 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 9.998756e-01 | 0.000 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 9.998869e-01 | 0.000 | 0 | 0 |
| Heparan sulfate/heparin (HS-GAG) metabolism | R-HSA-1638091 | 9.999000e-01 | 0.000 | 0 | 0 |
| Sialic acid metabolism | R-HSA-4085001 | 9.999000e-01 | 0.000 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 9.999033e-01 | 0.000 | 0 | 0 |
| SLC-mediated transport of organic anions | R-HSA-9955298 | 9.999062e-01 | 0.000 | 0 | 0 |
| Cholesterol biosynthesis | R-HSA-191273 | 9.999062e-01 | 0.000 | 0 | 0 |
| Interleukin-10 signaling | R-HSA-6783783 | 9.999062e-01 | 0.000 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 9.999063e-01 | 0.000 | 1 | 0 |
| RAB geranylgeranylation | R-HSA-8873719 | 9.999129e-01 | 0.000 | 0 | 0 |
| Glutathione conjugation | R-HSA-156590 | 9.999129e-01 | 0.000 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 9.999155e-01 | 0.000 | 1 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 9.999155e-01 | 0.000 | 1 | 0 |
| Platelet homeostasis | R-HSA-418346 | 9.999233e-01 | 0.000 | 0 | 0 |
| Nucleotide salvage | R-HSA-8956321 | 9.999241e-01 | 0.000 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 9.999241e-01 | 0.000 | 0 | 0 |
| Endogenous sterols | R-HSA-211976 | 9.999241e-01 | 0.000 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 9.999270e-01 | 0.000 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 9.999280e-01 | 0.000 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 9.999280e-01 | 0.000 | 0 | 0 |
| Metabolism of fat-soluble vitamins | R-HSA-6806667 | 9.999360e-01 | 0.000 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 9.999469e-01 | 0.000 | 0 | 0 |
| Xenobiotics | R-HSA-211981 | 9.999498e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation elongation | R-HSA-5389840 | 9.999498e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation initiation | R-HSA-5368286 | 9.999606e-01 | 0.000 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 9.999606e-01 | 0.000 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 9.999764e-01 | 0.000 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 9.999784e-01 | 0.000 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 9.999809e-01 | 0.000 | 0 | 0 |
| Metal ion assimilation from the host | R-HSA-9638482 | 9.999809e-01 | 0.000 | 0 | 0 |
| Metabolism of porphyrins | R-HSA-189445 | 9.999809e-01 | 0.000 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.999851e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation termination | R-HSA-5419276 | 9.999909e-01 | 0.000 | 0 | 0 |
| Developmental Lineage of Pancreatic Acinar Cells | R-HSA-9925561 | 9.999936e-01 | 0.000 | 0 | 0 |
| Metabolic disorders of biological oxidation enzymes | R-HSA-5579029 | 9.999936e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation | R-HSA-5368287 | 9.999944e-01 | 0.000 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 9.999957e-01 | 0.000 | 0 | 0 |
| Disease | R-HSA-1643685 | 9.999960e-01 | 0.000 | 1 | 0 |
| Keratinization | R-HSA-6805567 | 9.999969e-01 | 0.000 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.999973e-01 | 0.000 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 9.999976e-01 | 0.000 | 0 | 0 |
| Post-translational modification: synthesis of GPI-anchored proteins | R-HSA-163125 | 9.999980e-01 | 0.000 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 9.999984e-01 | 0.000 | 0 | 0 |
| Class B/2 (Secretin family receptors) | R-HSA-373080 | 9.999988e-01 | 0.000 | 0 | 0 |
| O-linked glycosylation | R-HSA-5173105 | 9.999989e-01 | 0.000 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 9.999991e-01 | 0.000 | 0 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 9.999992e-01 | 0.000 | 0 | 0 |
| Mitochondrial Fatty Acid Beta-Oxidation | R-HSA-77289 | 9.999995e-01 | 0.000 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.999998e-01 | 0.000 | 0 | 0 |
| Regulation of Complement cascade | R-HSA-977606 | 9.999999e-01 | 0.000 | 0 | 0 |
| Nucleotide catabolism | R-HSA-8956319 | 9.999999e-01 | 0.000 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 1.000000e+00 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 1.000000e+00 | 0.000 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 1.000000e+00 | 0.000 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 1.000000e+00 | 0.000 | 0 | 0 |
| Complement cascade | R-HSA-166658 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 1.000000e+00 | 0.000 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 1.000000e+00 | 0.000 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 1.000000e+00 | 0.000 | 0 | 0 |
| Synthesis of substrates in N-glycan biosythesis | R-HSA-446219 | 1.000000e+00 | 0.000 | 0 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 1.000000e+00 | 0.000 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 1.000000e+00 | 0.000 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 1.000000e+00 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 1.000000e+00 | 0.000 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 1.000000e+00 | 0.000 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 1.000000e+00 | 0.000 | 0 | 0 |
| Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein | R-HSA-446193 | 1.000000e+00 | 0.000 | 0 | 0 |
| Cytochrome P450 - arranged by substrate type | R-HSA-211897 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase II - Conjugation of compounds | R-HSA-156580 | 1.000000e+00 | 0.000 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 1.000000e+00 | 0.000 | 0 | 0 |
| Infection with Enterobacteria | R-HSA-9640148 | 1.000000e+00 | 0.000 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 1.000000e+00 | 0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 1.000000e+00 | 0.000 | 0 | 0 |
| Expression and translocation of olfactory receptors | R-HSA-9752946 | 1.000000e+00 | -0.000 | 0 | 0 |
| Olfactory Signaling Pathway | R-HSA-381753 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 1.000000e+00 | -0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 1.000000e+00 | -0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000e+00 | -0.000 | 0 | 0 |
Top15 pathways (red highlights are reference pathways)
Compared with reference pathways
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Cell Cycle | R-HSA-1640170 | 1.423528e-12 | 11.847 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 4.262772e-10 | 9.370 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 2.332427e-09 | 8.632 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 2.293397e-09 | 8.640 | 0 | 0 |
| M Phase | R-HSA-68886 | 1.351238e-08 | 7.869 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 2.277137e-08 | 7.643 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 2.596883e-08 | 7.586 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 2.596883e-08 | 7.586 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 4.715729e-08 | 7.326 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 6.254521e-08 | 7.204 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 6.724210e-08 | 7.172 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 9.122071e-08 | 7.040 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 1.034184e-07 | 6.985 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 1.200820e-07 | 6.921 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 1.608769e-07 | 6.794 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 2.399773e-07 | 6.620 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 3.065714e-07 | 6.513 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 3.532158e-07 | 6.452 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 9.974303e-07 | 6.001 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 1.227118e-06 | 5.911 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 1.450618e-06 | 5.838 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 1.482874e-06 | 5.829 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 1.637255e-06 | 5.786 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 1.596544e-06 | 5.797 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 1.863895e-06 | 5.730 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 2.226091e-06 | 5.652 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 2.495088e-06 | 5.603 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 2.555288e-06 | 5.593 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 2.836504e-06 | 5.547 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 3.073602e-06 | 5.512 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 5.144250e-06 | 5.289 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 5.665458e-06 | 5.247 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 5.921568e-06 | 5.228 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 6.095549e-06 | 5.215 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 6.923270e-06 | 5.160 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 7.087820e-06 | 5.149 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 8.329475e-06 | 5.079 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 8.329475e-06 | 5.079 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 9.957922e-06 | 5.002 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 1.189554e-05 | 4.925 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 1.201955e-05 | 4.920 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 1.317139e-05 | 4.880 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 1.292512e-05 | 4.889 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 1.336824e-05 | 4.874 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 1.541902e-05 | 4.812 | 1 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 2.277609e-05 | 4.643 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 2.277609e-05 | 4.643 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 4.645537e-05 | 4.333 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 4.705023e-05 | 4.327 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 5.799437e-05 | 4.237 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 5.799437e-05 | 4.237 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 7.373361e-05 | 4.132 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 7.922020e-05 | 4.101 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 8.127944e-05 | 4.090 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 8.777838e-05 | 4.057 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 9.863226e-05 | 4.006 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 1.032780e-04 | 3.986 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 1.071420e-04 | 3.970 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 1.525723e-04 | 3.817 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 1.492675e-04 | 3.826 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 1.628784e-04 | 3.788 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 1.568235e-04 | 3.805 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 1.568235e-04 | 3.805 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 1.675428e-04 | 3.776 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 1.697931e-04 | 3.770 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 1.872924e-04 | 3.727 | 0 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 1.989083e-04 | 3.701 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 2.040206e-04 | 3.690 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 2.445901e-04 | 3.612 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 2.770296e-04 | 3.557 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 2.986724e-04 | 3.525 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 3.004293e-04 | 3.522 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 3.142099e-04 | 3.503 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 3.239920e-04 | 3.489 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 3.458226e-04 | 3.461 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 3.521036e-04 | 3.453 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 3.457804e-04 | 3.461 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 3.858779e-04 | 3.414 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 4.249357e-04 | 3.372 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 4.343538e-04 | 3.362 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 4.766947e-04 | 3.322 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 4.845593e-04 | 3.315 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 4.883323e-04 | 3.311 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 5.211029e-04 | 3.283 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 5.211029e-04 | 3.283 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 5.291920e-04 | 3.276 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 6.046969e-04 | 3.218 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 6.418070e-04 | 3.193 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 6.649435e-04 | 3.177 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 7.510173e-04 | 3.124 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 7.519044e-04 | 3.124 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 7.805549e-04 | 3.108 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 8.818821e-04 | 3.055 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 8.818821e-04 | 3.055 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 9.333823e-04 | 3.030 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 1.001210e-03 | 2.999 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 9.973283e-04 | 3.001 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 1.001210e-03 | 2.999 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 1.075208e-03 | 2.969 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 1.131256e-03 | 2.946 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 1.134038e-03 | 2.945 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 1.227083e-03 | 2.911 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 1.256568e-03 | 2.901 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 1.371124e-03 | 2.863 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 1.348344e-03 | 2.870 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 1.410818e-03 | 2.851 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 1.435853e-03 | 2.843 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 1.435853e-03 | 2.843 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 1.570620e-03 | 2.804 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 1.759247e-03 | 2.755 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 1.836147e-03 | 2.736 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 1.767662e-03 | 2.753 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 1.728653e-03 | 2.762 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 2.036486e-03 | 2.691 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 2.134389e-03 | 2.671 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 2.211200e-03 | 2.655 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 2.217196e-03 | 2.654 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 2.287435e-03 | 2.641 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 2.403748e-03 | 2.619 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 2.623316e-03 | 2.581 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 2.623316e-03 | 2.581 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 2.727878e-03 | 2.564 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 2.727878e-03 | 2.564 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 3.041695e-03 | 2.517 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 3.111697e-03 | 2.507 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 3.200072e-03 | 2.495 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 3.281437e-03 | 2.484 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 3.284009e-03 | 2.484 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 3.330180e-03 | 2.478 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 3.496924e-03 | 2.456 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 3.962803e-03 | 2.402 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 3.950410e-03 | 2.403 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 3.973058e-03 | 2.401 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 3.984383e-03 | 2.400 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 4.279814e-03 | 2.369 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 4.515316e-03 | 2.345 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 4.515316e-03 | 2.345 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 4.541350e-03 | 2.343 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 4.593668e-03 | 2.338 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 4.728065e-03 | 2.325 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 4.728065e-03 | 2.325 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 4.754862e-03 | 2.323 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 5.286857e-03 | 2.277 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 5.347225e-03 | 2.272 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 5.789870e-03 | 2.237 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 6.033054e-03 | 2.219 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 6.054039e-03 | 2.218 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 6.447727e-03 | 2.191 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 6.591246e-03 | 2.181 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 7.467119e-03 | 2.127 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 7.467119e-03 | 2.127 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 7.377327e-03 | 2.132 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 6.894196e-03 | 2.162 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 7.377327e-03 | 2.132 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 7.377327e-03 | 2.132 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 7.746943e-03 | 2.111 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 7.746943e-03 | 2.111 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 7.885850e-03 | 2.103 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 7.961334e-03 | 2.099 | 0 | 0 |
| Depurination | R-HSA-73927 | 8.138781e-03 | 2.089 | 0 | 0 |
| G beta:gamma signalling through PI3Kgamma | R-HSA-392451 | 8.313014e-03 | 2.080 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 8.489520e-03 | 2.071 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 8.701528e-03 | 2.060 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 8.875090e-03 | 2.052 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 8.899859e-03 | 2.051 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 9.108174e-03 | 2.041 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 9.552461e-03 | 2.020 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 1.008520e-02 | 1.996 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 1.013610e-02 | 1.994 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 9.710725e-03 | 2.013 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 9.972998e-03 | 2.001 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 9.964057e-03 | 2.002 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 1.013610e-02 | 1.994 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 1.218316e-02 | 1.914 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 1.218316e-02 | 1.914 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 1.218316e-02 | 1.914 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 1.218316e-02 | 1.914 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 1.218316e-02 | 1.914 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 1.218316e-02 | 1.914 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 1.218316e-02 | 1.914 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 1.218316e-02 | 1.914 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 1.218316e-02 | 1.914 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 1.218316e-02 | 1.914 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 1.218316e-02 | 1.914 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 1.237839e-02 | 1.907 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 1.281754e-02 | 1.892 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 1.291607e-02 | 1.889 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 1.294514e-02 | 1.888 | 0 | 0 |
| MASTL Facilitates Mitotic Progression | R-HSA-2465910 | 1.457993e-02 | 1.836 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 1.457993e-02 | 1.836 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 1.358437e-02 | 1.867 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 1.424624e-02 | 1.846 | 1 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 1.463764e-02 | 1.835 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 1.486709e-02 | 1.828 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 1.513977e-02 | 1.820 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 1.581942e-02 | 1.801 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 1.604965e-02 | 1.795 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 1.637484e-02 | 1.786 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 1.693617e-02 | 1.771 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 1.710226e-02 | 1.767 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 1.710226e-02 | 1.767 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 1.730744e-02 | 1.762 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 1.765765e-02 | 1.753 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 1.776554e-02 | 1.750 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 1.883395e-02 | 1.725 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 1.888280e-02 | 1.724 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 1.888280e-02 | 1.724 | 0 | 0 |
| 2-LTR circle formation | R-HSA-164843 | 1.980720e-02 | 1.703 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 2.051764e-02 | 1.688 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 2.075489e-02 | 1.683 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 2.166362e-02 | 1.664 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 2.166362e-02 | 1.664 | 0 | 0 |
| Loss of MECP2 binding ability to 5mC-DNA | R-HSA-9022538 | 2.184463e-02 | 1.661 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 2.197965e-02 | 1.658 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 2.223458e-02 | 1.653 | 0 | 0 |
| Loss of MECP2 binding ability to 5hmC-DNA | R-HSA-9022534 | 2.361074e-02 | 1.627 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 2.442994e-02 | 1.612 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 2.513065e-02 | 1.600 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 2.557682e-02 | 1.592 | 0 | 0 |
| ChREBP activates metabolic gene expression | R-HSA-163765 | 2.613083e-02 | 1.583 | 0 | 0 |
| G beta:gamma signalling through BTK | R-HSA-8964315 | 2.634318e-02 | 1.579 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 2.634318e-02 | 1.579 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 2.797772e-02 | 1.553 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 2.878048e-02 | 1.541 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 2.878991e-02 | 1.541 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 2.905231e-02 | 1.537 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 2.925072e-02 | 1.534 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 2.925072e-02 | 1.534 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 2.995978e-02 | 1.523 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 3.013740e-02 | 1.521 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 3.013740e-02 | 1.521 | 0 | 0 |
| MTF1 activates gene expression | R-HSA-5660489 | 3.467268e-02 | 1.460 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 3.467268e-02 | 1.460 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 3.361462e-02 | 1.473 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 3.361462e-02 | 1.473 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 3.257223e-02 | 1.487 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 3.342245e-02 | 1.476 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 3.314463e-02 | 1.480 | 0 | 0 |
| Integration of provirus | R-HSA-162592 | 3.361462e-02 | 1.473 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 3.342245e-02 | 1.476 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 3.416902e-02 | 1.466 | 0 | 0 |
| AKT-mediated inactivation of FOXO1A | R-HSA-211163 | 3.467268e-02 | 1.460 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 3.560785e-02 | 1.448 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 3.166819e-02 | 1.499 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 3.560785e-02 | 1.448 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 3.788170e-02 | 1.422 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 3.807999e-02 | 1.419 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 3.807999e-02 | 1.419 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 3.835280e-02 | 1.416 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 3.968566e-02 | 1.401 | 0 | 0 |
| S Phase | R-HSA-69242 | 3.990749e-02 | 1.399 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 4.056055e-02 | 1.392 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 4.080927e-02 | 1.389 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 4.116741e-02 | 1.385 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 4.230444e-02 | 1.374 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 4.271732e-02 | 1.369 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 4.328226e-02 | 1.364 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 4.333578e-02 | 1.363 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 4.375153e-02 | 1.359 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 4.386734e-02 | 1.358 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 4.387721e-02 | 1.358 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 4.387721e-02 | 1.358 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 4.415296e-02 | 1.355 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 4.456090e-02 | 1.351 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 4.489757e-02 | 1.348 | 0 | 0 |
| Manipulation of host energy metabolism | R-HSA-9636667 | 4.922328e-02 | 1.308 | 0 | 0 |
| Post-transcriptional silencing by small RNAs | R-HSA-426496 | 5.060288e-02 | 1.296 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 5.051038e-02 | 1.297 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 5.051038e-02 | 1.297 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 5.522927e-02 | 1.258 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 5.338672e-02 | 1.273 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 5.451674e-02 | 1.263 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 5.222793e-02 | 1.282 | 0 | 0 |
| Unwinding of DNA | R-HSA-176974 | 5.469821e-02 | 1.262 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to lipogenesis | R-HSA-9029558 | 5.222793e-02 | 1.282 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 5.510797e-02 | 1.259 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 5.643037e-02 | 1.248 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 4.922328e-02 | 1.308 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 5.429451e-02 | 1.265 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 4.859467e-02 | 1.313 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 5.451674e-02 | 1.263 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 5.457701e-02 | 1.263 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 5.071010e-02 | 1.295 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 5.557541e-02 | 1.255 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 5.062236e-02 | 1.296 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 5.667392e-02 | 1.247 | 0 | 0 |
| G beta:gamma signalling through PLC beta | R-HSA-418217 | 5.667392e-02 | 1.247 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 5.667392e-02 | 1.247 | 0 | 0 |
| Presynaptic function of Kainate receptors | R-HSA-500657 | 5.667392e-02 | 1.247 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 5.670289e-02 | 1.246 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 5.719428e-02 | 1.243 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 5.736348e-02 | 1.241 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 5.775870e-02 | 1.238 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 5.804956e-02 | 1.236 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 5.804956e-02 | 1.236 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 5.804956e-02 | 1.236 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 5.804956e-02 | 1.236 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 5.804956e-02 | 1.236 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 5.808080e-02 | 1.236 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 5.825624e-02 | 1.235 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 6.080402e-02 | 1.216 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 6.089575e-02 | 1.215 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 6.089575e-02 | 1.215 | 0 | 0 |
| Protein folding | R-HSA-391251 | 6.152249e-02 | 1.211 | 0 | 0 |
| Kinesins | R-HSA-983189 | 6.268889e-02 | 1.203 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 6.329019e-02 | 1.199 | 0 | 0 |
| Regulation of CDH1 mRNA translation by microRNAs | R-HSA-9764562 | 6.339481e-02 | 1.198 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 6.563270e-02 | 1.183 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 6.563270e-02 | 1.183 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 6.568990e-02 | 1.183 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 6.600202e-02 | 1.180 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 6.600202e-02 | 1.180 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 6.689072e-02 | 1.175 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 6.773954e-02 | 1.169 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 6.773954e-02 | 1.169 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 6.791577e-02 | 1.168 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 6.903037e-02 | 1.161 | 0 | 0 |
| Phosphorylation of Emi1 | R-HSA-176417 | 6.946267e-02 | 1.158 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 7.742849e-02 | 1.111 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 7.413899e-02 | 1.130 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 7.413899e-02 | 1.130 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 7.413899e-02 | 1.130 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 7.413899e-02 | 1.130 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 7.111156e-02 | 1.148 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 7.784175e-02 | 1.109 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 6.965636e-02 | 1.157 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 8.037356e-02 | 1.095 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 8.561540e-02 | 1.067 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 7.454310e-02 | 1.128 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 8.491539e-02 | 1.071 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 7.742849e-02 | 1.111 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 7.646093e-02 | 1.117 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 7.646093e-02 | 1.117 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 7.111156e-02 | 1.148 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 8.375754e-02 | 1.077 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 7.454310e-02 | 1.128 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 7.095571e-02 | 1.149 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 8.415810e-02 | 1.075 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 7.053784e-02 | 1.152 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 7.499260e-02 | 1.125 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 8.684636e-02 | 1.061 | 1 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 7.579770e-02 | 1.120 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 7.579770e-02 | 1.120 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 7.042311e-02 | 1.152 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 7.534839e-02 | 1.123 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 7.579770e-02 | 1.120 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 7.571656e-02 | 1.121 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 8.728424e-02 | 1.059 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 8.774467e-02 | 1.057 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 8.784446e-02 | 1.056 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 8.848539e-02 | 1.053 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in apoptosis | R-HSA-9824594 | 8.921418e-02 | 1.050 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 8.941317e-02 | 1.049 | 0 | 0 |
| Activation of NIMA Kinases NEK9, NEK6, NEK7 | R-HSA-2980767 | 9.100528e-02 | 1.041 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 9.305459e-02 | 1.031 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 9.305459e-02 | 1.031 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 9.305459e-02 | 1.031 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 9.305459e-02 | 1.031 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 9.305459e-02 | 1.031 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 9.313272e-02 | 1.031 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 9.494953e-02 | 1.023 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 9.675541e-02 | 1.014 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 9.675541e-02 | 1.014 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 9.719846e-02 | 1.012 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 9.787123e-02 | 1.009 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 9.934144e-02 | 1.003 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 1.014237e-01 | 0.994 | 0 | 0 |
| Drug resistance of FLT3 mutants | R-HSA-9702506 | 1.108019e-01 | 0.955 | 0 | 0 |
| Defective Base Excision Repair Associated with NEIL1 | R-HSA-9616334 | 1.108019e-01 | 0.955 | 0 | 0 |
| FLT3 mutants bind TKIs | R-HSA-9702509 | 1.108019e-01 | 0.955 | 0 | 0 |
| tamatinib-resistant FLT3 mutants | R-HSA-9703009 | 1.108019e-01 | 0.955 | 0 | 0 |
| tandutinib-resistant FLT3 mutants | R-HSA-9702636 | 1.108019e-01 | 0.955 | 0 | 0 |
| sorafenib-resistant FLT3 mutants | R-HSA-9702624 | 1.108019e-01 | 0.955 | 0 | 0 |
| sunitinib-resistant FLT3 mutants | R-HSA-9702632 | 1.108019e-01 | 0.955 | 0 | 0 |
| pexidartinib-resistant FLT3 mutants | R-HSA-9702605 | 1.108019e-01 | 0.955 | 0 | 0 |
| midostaurin-resistant FLT3 mutants | R-HSA-9702600 | 1.108019e-01 | 0.955 | 0 | 0 |
| semaxanib-resistant FLT3 mutants | R-HSA-9702577 | 1.108019e-01 | 0.955 | 0 | 0 |
| lestaurtinib-resistant FLT3 mutants | R-HSA-9702596 | 1.108019e-01 | 0.955 | 0 | 0 |
| ponatinib-resistant FLT3 mutants | R-HSA-9702614 | 1.108019e-01 | 0.955 | 0 | 0 |
| KW2449-resistant FLT3 mutants | R-HSA-9702569 | 1.108019e-01 | 0.955 | 0 | 0 |
| linifanib-resistant FLT3 mutants | R-HSA-9702998 | 1.108019e-01 | 0.955 | 0 | 0 |
| quizartinib-resistant FLT3 mutants | R-HSA-9702620 | 1.108019e-01 | 0.955 | 0 | 0 |
| gilteritinib-resistant FLT3 mutants | R-HSA-9702590 | 1.108019e-01 | 0.955 | 0 | 0 |
| crenolanib-resistant FLT3 mutants | R-HSA-9702581 | 1.108019e-01 | 0.955 | 0 | 0 |
| Diseases of Mismatch Repair (MMR) | R-HSA-5423599 | 1.176700e-01 | 0.929 | 0 | 0 |
| Signaling by cytosolic PDGFRA and PDGFRB fusion proteins | R-HSA-9673766 | 1.176700e-01 | 0.929 | 0 | 0 |
| 3-Methylcrotonyl-CoA carboxylase deficiency | R-HSA-9909438 | 1.176700e-01 | 0.929 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 1.149365e-01 | 0.940 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 1.149365e-01 | 0.940 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 1.025081e-01 | 0.989 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 1.216189e-01 | 0.915 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 1.216189e-01 | 0.915 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 1.216189e-01 | 0.915 | 0 | 0 |
| Advanced glycosylation endproduct receptor signaling | R-HSA-879415 | 1.216189e-01 | 0.915 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 1.216189e-01 | 0.915 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 1.216189e-01 | 0.915 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 1.216189e-01 | 0.915 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 1.216189e-01 | 0.915 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 1.042032e-01 | 0.982 | 0 | 0 |
| Antigen processing: Ub, ATP-independent proteasomal degradation | R-HSA-9912633 | 1.042032e-01 | 0.982 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 1.201168e-01 | 0.920 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 1.201168e-01 | 0.920 | 0 | 0 |
| Regulation of PTEN mRNA translation | R-HSA-8943723 | 1.299732e-01 | 0.886 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 1.222331e-01 | 0.913 | 0 | 0 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | R-HSA-6814122 | 1.144781e-01 | 0.941 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 1.069765e-01 | 0.971 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 1.069765e-01 | 0.971 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 1.069765e-01 | 0.971 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 1.069765e-01 | 0.971 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 1.183070e-01 | 0.927 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 1.041986e-01 | 0.982 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 1.026556e-01 | 0.989 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 1.314301e-01 | 0.881 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 1.104108e-01 | 0.957 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 1.034570e-01 | 0.985 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 1.266777e-01 | 0.897 | 0 | 0 |
| G beta:gamma signalling through CDC42 | R-HSA-8964616 | 1.042032e-01 | 0.982 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 1.020582e-01 | 0.991 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 1.019186e-01 | 0.992 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 1.216189e-01 | 0.915 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 1.341155e-01 | 0.873 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 1.069765e-01 | 0.971 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 1.288741e-01 | 0.890 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 1.116003e-01 | 0.952 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 1.270639e-01 | 0.896 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 1.019186e-01 | 0.992 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 1.018762e-01 | 0.992 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 1.144781e-01 | 0.941 | 0 | 0 |
| Regulation of MITF-M dependent genes involved in metabolism | R-HSA-9854907 | 1.176700e-01 | 0.929 | 0 | 0 |
| Defective HLCS causes multiple carboxylase deficiency | R-HSA-3371599 | 1.149365e-01 | 0.940 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 1.096915e-01 | 0.960 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 1.144781e-01 | 0.941 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 1.291000e-01 | 0.889 | 0 | 0 |
| Thrombin signalling through proteinase activated receptors (PARs) | R-HSA-456926 | 1.354728e-01 | 0.868 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 1.069765e-01 | 0.971 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 1.101096e-01 | 0.958 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 1.336241e-01 | 0.874 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 1.155160e-01 | 0.937 | 1 | 1 |
| RNA Polymerase II Transcription | R-HSA-73857 | 1.021510e-01 | 0.991 | 1 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 1.299732e-01 | 0.886 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 1.034570e-01 | 0.985 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 1.354728e-01 | 0.868 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 1.356228e-01 | 0.868 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 1.356228e-01 | 0.868 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 1.370916e-01 | 0.863 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 1.383207e-01 | 0.859 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 1.383351e-01 | 0.859 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 1.386790e-01 | 0.858 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 1.396450e-01 | 0.855 | 0 | 0 |
| Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation | R-HSA-9828211 | 1.409356e-01 | 0.851 | 0 | 0 |
| Regulation of NPAS4 mRNA translation | R-HSA-9768778 | 1.409356e-01 | 0.851 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 1.410232e-01 | 0.851 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 1.447775e-01 | 0.839 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 1.447775e-01 | 0.839 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 1 | R-HSA-418592 | 1.452501e-01 | 0.838 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 1.481385e-01 | 0.829 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 1.493832e-01 | 0.826 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 1.493832e-01 | 0.826 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 1.498941e-01 | 0.824 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 1.501056e-01 | 0.824 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 1.550556e-01 | 0.810 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 1.550556e-01 | 0.810 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 1.550556e-01 | 0.810 | 0 | 0 |
| Prostacyclin signalling through prostacyclin receptor | R-HSA-392851 | 1.550556e-01 | 0.810 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 1.550556e-01 | 0.810 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 2.093324e-01 | 0.679 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 2.093324e-01 | 0.679 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 2.093324e-01 | 0.679 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis Due to p14ARF Loss of Function | R-HSA-9645722 | 2.093324e-01 | 0.679 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH3 | R-HSA-5632927 | 2.093324e-01 | 0.679 | 0 | 0 |
| TICAM1 deficiency - HSE | R-HSA-5602566 | 2.093324e-01 | 0.679 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 2.093324e-01 | 0.679 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 2.093324e-01 | 0.679 | 0 | 0 |
| Defective Mismatch Repair Associated With PMS2 | R-HSA-5632987 | 2.093324e-01 | 0.679 | 0 | 0 |
| Defective SLC2A1 causes GLUT1 deficiency syndrome 1 (GLUT1DS1) | R-HSA-5619043 | 2.093324e-01 | 0.679 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH6 | R-HSA-5632968 | 2.093324e-01 | 0.679 | 0 | 0 |
| Defective Mismatch Repair Associated With MLH1 | R-HSA-5545483 | 2.093324e-01 | 0.679 | 0 | 0 |
| MECP2 regulates transcription of genes involved in GABA signaling | R-HSA-9022927 | 1.573826e-01 | 0.803 | 0 | 0 |
| TLR3-mediated TICAM1-dependent programmed cell death | R-HSA-9013957 | 1.573826e-01 | 0.803 | 0 | 0 |
| Inhibition of TSC complex formation by PKB | R-HSA-165181 | 1.573826e-01 | 0.803 | 0 | 0 |
| Loss of Function of FBXW7 in Cancer and NOTCH1 Signaling | R-HSA-2644607 | 1.573826e-01 | 0.803 | 0 | 0 |
| FBXW7 Mutants and NOTCH1 in Cancer | R-HSA-2644605 | 1.573826e-01 | 0.803 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 1.991304e-01 | 0.701 | 0 | 0 |
| Loss of phosphorylation of MECP2 at T308 | R-HSA-9022535 | 1.991304e-01 | 0.701 | 0 | 0 |
| FLT3 signaling by CBL mutants | R-HSA-9706377 | 1.991304e-01 | 0.701 | 0 | 0 |
| AKT phosphorylates targets in the nucleus | R-HSA-198693 | 1.686712e-01 | 0.773 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 1.686712e-01 | 0.773 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 1.978134e-01 | 0.704 | 0 | 0 |
| MECP2 regulates transcription of neuronal ligands | R-HSA-9022702 | 1.978134e-01 | 0.704 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 1.978134e-01 | 0.704 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 1.978134e-01 | 0.704 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 1.978134e-01 | 0.704 | 0 | 0 |
| DNA replication initiation | R-HSA-68952 | 1.978134e-01 | 0.704 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 2.280426e-01 | 0.642 | 0 | 0 |
| Regulation of CDH11 mRNA translation by microRNAs | R-HSA-9759811 | 2.280426e-01 | 0.642 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 2.280426e-01 | 0.642 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 2.280426e-01 | 0.642 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 2.280426e-01 | 0.642 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 1.867266e-01 | 0.729 | 0 | 0 |
| Competing endogenous RNAs (ceRNAs) regulate PTEN translation | R-HSA-8948700 | 1.867266e-01 | 0.729 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 1.867266e-01 | 0.729 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 1.867266e-01 | 0.729 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 1.739292e-01 | 0.760 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 1.739292e-01 | 0.760 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 1.739292e-01 | 0.760 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 1.739292e-01 | 0.760 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 1.739292e-01 | 0.760 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 2.105278e-01 | 0.677 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 1.936264e-01 | 0.713 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 1.936264e-01 | 0.713 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 2.351205e-01 | 0.629 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 2.351205e-01 | 0.629 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 1.780734e-01 | 0.749 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 2.140570e-01 | 0.669 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 1.955127e-01 | 0.709 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 2.135591e-01 | 0.670 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 2.135591e-01 | 0.670 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 1.948015e-01 | 0.710 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 2.321508e-01 | 0.634 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 1.738131e-01 | 0.760 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 1.738131e-01 | 0.760 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 1.896085e-01 | 0.722 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 1.860747e-01 | 0.730 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 1.860747e-01 | 0.730 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 1.860747e-01 | 0.730 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 1.860747e-01 | 0.730 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 2.117097e-01 | 0.674 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 2.250428e-01 | 0.648 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 2.328337e-01 | 0.633 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 1.822401e-01 | 0.739 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 1.701797e-01 | 0.769 | 0 | 0 |
| G-protein activation | R-HSA-202040 | 1.936264e-01 | 0.713 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 1.978134e-01 | 0.704 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 1.638728e-01 | 0.785 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 1.867266e-01 | 0.729 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 1.926325e-01 | 0.715 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 2.123018e-01 | 0.673 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 1.686712e-01 | 0.773 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 1.613007e-01 | 0.792 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 12 | R-HSA-392170 | 1.936264e-01 | 0.713 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 1.987134e-01 | 0.702 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 2.074377e-01 | 0.683 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 1.780734e-01 | 0.749 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 1.741510e-01 | 0.759 | 0 | 0 |
| Translation | R-HSA-72766 | 2.125387e-01 | 0.673 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 2.351205e-01 | 0.629 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 1.790848e-01 | 0.747 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 1.782369e-01 | 0.749 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 1.782888e-01 | 0.749 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 2.021087e-01 | 0.694 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 1.739292e-01 | 0.760 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 1.717005e-01 | 0.765 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 1.867266e-01 | 0.729 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 1.640494e-01 | 0.785 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 1.807567e-01 | 0.743 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 2.334137e-01 | 0.632 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 2.220091e-01 | 0.654 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 2.078093e-01 | 0.682 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 2.046401e-01 | 0.689 | 0 | 0 |
| Inhibition of PKR | R-HSA-169131 | 2.093324e-01 | 0.679 | 0 | 0 |
| Trafficking of myristoylated proteins to the cilium | R-HSA-5624138 | 1.991304e-01 | 0.701 | 0 | 0 |
| NrCAM interactions | R-HSA-447038 | 1.991304e-01 | 0.701 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 2.280426e-01 | 0.642 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 2.316360e-01 | 0.635 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 2.316360e-01 | 0.635 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 1.568361e-01 | 0.805 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 1.613007e-01 | 0.792 | 0 | 0 |
| Biotin transport and metabolism | R-HSA-196780 | 1.867266e-01 | 0.729 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 2.061513e-01 | 0.686 | 0 | 0 |
| CD163 mediating an anti-inflammatory response | R-HSA-9662834 | 2.280426e-01 | 0.642 | 1 | 1 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 1.686712e-01 | 0.773 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 1.955127e-01 | 0.709 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 1.790848e-01 | 0.747 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 1.644371e-01 | 0.784 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 2.078093e-01 | 0.682 | 0 | 0 |
| p75NTR negatively regulates cell cycle via SC1 | R-HSA-193670 | 1.573826e-01 | 0.803 | 0 | 0 |
| Defects in biotin (Btn) metabolism | R-HSA-3323169 | 1.686712e-01 | 0.773 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 1.936264e-01 | 0.713 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 1.936264e-01 | 0.713 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 1.955127e-01 | 0.709 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 2.277592e-01 | 0.643 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 2.351205e-01 | 0.629 | 0 | 0 |
| Butyrophilin (BTN) family interactions | R-HSA-8851680 | 1.686712e-01 | 0.773 | 0 | 0 |
| Glucagon-type ligand receptors | R-HSA-420092 | 2.321508e-01 | 0.634 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 2.074377e-01 | 0.683 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 2.185866e-01 | 0.660 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 1.644371e-01 | 0.784 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 2.250428e-01 | 0.648 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 1.623348e-01 | 0.790 | 0 | 0 |
| RUNX2 regulates genes involved in cell migration | R-HSA-8941332 | 2.280426e-01 | 0.642 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 2.125649e-01 | 0.673 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 2.351278e-01 | 0.629 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 2.351278e-01 | 0.629 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 2.383002e-01 | 0.623 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 2.406457e-01 | 0.619 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 2.419754e-01 | 0.616 | 0 | 0 |
| Loss of MECP2 binding ability to the NCoR/SMRT complex | R-HSA-9022537 | 2.419754e-01 | 0.616 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 2.419754e-01 | 0.616 | 0 | 0 |
| RUNX1 regulates expression of components of tight junctions | R-HSA-8935964 | 2.419754e-01 | 0.616 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 2.419754e-01 | 0.616 | 0 | 0 |
| Interactions of Tat with host cellular proteins | R-HSA-176034 | 2.969501e-01 | 0.527 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH2 | R-HSA-5632928 | 2.969501e-01 | 0.527 | 0 | 0 |
| Defective SLC12A6 causes agenesis of the corpus callosum, with peripheral neuropathy (ACCPN) | R-HSA-5619039 | 2.969501e-01 | 0.527 | 0 | 0 |
| TRAF3 deficiency - HSE | R-HSA-5602571 | 2.969501e-01 | 0.527 | 0 | 0 |
| Defective SLC4A4 causes renal tubular acidosis, proximal, with ocular abnormalities and mental retardation (pRTA-OA) | R-HSA-5619054 | 2.969501e-01 | 0.527 | 0 | 0 |
| Defective SLC6A2 causes orthostatic intolerance (OI) | R-HSA-5619109 | 2.969501e-01 | 0.527 | 0 | 0 |
| PTEN Loss of Function in Cancer | R-HSA-5674404 | 2.969501e-01 | 0.527 | 0 | 0 |
| Signalling to ERK5 | R-HSA-198765 | 3.748630e-01 | 0.426 | 0 | 0 |
| Mitotic Metaphase/Anaphase Transition | R-HSA-68881 | 3.748630e-01 | 0.426 | 0 | 0 |
| Defective SLC6A5 causes hyperekplexia 3 (HKPX3) | R-HSA-5619089 | 3.748630e-01 | 0.426 | 0 | 0 |
| TGFBR1 LBD Mutants in Cancer | R-HSA-3656535 | 3.748630e-01 | 0.426 | 0 | 0 |
| PTK6 promotes HIF1A stabilization | R-HSA-8857538 | 2.851624e-01 | 0.545 | 0 | 0 |
| Small interfering RNA (siRNA) biogenesis | R-HSA-426486 | 2.851624e-01 | 0.545 | 0 | 0 |
| Hydrolysis of LPE | R-HSA-1483152 | 2.851624e-01 | 0.545 | 0 | 0 |
| Autointegration results in viral DNA circles | R-HSA-177539 | 2.851624e-01 | 0.545 | 0 | 0 |
| E2F-enabled inhibition of pre-replication complex formation | R-HSA-113507 | 2.851624e-01 | 0.545 | 0 | 0 |
| Proton-coupled monocarboxylate transport | R-HSA-433692 | 2.590560e-01 | 0.587 | 0 | 0 |
| Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7 | R-HSA-9824878 | 2.590560e-01 | 0.587 | 0 | 0 |
| MECP2 regulates transcription factors | R-HSA-9022707 | 3.280899e-01 | 0.484 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 3.280899e-01 | 0.484 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 3.280899e-01 | 0.484 | 0 | 0 |
| TRIF-mediated programmed cell death | R-HSA-2562578 | 3.280899e-01 | 0.484 | 0 | 0 |
| Recycling of eIF2:GDP | R-HSA-72731 | 3.280899e-01 | 0.484 | 0 | 0 |
| PLC-gamma1 signalling | R-HSA-167021 | 4.441456e-01 | 0.352 | 0 | 0 |
| Activated NTRK3 signals through PLCG1 | R-HSA-9034793 | 4.441456e-01 | 0.352 | 0 | 0 |
| Axonal growth stimulation | R-HSA-209563 | 4.441456e-01 | 0.352 | 0 | 0 |
| Defective DPM1 causes DPM1-CDG | R-HSA-4717374 | 4.441456e-01 | 0.352 | 0 | 0 |
| Defective HPRT1 disrupts guanine and hypoxanthine salvage | R-HSA-9734281 | 4.441456e-01 | 0.352 | 0 | 0 |
| Defective DPM3 causes DPM3-CDG | R-HSA-4719360 | 4.441456e-01 | 0.352 | 0 | 0 |
| Defective SLC7A7 causes lysinuric protein intolerance (LPI) | R-HSA-5660862 | 4.441456e-01 | 0.352 | 0 | 0 |
| Defective ABCA1 causes TGD | R-HSA-5682113 | 4.441456e-01 | 0.352 | 0 | 0 |
| Loss of Function of KMT2D in MLL4 Complex Formation in Kabuki Syndrome | R-HSA-9944997 | 4.441456e-01 | 0.352 | 0 | 0 |
| MET activates PTPN11 | R-HSA-8865999 | 4.441456e-01 | 0.352 | 0 | 0 |
| Loss of Function of KMT2D in Kabuki Syndrome | R-HSA-9944971 | 4.441456e-01 | 0.352 | 0 | 0 |
| Invadopodia formation | R-HSA-8941237 | 4.441456e-01 | 0.352 | 0 | 0 |
| Defective DPM2 causes DPM2-CDG | R-HSA-4719377 | 4.441456e-01 | 0.352 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 2.905716e-01 | 0.537 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 2.905716e-01 | 0.537 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 2.905716e-01 | 0.537 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 2.905716e-01 | 0.537 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 2.603498e-01 | 0.584 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 3.702855e-01 | 0.431 | 0 | 0 |
| EGFR interacts with phospholipase C-gamma | R-HSA-212718 | 3.702855e-01 | 0.431 | 0 | 0 |
| SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs | R-HSA-77588 | 3.702855e-01 | 0.431 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 3.702855e-01 | 0.431 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 3.223313e-01 | 0.492 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 2.567438e-01 | 0.591 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 2.567438e-01 | 0.591 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 2.567438e-01 | 0.591 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 2.512236e-01 | 0.600 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 2.788102e-01 | 0.555 | 0 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 2.788102e-01 | 0.555 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 3.121190e-01 | 0.506 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 4.113843e-01 | 0.386 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 4.113843e-01 | 0.386 | 0 | 0 |
| Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits | R-HSA-997272 | 3.012327e-01 | 0.521 | 0 | 0 |
| Activation of G protein gated Potassium channels | R-HSA-1296041 | 3.012327e-01 | 0.521 | 0 | 0 |
| G protein gated Potassium channels | R-HSA-1296059 | 3.012327e-01 | 0.521 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 3.012327e-01 | 0.521 | 0 | 0 |
| BBSome-mediated cargo-targeting to cilium | R-HSA-5620922 | 3.383741e-01 | 0.471 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 3.856762e-01 | 0.414 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 3.856762e-01 | 0.414 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 3.239192e-01 | 0.490 | 0 | 0 |
| ERK/MAPK targets | R-HSA-198753 | 3.646993e-01 | 0.438 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 3.646993e-01 | 0.438 | 0 | 0 |
| TICAM1,TRAF6-dependent induction of TAK1 complex | R-HSA-9014325 | 4.511115e-01 | 0.346 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 4.511115e-01 | 0.346 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 3.467802e-01 | 0.460 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 4.168716e-01 | 0.380 | 0 | 0 |
| Class I peroxisomal membrane protein import | R-HSA-9603798 | 4.168716e-01 | 0.380 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 4.168716e-01 | 0.380 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 3.040328e-01 | 0.517 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 3.040328e-01 | 0.517 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 3.909730e-01 | 0.408 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 3.909730e-01 | 0.408 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 3.909730e-01 | 0.408 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 3.697299e-01 | 0.432 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 3.515205e-01 | 0.454 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 3.210824e-01 | 0.493 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 3.383024e-01 | 0.471 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 3.721156e-01 | 0.429 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 3.926863e-01 | 0.406 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 3.926863e-01 | 0.406 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 4.170832e-01 | 0.380 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 4.170832e-01 | 0.380 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 4.892663e-01 | 0.310 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 3.927456e-01 | 0.406 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 3.725975e-01 | 0.429 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 4.775193e-01 | 0.321 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 4.775193e-01 | 0.321 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 2.512835e-01 | 0.600 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 4.684154e-01 | 0.329 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 4.049078e-01 | 0.393 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 4.831108e-01 | 0.316 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 4.745132e-01 | 0.324 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 4.777983e-01 | 0.321 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 3.927456e-01 | 0.406 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 4.831108e-01 | 0.316 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 3.168854e-01 | 0.499 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 3.168854e-01 | 0.499 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 2.512236e-01 | 0.600 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 3.926863e-01 | 0.406 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 4.155722e-01 | 0.381 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 2.741713e-01 | 0.562 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 2.945525e-01 | 0.531 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 2.945525e-01 | 0.531 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 2.945525e-01 | 0.531 | 0 | 0 |
| TICAM1-dependent activation of IRF3/IRF7 | R-HSA-9013973 | 2.590560e-01 | 0.587 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 2.905518e-01 | 0.537 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 4.475308e-01 | 0.349 | 0 | 0 |
| Repression of WNT target genes | R-HSA-4641265 | 2.905716e-01 | 0.537 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 3.223313e-01 | 0.492 | 0 | 0 |
| Hydrolysis of LPC | R-HSA-1483115 | 3.541020e-01 | 0.451 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 3.927456e-01 | 0.406 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 2.905518e-01 | 0.537 | 0 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 4.775193e-01 | 0.321 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 2.629790e-01 | 0.580 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 3.467802e-01 | 0.460 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 4.745132e-01 | 0.324 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 3.415583e-01 | 0.467 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 3.919288e-01 | 0.407 | 0 | 0 |
| Synaptic adhesion-like molecules | R-HSA-8849932 | 2.860646e-01 | 0.544 | 0 | 0 |
| Thromboxane signalling through TP receptor | R-HSA-428930 | 2.788102e-01 | 0.555 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 4.511115e-01 | 0.346 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 4.475308e-01 | 0.349 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 3.414981e-01 | 0.467 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 3.106759e-01 | 0.508 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 2.821366e-01 | 0.550 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 4.296660e-01 | 0.367 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 3.467802e-01 | 0.460 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 4.934637e-01 | 0.307 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 4.382267e-01 | 0.358 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 4.831108e-01 | 0.316 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 3.271111e-01 | 0.485 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 4.168716e-01 | 0.380 | 0 | 0 |
| Signal amplification | R-HSA-392518 | 3.515205e-01 | 0.454 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 3.926863e-01 | 0.406 | 0 | 0 |
| Inhibition of replication initiation of damaged DNA by RB1/E2F1 | R-HSA-113501 | 2.590560e-01 | 0.587 | 0 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 3.223313e-01 | 0.492 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 3.541020e-01 | 0.451 | 0 | 0 |
| Post-chaperonin tubulin folding pathway | R-HSA-389977 | 3.383741e-01 | 0.471 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 3.856762e-01 | 0.414 | 0 | 0 |
| Adrenaline,noradrenaline inhibits insulin secretion | R-HSA-400042 | 3.239192e-01 | 0.490 | 0 | 0 |
| Formation of the posterior neural plate | R-HSA-9832991 | 4.892663e-01 | 0.310 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 4.155722e-01 | 0.381 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 4.393264e-01 | 0.357 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 4.170832e-01 | 0.380 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 4.777983e-01 | 0.321 | 0 | 0 |
| p75NTR regulates axonogenesis | R-HSA-193697 | 4.113843e-01 | 0.386 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 3.856762e-01 | 0.414 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 4.608488e-01 | 0.336 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 3.630296e-01 | 0.440 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 4.168716e-01 | 0.380 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 3.889832e-01 | 0.410 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 3.283763e-01 | 0.484 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 3.046837e-01 | 0.516 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 3.630296e-01 | 0.440 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 4.133533e-01 | 0.384 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 3.926863e-01 | 0.406 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 3.630296e-01 | 0.440 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 4.143459e-01 | 0.383 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 4.906621e-01 | 0.309 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 2.705973e-01 | 0.568 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 3.385064e-01 | 0.470 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 3.414981e-01 | 0.467 | 0 | 0 |
| tRNA-derived small RNA (tsRNA or tRNA-related fragment, tRF) biogenesis | R-HSA-9708296 | 3.748630e-01 | 0.426 | 0 | 0 |
| Antagonism of Activin by Follistatin | R-HSA-2473224 | 3.748630e-01 | 0.426 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 3.748630e-01 | 0.426 | 0 | 0 |
| CREB phosphorylation | R-HSA-199920 | 2.851624e-01 | 0.545 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 2.590560e-01 | 0.587 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 2.590560e-01 | 0.587 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 4.441456e-01 | 0.352 | 0 | 0 |
| PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | R-HSA-8849469 | 3.702855e-01 | 0.431 | 0 | 0 |
| Axonal growth inhibition (RHOA activation) | R-HSA-193634 | 3.702855e-01 | 0.431 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 3.223313e-01 | 0.492 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 2.860646e-01 | 0.544 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 2.860646e-01 | 0.544 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 2.871917e-01 | 0.542 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 3.909730e-01 | 0.408 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 2.959646e-01 | 0.529 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 3.926863e-01 | 0.406 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 4.892663e-01 | 0.310 | 0 | 0 |
| Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | R-HSA-190840 | 4.775193e-01 | 0.321 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 4.383154e-01 | 0.358 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 4.542870e-01 | 0.343 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 4.904635e-01 | 0.309 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 3.383024e-01 | 0.471 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 3.225605e-01 | 0.491 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 4.168716e-01 | 0.380 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 4.218263e-01 | 0.375 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 2.871917e-01 | 0.542 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 4.215122e-01 | 0.375 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 4.437559e-01 | 0.353 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 3.542148e-01 | 0.451 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 2.875600e-01 | 0.541 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 3.725975e-01 | 0.429 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 3.989321e-01 | 0.399 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 2.871917e-01 | 0.542 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 3.383024e-01 | 0.471 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 2.658794e-01 | 0.575 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 2.860646e-01 | 0.544 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 4.113843e-01 | 0.386 | 0 | 0 |
| Receptor Mediated Mitophagy | R-HSA-8934903 | 4.511115e-01 | 0.346 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 3.108303e-01 | 0.507 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 3.239407e-01 | 0.490 | 0 | 0 |
| Inwardly rectifying K+ channels | R-HSA-1296065 | 4.608488e-01 | 0.336 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 3.730468e-01 | 0.428 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 2.821366e-01 | 0.550 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 3.280899e-01 | 0.484 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 4.113843e-01 | 0.386 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 4.170832e-01 | 0.380 | 0 | 0 |
| LGI-ADAM interactions | R-HSA-5682910 | 4.892663e-01 | 0.310 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 2.984833e-01 | 0.525 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 4.545764e-01 | 0.342 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 2.742668e-01 | 0.562 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 4.346532e-01 | 0.362 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 3.354786e-01 | 0.474 | 0 | 0 |
| Regulation of NPAS4 gene expression | R-HSA-9768759 | 2.603498e-01 | 0.584 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 2.860646e-01 | 0.544 | 0 | 0 |
| Integration of viral DNA into host genomic DNA | R-HSA-175567 | 2.851624e-01 | 0.545 | 0 | 0 |
| Cellular response to mitochondrial stress | R-HSA-9840373 | 4.113843e-01 | 0.386 | 0 | 0 |
| Glucagon signaling in metabolic regulation | R-HSA-163359 | 3.310199e-01 | 0.480 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 4.475308e-01 | 0.349 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 4.608488e-01 | 0.336 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 4.745132e-01 | 0.324 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 4.726692e-01 | 0.325 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 3.383741e-01 | 0.471 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 4.484375e-01 | 0.348 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 3.523996e-01 | 0.453 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 4.133533e-01 | 0.384 | 0 | 0 |
| Synthesis of PIPs at the late endosome membrane | R-HSA-1660517 | 4.775193e-01 | 0.321 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 4.542870e-01 | 0.343 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 4.542870e-01 | 0.343 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 2.788102e-01 | 0.555 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 2.788102e-01 | 0.555 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 3.542148e-01 | 0.451 | 0 | 0 |
| Activation, myristolyation of BID and translocation to mitochondria | R-HSA-75108 | 3.748630e-01 | 0.426 | 0 | 0 |
| Displacement of DNA glycosylase by APEX1 | R-HSA-110357 | 3.280899e-01 | 0.484 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 3.280899e-01 | 0.484 | 0 | 0 |
| Sodium/Proton exchangers | R-HSA-425986 | 3.702855e-01 | 0.431 | 0 | 0 |
| Assembly and release of respiratory syncytial virus (RSV) virions | R-HSA-9820962 | 4.511115e-01 | 0.346 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 4.271500e-01 | 0.369 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 4.351118e-01 | 0.361 | 0 | 0 |
| Uptake and function of diphtheria toxin | R-HSA-5336415 | 3.280899e-01 | 0.484 | 0 | 0 |
| RUNX3 Regulates Immune Response and Cell Migration | R-HSA-8949275 | 3.280899e-01 | 0.484 | 0 | 0 |
| Expression and Processing of Neurotrophins | R-HSA-9036866 | 4.441456e-01 | 0.352 | 0 | 0 |
| NGF processing | R-HSA-167060 | 4.441456e-01 | 0.352 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence | R-HSA-9825895 | 3.702855e-01 | 0.431 | 0 | 0 |
| Respiratory syncytial virus genome replication | R-HSA-9834752 | 4.113843e-01 | 0.386 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 3.040328e-01 | 0.517 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 4.441041e-01 | 0.353 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 2.860646e-01 | 0.544 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 3.111408e-01 | 0.507 | 0 | 0 |
| Response to metal ions | R-HSA-5660526 | 4.475308e-01 | 0.349 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 4.799586e-01 | 0.319 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 4.542870e-01 | 0.343 | 0 | 0 |
| Synthesis and processing of ENV and VPU | R-HSA-171286 | 3.748630e-01 | 0.426 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 4.945179e-01 | 0.306 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 4.945179e-01 | 0.306 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 4.945179e-01 | 0.306 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 4.945179e-01 | 0.306 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 5.010192e-01 | 0.300 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 5.018722e-01 | 0.299 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 5.039028e-01 | 0.298 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 5.050451e-01 | 0.297 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 5.050451e-01 | 0.297 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 5.050451e-01 | 0.297 | 0 | 0 |
| FLT3 signaling through SRC family kinases | R-HSA-9706374 | 5.057533e-01 | 0.296 | 0 | 0 |
| Activated NTRK2 signals through PLCG1 | R-HSA-9026527 | 5.057533e-01 | 0.296 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 5.057533e-01 | 0.296 | 0 | 0 |
| Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes | R-HSA-69200 | 5.057533e-01 | 0.296 | 0 | 0 |
| Signaling by LRP5 mutants | R-HSA-5339717 | 5.057533e-01 | 0.296 | 0 | 0 |
| Regulation of gap junction activity | R-HSA-191650 | 5.057533e-01 | 0.296 | 0 | 0 |
| TNFR1-mediated ceramide production | R-HSA-5626978 | 5.057533e-01 | 0.296 | 0 | 0 |
| SARS-CoV-1-mediated effects on programmed cell death | R-HSA-9692913 | 5.057533e-01 | 0.296 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 5.057533e-01 | 0.296 | 0 | 0 |
| NADE modulates death signalling | R-HSA-205025 | 5.057533e-01 | 0.296 | 0 | 0 |
| Regulation of HMOX1 expression and activity | R-HSA-9707587 | 5.057533e-01 | 0.296 | 0 | 0 |
| Trafficking of GluR2-containing AMPA receptors | R-HSA-416993 | 5.067248e-01 | 0.295 | 0 | 0 |
| Transport of connexons to the plasma membrane | R-HSA-190872 | 5.067248e-01 | 0.295 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 5.102685e-01 | 0.292 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 5.125330e-01 | 0.290 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 5.142597e-01 | 0.289 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 5.142597e-01 | 0.289 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 5.142597e-01 | 0.289 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 5.142597e-01 | 0.289 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 5.142597e-01 | 0.289 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 5.142597e-01 | 0.289 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 5.150550e-01 | 0.288 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 5.180010e-01 | 0.286 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 5.180010e-01 | 0.286 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 5.180010e-01 | 0.286 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 5.180010e-01 | 0.286 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 5.180010e-01 | 0.286 | 0 | 0 |
| ERKs are inactivated | R-HSA-202670 | 5.257094e-01 | 0.279 | 0 | 0 |
| Sensing of DNA Double Strand Breaks | R-HSA-5693548 | 5.257094e-01 | 0.279 | 0 | 0 |
| APOBEC3G mediated resistance to HIV-1 infection | R-HSA-180689 | 5.257094e-01 | 0.279 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 5.257094e-01 | 0.279 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperone genes | R-HSA-381183 | 5.257094e-01 | 0.279 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 5.266011e-01 | 0.279 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 5.266011e-01 | 0.279 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 5.266011e-01 | 0.279 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 5.266011e-01 | 0.279 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 5.266011e-01 | 0.279 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 5.269554e-01 | 0.278 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 5.335381e-01 | 0.273 | 1 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 5.337005e-01 | 0.273 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 5.350553e-01 | 0.272 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9694631 | 5.350553e-01 | 0.272 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 5.379635e-01 | 0.269 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 5.411196e-01 | 0.267 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 5.419650e-01 | 0.266 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 5.419650e-01 | 0.266 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 5.477335e-01 | 0.261 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 5.477335e-01 | 0.261 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 5.477335e-01 | 0.261 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 5.528057e-01 | 0.257 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 5.528057e-01 | 0.257 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 5.528057e-01 | 0.257 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 5.547717e-01 | 0.256 | 0 | 0 |
| Leading Strand Synthesis | R-HSA-69109 | 5.603516e-01 | 0.252 | 0 | 0 |
| Polymerase switching | R-HSA-69091 | 5.603516e-01 | 0.252 | 0 | 0 |
| Scavenging by Class F Receptors | R-HSA-3000484 | 5.603516e-01 | 0.252 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 5.603516e-01 | 0.252 | 0 | 0 |
| VLDLR internalisation and degradation | R-HSA-8866427 | 5.603516e-01 | 0.252 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 5.603516e-01 | 0.252 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 5.603516e-01 | 0.252 | 0 | 0 |
| Co-inhibition by BTLA | R-HSA-9927353 | 5.605360e-01 | 0.251 | 0 | 0 |
| G2 Phase | R-HSA-68911 | 5.605360e-01 | 0.251 | 0 | 0 |
| Defective F9 activation | R-HSA-9673221 | 5.605360e-01 | 0.251 | 0 | 0 |
| Defective SLC1A3 causes episodic ataxia 6 (EA6) | R-HSA-5619062 | 5.605360e-01 | 0.251 | 0 | 0 |
| Defective binding of VWF variant to GPIb:IX:V | R-HSA-9846298 | 5.605360e-01 | 0.251 | 0 | 0 |
| Enhanced binding of GP1BA variant to VWF multimer:collagen | R-HSA-9845620 | 5.605360e-01 | 0.251 | 0 | 0 |
| Activation of AKT2 | R-HSA-165158 | 5.605360e-01 | 0.251 | 0 | 0 |
| Reelin signalling pathway | R-HSA-8866376 | 5.605360e-01 | 0.251 | 0 | 0 |
| Loss of Function of TGFBR1 in Cancer | R-HSA-3656534 | 5.605360e-01 | 0.251 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 5.605360e-01 | 0.251 | 0 | 0 |
| SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes | R-HSA-111464 | 5.605360e-01 | 0.251 | 0 | 0 |
| Nectin/Necl trans heterodimerization | R-HSA-420597 | 5.605360e-01 | 0.251 | 0 | 0 |
| Phosphorylation and nuclear translocation of BMAL1 (ARNTL) and CLOCK | R-HSA-9931529 | 5.605360e-01 | 0.251 | 0 | 0 |
| SMAC (DIABLO) binds to IAPs | R-HSA-111463 | 5.605360e-01 | 0.251 | 0 | 0 |
| DEx/H-box helicases activate type I IFN and inflammatory cytokines production | R-HSA-3134963 | 5.605360e-01 | 0.251 | 0 | 0 |
| Toxicity of botulinum toxin type C (botC) | R-HSA-5250971 | 5.605360e-01 | 0.251 | 0 | 0 |
| PTK6 Regulates Proteins Involved in RNA Processing | R-HSA-8849468 | 5.605360e-01 | 0.251 | 0 | 0 |
| Assembly of Viral Components at the Budding Site | R-HSA-168316 | 5.605360e-01 | 0.251 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 5.616170e-01 | 0.251 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 5.616744e-01 | 0.251 | 0 | 0 |
| Regulation of PD-L1(CD274) translation | R-HSA-9909620 | 5.624373e-01 | 0.250 | 0 | 0 |
| Formation of ATP by chemiosmotic coupling | R-HSA-163210 | 5.624373e-01 | 0.250 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 5.624373e-01 | 0.250 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 5.624373e-01 | 0.250 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 5.624373e-01 | 0.250 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 5.624373e-01 | 0.250 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 5.653023e-01 | 0.248 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 5.653023e-01 | 0.248 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 5.655534e-01 | 0.248 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 5.684024e-01 | 0.245 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 5.684024e-01 | 0.245 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 5.715441e-01 | 0.243 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 5.715441e-01 | 0.243 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 5.715441e-01 | 0.243 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 5.715441e-01 | 0.243 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 5.755137e-01 | 0.240 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 5.755137e-01 | 0.240 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 5.799923e-01 | 0.237 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 5.835372e-01 | 0.234 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 5.852954e-01 | 0.233 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 5.879686e-01 | 0.231 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 5.885732e-01 | 0.230 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 5.885732e-01 | 0.230 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 5.885732e-01 | 0.230 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 5.886803e-01 | 0.230 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 5.888143e-01 | 0.230 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 5.898881e-01 | 0.229 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 5.898881e-01 | 0.229 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 5.898881e-01 | 0.229 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 5.898881e-01 | 0.229 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 5.898881e-01 | 0.229 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 5.898881e-01 | 0.229 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 5.898881e-01 | 0.229 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 5.898881e-01 | 0.229 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 5.898881e-01 | 0.229 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 5.898881e-01 | 0.229 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9683610 | 5.931442e-01 | 0.227 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperones | R-HSA-381033 | 5.931442e-01 | 0.227 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 5.934888e-01 | 0.227 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 5.934888e-01 | 0.227 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 5.997258e-01 | 0.222 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 6.061035e-01 | 0.217 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 6.063674e-01 | 0.217 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 6.081678e-01 | 0.216 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 6.082160e-01 | 0.216 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 6.082160e-01 | 0.216 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 6.085570e-01 | 0.216 | 0 | 0 |
| Nef Mediated CD8 Down-regulation | R-HSA-182218 | 6.092494e-01 | 0.215 | 0 | 0 |
| Inhibition of Signaling by Overexpressed EGFR | R-HSA-5638303 | 6.092494e-01 | 0.215 | 0 | 0 |
| SLIT2:ROBO1 increases RHOA activity | R-HSA-8985586 | 6.092494e-01 | 0.215 | 0 | 0 |
| IkBA variant leads to EDA-ID | R-HSA-5603029 | 6.092494e-01 | 0.215 | 0 | 0 |
| Signaling by Overexpressed Wild-Type EGFR in Cancer | R-HSA-5638302 | 6.092494e-01 | 0.215 | 0 | 0 |
| PTK6 Regulates Cell Cycle | R-HSA-8849470 | 6.092494e-01 | 0.215 | 0 | 0 |
| Signaling by RNF43 mutants | R-HSA-5340588 | 6.092494e-01 | 0.215 | 0 | 0 |
| SLC15A4:TASL-dependent IRF5 activation | R-HSA-9860276 | 6.092494e-01 | 0.215 | 0 | 0 |
| CDC6 association with the ORC:origin complex | R-HSA-68689 | 6.092494e-01 | 0.215 | 0 | 0 |
| PDE3B signalling | R-HSA-165160 | 6.092494e-01 | 0.215 | 0 | 0 |
| Activation of caspases through apoptosome-mediated cleavage | R-HSA-111459 | 6.092494e-01 | 0.215 | 0 | 0 |
| Synthesis of dolichyl-phosphate mannose | R-HSA-162699 | 6.092494e-01 | 0.215 | 0 | 0 |
| PKB-mediated events | R-HSA-109703 | 6.092494e-01 | 0.215 | 0 | 0 |
| Noncanonical activation of NOTCH3 | R-HSA-9017802 | 6.092494e-01 | 0.215 | 0 | 0 |
| Defects of platelet adhesion to exposed collagen | R-HSA-9823587 | 6.092494e-01 | 0.215 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 6.092494e-01 | 0.215 | 0 | 0 |
| Signalling to p38 via RIT and RIN | R-HSA-187706 | 6.092494e-01 | 0.215 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 6.092494e-01 | 0.215 | 0 | 0 |
| SMAC, XIAP-regulated apoptotic response | R-HSA-111469 | 6.092494e-01 | 0.215 | 0 | 0 |
| Diseases of Base Excision Repair | R-HSA-9605308 | 6.092494e-01 | 0.215 | 0 | 0 |
| Epithelial-Mesenchymal Transition (EMT) during gastrulation | R-HSA-9758919 | 6.092494e-01 | 0.215 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 6.099275e-01 | 0.215 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 6.099275e-01 | 0.215 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 6.099275e-01 | 0.215 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 6.141447e-01 | 0.212 | 0 | 0 |
| Removal of the Flap Intermediate | R-HSA-69166 | 6.240718e-01 | 0.205 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 6.240718e-01 | 0.205 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 6.240718e-01 | 0.205 | 0 | 0 |
| CLEC7A (Dectin-1) induces NFAT activation | R-HSA-5607763 | 6.240718e-01 | 0.205 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | R-HSA-975163 | 6.240718e-01 | 0.205 | 0 | 0 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 6.240718e-01 | 0.205 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 6.240718e-01 | 0.205 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 6.243887e-01 | 0.205 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 6.243887e-01 | 0.205 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 6.244479e-01 | 0.205 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 6.252984e-01 | 0.204 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 6.268753e-01 | 0.203 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 6.268753e-01 | 0.203 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 6.268753e-01 | 0.203 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 6.268753e-01 | 0.203 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 6.292276e-01 | 0.201 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 6.311503e-01 | 0.200 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 6.318700e-01 | 0.199 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 6.384008e-01 | 0.195 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 6.384008e-01 | 0.195 | 0 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 6.384008e-01 | 0.195 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 6.414449e-01 | 0.193 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 6.423256e-01 | 0.192 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 6.512754e-01 | 0.186 | 0 | 0 |
| VLDL assembly | R-HSA-8866423 | 6.525656e-01 | 0.185 | 0 | 0 |
| Chylomicron clearance | R-HSA-8964026 | 6.525656e-01 | 0.185 | 0 | 0 |
| Signaling by LTK in cancer | R-HSA-9842640 | 6.525656e-01 | 0.185 | 0 | 0 |
| STAT5 Activation | R-HSA-9645135 | 6.525656e-01 | 0.185 | 0 | 0 |
| RUNX3 regulates YAP1-mediated transcription | R-HSA-8951671 | 6.525656e-01 | 0.185 | 0 | 0 |
| G2/M DNA replication checkpoint | R-HSA-69478 | 6.525656e-01 | 0.185 | 0 | 0 |
| Defective SLC16A1 causes symptomatic deficiency in lactate transport (SDLT) | R-HSA-5619070 | 6.525656e-01 | 0.185 | 0 | 0 |
| Defective CHST3 causes SEDCJD | R-HSA-3595172 | 6.525656e-01 | 0.185 | 0 | 0 |
| Defective CHST14 causes EDS, musculocontractural type | R-HSA-3595174 | 6.525656e-01 | 0.185 | 0 | 0 |
| Neurofascin interactions | R-HSA-447043 | 6.525656e-01 | 0.185 | 0 | 0 |
| Lactose synthesis | R-HSA-5653890 | 6.525656e-01 | 0.185 | 0 | 0 |
| NADPH regeneration | R-HSA-389542 | 6.525656e-01 | 0.185 | 0 | 0 |
| Nef and signal transduction | R-HSA-164944 | 6.525656e-01 | 0.185 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex in Cancer | R-HSA-3304351 | 6.525656e-01 | 0.185 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 6.531448e-01 | 0.185 | 0 | 0 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | R-HSA-937072 | 6.531448e-01 | 0.185 | 0 | 0 |
| RNA Polymerase III Chain Elongation | R-HSA-73780 | 6.531448e-01 | 0.185 | 0 | 0 |
| TICAM1, RIP1-mediated IKK complex recruitment | R-HSA-168927 | 6.531448e-01 | 0.185 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 6.531448e-01 | 0.185 | 0 | 0 |
| Processive synthesis on the lagging strand | R-HSA-69183 | 6.531448e-01 | 0.185 | 0 | 0 |
| Telomere C-strand synthesis initiation | R-HSA-174430 | 6.531448e-01 | 0.185 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 6.531448e-01 | 0.185 | 0 | 0 |
| Other semaphorin interactions | R-HSA-416700 | 6.531448e-01 | 0.185 | 0 | 0 |
| Formation of the anterior neural plate | R-HSA-9823739 | 6.531448e-01 | 0.185 | 0 | 0 |
| Lysosphingolipid and LPA receptors | R-HSA-419408 | 6.531448e-01 | 0.185 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 6.531448e-01 | 0.185 | 0 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 6.531448e-01 | 0.185 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 6.594319e-01 | 0.181 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 6.626140e-01 | 0.179 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 6.637502e-01 | 0.178 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 6.707193e-01 | 0.173 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 6.713076e-01 | 0.173 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 6.713076e-01 | 0.173 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 6.713076e-01 | 0.173 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 6.749487e-01 | 0.171 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 6.771784e-01 | 0.169 | 0 | 0 |
| Caspase activation via Death Receptors in the presence of ligand | R-HSA-140534 | 6.803943e-01 | 0.167 | 0 | 0 |
| Activation of SMO | R-HSA-5635838 | 6.803943e-01 | 0.167 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 6.803943e-01 | 0.167 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 6.810761e-01 | 0.167 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 6.810761e-01 | 0.167 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 6.810761e-01 | 0.167 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 6.832268e-01 | 0.165 | 0 | 0 |
| Translocation of ZAP-70 to Immunological synapse | R-HSA-202430 | 6.836361e-01 | 0.165 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 6.836361e-01 | 0.165 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 6.836361e-01 | 0.165 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 6.891117e-01 | 0.162 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 6.905230e-01 | 0.161 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 6.905230e-01 | 0.161 | 0 | 0 |
| Removal of aminoterminal propeptides from gamma-carboxylated proteins | R-HSA-159782 | 6.910822e-01 | 0.160 | 0 | 0 |
| MET activates PI3K/AKT signaling | R-HSA-8851907 | 6.910822e-01 | 0.160 | 0 | 0 |
| PP2A-mediated dephosphorylation of key metabolic factors | R-HSA-163767 | 6.910822e-01 | 0.160 | 0 | 0 |
| VLDL clearance | R-HSA-8964046 | 6.910822e-01 | 0.160 | 0 | 0 |
| Defective CHSY1 causes TPBS | R-HSA-3595177 | 6.910822e-01 | 0.160 | 0 | 0 |
| SLBP independent Processing of Histone Pre-mRNAs | R-HSA-111367 | 6.910822e-01 | 0.160 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to gluconeogenesis | R-HSA-9632974 | 6.910822e-01 | 0.160 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 6.910822e-01 | 0.160 | 0 | 0 |
| PTK6 Expression | R-HSA-8849473 | 6.910822e-01 | 0.160 | 0 | 0 |
| LDL remodeling | R-HSA-8964041 | 6.910822e-01 | 0.160 | 0 | 0 |
| Nef Mediated CD4 Down-regulation | R-HSA-167590 | 6.910822e-01 | 0.160 | 0 | 0 |
| Microbial modulation of RIPK1-mediated regulated necrosis | R-HSA-9686347 | 6.910822e-01 | 0.160 | 0 | 0 |
| Activation of PUMA and translocation to mitochondria | R-HSA-139915 | 6.910822e-01 | 0.160 | 0 | 0 |
| Phase 3 - rapid repolarisation | R-HSA-5576890 | 6.910822e-01 | 0.160 | 0 | 0 |
| Cation-coupled Chloride cotransporters | R-HSA-426117 | 6.910822e-01 | 0.160 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation | R-HSA-2892245 | 6.910822e-01 | 0.160 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 6.942794e-01 | 0.158 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 6.942794e-01 | 0.158 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 6.950594e-01 | 0.158 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 6.950594e-01 | 0.158 | 0 | 0 |
| Activation of GABAB receptors | R-HSA-991365 | 6.977922e-01 | 0.156 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 6.977922e-01 | 0.156 | 0 | 0 |
| GABA B receptor activation | R-HSA-977444 | 6.977922e-01 | 0.156 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 6.995539e-01 | 0.155 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 6.995539e-01 | 0.155 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 7.046131e-01 | 0.152 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 7.046131e-01 | 0.152 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 7.046131e-01 | 0.152 | 0 | 0 |
| MicroRNA (miRNA) biogenesis | R-HSA-203927 | 7.046131e-01 | 0.152 | 0 | 0 |
| Synthesis of PIPs at the early endosome membrane | R-HSA-1660516 | 7.046131e-01 | 0.152 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 7.046131e-01 | 0.152 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 7.055958e-01 | 0.151 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 7.055958e-01 | 0.151 | 1 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 7.058672e-01 | 0.151 | 0 | 0 |
| Glycine degradation | R-HSA-6783984 | 7.058672e-01 | 0.151 | 0 | 0 |
| Acetylcholine regulates insulin secretion | R-HSA-399997 | 7.058672e-01 | 0.151 | 0 | 0 |
| Transcriptional regulation of testis differentiation | R-HSA-9690406 | 7.058672e-01 | 0.151 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 7.081570e-01 | 0.150 | 0 | 0 |
| Antigen Presentation: Folding, assembly and peptide loading of class I MHC | R-HSA-983170 | 7.083417e-01 | 0.150 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 7.099254e-01 | 0.149 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 7.104604e-01 | 0.148 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 7.133331e-01 | 0.147 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 7.163489e-01 | 0.145 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 7.193934e-01 | 0.143 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 7.209010e-01 | 0.142 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 7.241283e-01 | 0.140 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 7.241283e-01 | 0.140 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 7.245085e-01 | 0.140 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 7.245085e-01 | 0.140 | 0 | 0 |
| ALKBH3 mediated reversal of alkylation damage | R-HSA-112126 | 7.253309e-01 | 0.139 | 0 | 0 |
| RSK activation | R-HSA-444257 | 7.253309e-01 | 0.139 | 0 | 0 |
| phospho-PLA2 pathway | R-HSA-111995 | 7.253309e-01 | 0.139 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 7.253309e-01 | 0.139 | 0 | 0 |
| Activated NTRK2 signals through PI3K | R-HSA-9028335 | 7.253309e-01 | 0.139 | 0 | 0 |
| MET receptor recycling | R-HSA-8875656 | 7.253309e-01 | 0.139 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 7.253309e-01 | 0.139 | 0 | 0 |
| Adrenoceptors | R-HSA-390696 | 7.253309e-01 | 0.139 | 0 | 0 |
| Negative regulation of activity of TFAP2 (AP-2) family transcription factors | R-HSA-8866904 | 7.253309e-01 | 0.139 | 0 | 0 |
| Regulation by c-FLIP | R-HSA-3371378 | 7.253309e-01 | 0.139 | 0 | 0 |
| Co-stimulation by ICOS | R-HSA-9927354 | 7.253309e-01 | 0.139 | 0 | 0 |
| Downregulation of ERBB4 signaling | R-HSA-1253288 | 7.253309e-01 | 0.139 | 0 | 0 |
| Astrocytic Glutamate-Glutamine Uptake And Metabolism | R-HSA-210455 | 7.253309e-01 | 0.139 | 0 | 0 |
| Neurotransmitter uptake and metabolism In glial cells | R-HSA-112313 | 7.253309e-01 | 0.139 | 0 | 0 |
| TGFBR3 PTM regulation | R-HSA-9839383 | 7.253309e-01 | 0.139 | 0 | 0 |
| Dimerization of procaspase-8 | R-HSA-69416 | 7.253309e-01 | 0.139 | 0 | 0 |
| Formyl peptide receptors bind formyl peptides and many other ligands | R-HSA-444473 | 7.253309e-01 | 0.139 | 0 | 0 |
| Nucleotide salvage defects | R-HSA-9734207 | 7.253309e-01 | 0.139 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 7.253309e-01 | 0.139 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 7.256803e-01 | 0.139 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 7.293779e-01 | 0.137 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 7.293779e-01 | 0.137 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 7.296225e-01 | 0.137 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | R-HSA-5358606 | 7.296225e-01 | 0.137 | 0 | 0 |
| Modulation of host responses by IFN-stimulated genes | R-HSA-9909505 | 7.296225e-01 | 0.137 | 0 | 0 |
| Regulation of FZD by ubiquitination | R-HSA-4641263 | 7.296225e-01 | 0.137 | 0 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 7.296225e-01 | 0.137 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 7.318865e-01 | 0.136 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 7.408023e-01 | 0.130 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 7.420386e-01 | 0.130 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 7.422386e-01 | 0.129 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 7.422386e-01 | 0.129 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 7.422386e-01 | 0.129 | 0 | 0 |
| Phosphorylation of CD3 and TCR zeta chains | R-HSA-202427 | 7.433401e-01 | 0.129 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 7.433401e-01 | 0.129 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 7.433401e-01 | 0.129 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 7.433401e-01 | 0.129 | 0 | 0 |
| Maturation of hRSV A proteins | R-HSA-9828806 | 7.433401e-01 | 0.129 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 7.442468e-01 | 0.128 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 7.443715e-01 | 0.128 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 7.451996e-01 | 0.128 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 7.477700e-01 | 0.126 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 7.517279e-01 | 0.124 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 7.517279e-01 | 0.124 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 7.517279e-01 | 0.124 | 0 | 0 |
| Cytosolic iron-sulfur cluster assembly | R-HSA-2564830 | 7.517279e-01 | 0.124 | 0 | 0 |
| Apoptotic factor-mediated response | R-HSA-111471 | 7.517279e-01 | 0.124 | 0 | 0 |
| FOXO-mediated transcription of cell death genes | R-HSA-9614657 | 7.517279e-01 | 0.124 | 0 | 0 |
| Nephron development | R-HSA-9831926 | 7.517279e-01 | 0.124 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9679504 | 7.517279e-01 | 0.124 | 0 | 0 |
| APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway | R-HSA-5649702 | 7.557844e-01 | 0.122 | 0 | 0 |
| CASP8 activity is inhibited | R-HSA-5218900 | 7.557844e-01 | 0.122 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex | R-HSA-937042 | 7.557844e-01 | 0.122 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 7.557844e-01 | 0.122 | 0 | 0 |
| WNT mediated activation of DVL | R-HSA-201688 | 7.557844e-01 | 0.122 | 0 | 0 |
| Regulation of NPAS4 gene transcription | R-HSA-9768777 | 7.557844e-01 | 0.122 | 0 | 0 |
| Interleukin-1 processing | R-HSA-448706 | 7.557844e-01 | 0.122 | 0 | 0 |
| Regulated proteolysis of p75NTR | R-HSA-193692 | 7.557844e-01 | 0.122 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 7.585038e-01 | 0.120 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 7.608123e-01 | 0.119 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 7.611307e-01 | 0.119 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 7.611307e-01 | 0.119 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 7.620800e-01 | 0.118 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 7.639976e-01 | 0.117 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 7.721548e-01 | 0.112 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 7.721548e-01 | 0.112 | 0 | 0 |
| Synthesis of PC | R-HSA-1483191 | 7.721548e-01 | 0.112 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 7.722025e-01 | 0.112 | 0 | 0 |
| PI-3K cascade:FGFR3 | R-HSA-5654710 | 7.722571e-01 | 0.112 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 7.722571e-01 | 0.112 | 0 | 0 |
| IKK complex recruitment mediated by RIP1 | R-HSA-937041 | 7.722571e-01 | 0.112 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 7.722571e-01 | 0.112 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 7.722571e-01 | 0.112 | 0 | 0 |
| Specification of the neural plate border | R-HSA-9834899 | 7.722571e-01 | 0.112 | 0 | 0 |
| mRNA decay by 3' to 5' exoribonuclease | R-HSA-429958 | 7.722571e-01 | 0.112 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 7.722571e-01 | 0.112 | 0 | 0 |
| Translesion Synthesis by POLH | R-HSA-110320 | 7.722571e-01 | 0.112 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 7.724652e-01 | 0.112 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 7.730526e-01 | 0.112 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 7.757404e-01 | 0.110 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 7.779078e-01 | 0.109 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 7.779078e-01 | 0.109 | 0 | 0 |
| Activation of Ca-permeable Kainate Receptor | R-HSA-451308 | 7.828629e-01 | 0.106 | 0 | 0 |
| Defective RIPK1-mediated regulated necrosis | R-HSA-9693928 | 7.828629e-01 | 0.106 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 7.828629e-01 | 0.106 | 0 | 0 |
| Ion influx/efflux at host-pathogen interface | R-HSA-6803544 | 7.828629e-01 | 0.106 | 0 | 0 |
| WNT5A-dependent internalization of FZD2, FZD5 and ROR2 | R-HSA-5140745 | 7.828629e-01 | 0.106 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 7.828629e-01 | 0.106 | 0 | 0 |
| Pexophagy | R-HSA-9664873 | 7.828629e-01 | 0.106 | 0 | 0 |
| MAPK3 (ERK1) activation | R-HSA-110056 | 7.828629e-01 | 0.106 | 0 | 0 |
| Defective factor IX causes hemophilia B | R-HSA-9668250 | 7.828629e-01 | 0.106 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 7.828629e-01 | 0.106 | 0 | 0 |
| Josephin domain DUBs | R-HSA-5689877 | 7.828629e-01 | 0.106 | 0 | 0 |
| Interleukin-27 signaling | R-HSA-9020956 | 7.828629e-01 | 0.106 | 0 | 0 |
| Maturation of spike protein | R-HSA-9683686 | 7.828629e-01 | 0.106 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 7.852080e-01 | 0.105 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 7.852080e-01 | 0.105 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 7.861486e-01 | 0.104 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 7.873350e-01 | 0.104 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 7.873350e-01 | 0.104 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 7.893000e-01 | 0.103 | 0 | 0 |
| PI-3K cascade:FGFR4 | R-HSA-5654720 | 7.912879e-01 | 0.102 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 7.912879e-01 | 0.102 | 0 | 0 |
| Acyl chain remodelling of PI | R-HSA-1482922 | 7.912879e-01 | 0.102 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 7.937025e-01 | 0.100 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 7.937025e-01 | 0.100 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 7.937025e-01 | 0.100 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 7.976731e-01 | 0.098 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 7.976731e-01 | 0.098 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 7.986615e-01 | 0.098 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 8.008898e-01 | 0.096 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 8.008898e-01 | 0.096 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 8.008898e-01 | 0.096 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 8.061169e-01 | 0.094 | 0 | 0 |
| Chylomicron assembly | R-HSA-8963888 | 8.069404e-01 | 0.093 | 0 | 0 |
| NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | R-HSA-933543 | 8.069404e-01 | 0.093 | 0 | 0 |
| Ionotropic activity of kainate receptors | R-HSA-451306 | 8.069404e-01 | 0.093 | 0 | 0 |
| vRNP Assembly | R-HSA-192905 | 8.069404e-01 | 0.093 | 0 | 0 |
| vRNA Synthesis | R-HSA-192814 | 8.069404e-01 | 0.093 | 0 | 0 |
| Synthesis of PI | R-HSA-1483226 | 8.069404e-01 | 0.093 | 0 | 0 |
| RHOBTB3 ATPase cycle | R-HSA-9706019 | 8.069404e-01 | 0.093 | 0 | 0 |
| Alpha-protein kinase 1 signaling pathway | R-HSA-9645460 | 8.069404e-01 | 0.093 | 0 | 0 |
| Inorganic anion exchange by SLC26 transporters | R-HSA-427601 | 8.069404e-01 | 0.093 | 0 | 0 |
| SARS-CoV-2 modulates autophagy | R-HSA-9754560 | 8.069404e-01 | 0.093 | 0 | 0 |
| Suppression of apoptosis | R-HSA-9635465 | 8.069404e-01 | 0.093 | 0 | 0 |
| Interleukin-2 signaling | R-HSA-9020558 | 8.069404e-01 | 0.093 | 0 | 0 |
| Dissolution of Fibrin Clot | R-HSA-75205 | 8.069404e-01 | 0.093 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 8.079993e-01 | 0.093 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 8.079993e-01 | 0.093 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 8.079993e-01 | 0.093 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 8.079993e-01 | 0.093 | 0 | 0 |
| GABA receptor activation | R-HSA-977443 | 8.079993e-01 | 0.093 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 8.079993e-01 | 0.093 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 8.089000e-01 | 0.092 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 8.089000e-01 | 0.092 | 0 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 8.089000e-01 | 0.092 | 0 | 0 |
| Intrinsic Pathway of Fibrin Clot Formation | R-HSA-140837 | 8.089000e-01 | 0.092 | 0 | 0 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 8.089000e-01 | 0.092 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 8.089000e-01 | 0.092 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 8.095617e-01 | 0.092 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 8.095617e-01 | 0.092 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 8.137706e-01 | 0.089 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 8.185849e-01 | 0.087 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 8.189568e-01 | 0.087 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 8.197144e-01 | 0.086 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 8.208867e-01 | 0.086 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 8.224821e-01 | 0.085 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 8.251740e-01 | 0.083 | 0 | 0 |
| Attachment and Entry | R-HSA-9694614 | 8.251740e-01 | 0.083 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 8.251740e-01 | 0.083 | 0 | 0 |
| SLC-mediated transport of neurotransmitters | R-HSA-442660 | 8.258946e-01 | 0.083 | 0 | 0 |
| Sema4D mediated inhibition of cell attachment and migration | R-HSA-416550 | 8.283493e-01 | 0.082 | 0 | 0 |
| DS-GAG biosynthesis | R-HSA-2022923 | 8.283493e-01 | 0.082 | 0 | 0 |
| Scavenging by Class H Receptors | R-HSA-3000497 | 8.283493e-01 | 0.082 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 8.283493e-01 | 0.082 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by WNT ligand antagonists | R-HSA-3772470 | 8.283493e-01 | 0.082 | 0 | 0 |
| POLB-Dependent Long Patch Base Excision Repair | R-HSA-110362 | 8.283493e-01 | 0.082 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 8.283493e-01 | 0.082 | 0 | 0 |
| Reduction of cytosolic Ca++ levels | R-HSA-418359 | 8.283493e-01 | 0.082 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 8.283493e-01 | 0.082 | 0 | 0 |
| Sodium/Calcium exchangers | R-HSA-425561 | 8.283493e-01 | 0.082 | 0 | 0 |
| Cytochrome c-mediated apoptotic response | R-HSA-111461 | 8.283493e-01 | 0.082 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 8.313100e-01 | 0.080 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 8.316621e-01 | 0.080 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 8.373875e-01 | 0.077 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 8.373922e-01 | 0.077 | 0 | 0 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 8.401901e-01 | 0.076 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 8.401901e-01 | 0.076 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9694676 | 8.401901e-01 | 0.076 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 8.444346e-01 | 0.073 | 0 | 0 |
| NOTCH2 intracellular domain regulates transcription | R-HSA-2197563 | 8.473853e-01 | 0.072 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 8.473853e-01 | 0.072 | 0 | 0 |
| Activated NTRK2 signals through FRS2 and FRS3 | R-HSA-9028731 | 8.473853e-01 | 0.072 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 8.473853e-01 | 0.072 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 8.473853e-01 | 0.072 | 0 | 0 |
| Serotonin clearance from the synaptic cleft | R-HSA-380615 | 8.473853e-01 | 0.072 | 0 | 0 |
| Role of second messengers in netrin-1 signaling | R-HSA-418890 | 8.473853e-01 | 0.072 | 0 | 0 |
| Reversal of alkylation damage by DNA dioxygenases | R-HSA-73943 | 8.473853e-01 | 0.072 | 0 | 0 |
| Gamma-carboxylation, transport, and amino-terminal cleavage of proteins | R-HSA-159854 | 8.473853e-01 | 0.072 | 0 | 0 |
| Trafficking and processing of endosomal TLR | R-HSA-1679131 | 8.473853e-01 | 0.072 | 0 | 0 |
| Regulation of IFNG signaling | R-HSA-877312 | 8.473853e-01 | 0.072 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 8.473853e-01 | 0.072 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 8.473853e-01 | 0.072 | 0 | 0 |
| Interleukin-35 Signalling | R-HSA-8984722 | 8.473853e-01 | 0.072 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 8.475839e-01 | 0.072 | 0 | 0 |
| Acyl chain remodelling of PC | R-HSA-1482788 | 8.477616e-01 | 0.072 | 0 | 0 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 8.477616e-01 | 0.072 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 8.477616e-01 | 0.072 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 8.482377e-01 | 0.071 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 8.482377e-01 | 0.071 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 8.482377e-01 | 0.071 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 8.521881e-01 | 0.069 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 8.537424e-01 | 0.069 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 8.540271e-01 | 0.069 | 0 | 0 |
| ABC transporters in lipid homeostasis | R-HSA-1369062 | 8.540271e-01 | 0.069 | 0 | 0 |
| Synthesis of pyrophosphates in the cytosol | R-HSA-1855167 | 8.540271e-01 | 0.069 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 8.556664e-01 | 0.068 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 8.584691e-01 | 0.066 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 8.584691e-01 | 0.066 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 8.591849e-01 | 0.066 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 8.591849e-01 | 0.066 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 8.591849e-01 | 0.066 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 8.591849e-01 | 0.066 | 0 | 0 |
| Calnexin/calreticulin cycle | R-HSA-901042 | 8.591849e-01 | 0.066 | 0 | 0 |
| Gap junction assembly | R-HSA-190861 | 8.591849e-01 | 0.066 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 8.591849e-01 | 0.066 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 8.592630e-01 | 0.066 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 8.617354e-01 | 0.065 | 0 | 0 |
| OGDH complex synthesizes succinyl-CoA from 2-OG | R-HSA-9853506 | 8.643111e-01 | 0.063 | 0 | 0 |
| Chylomicron remodeling | R-HSA-8963901 | 8.643111e-01 | 0.063 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 8.643111e-01 | 0.063 | 0 | 0 |
| Processing of SMDT1 | R-HSA-8949664 | 8.643111e-01 | 0.063 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 8.643111e-01 | 0.063 | 0 | 0 |
| CREB1 phosphorylation through the activation of Adenylate Cyclase | R-HSA-442720 | 8.643111e-01 | 0.063 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 8.643111e-01 | 0.063 | 0 | 0 |
| Diseases of nucleotide metabolism | R-HSA-9735804 | 8.643111e-01 | 0.063 | 0 | 0 |
| Platelet Adhesion to exposed collagen | R-HSA-75892 | 8.643111e-01 | 0.063 | 0 | 0 |
| Interleukin-6 signaling | R-HSA-1059683 | 8.643111e-01 | 0.063 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 8.644719e-01 | 0.063 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 8.646316e-01 | 0.063 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 8.647319e-01 | 0.063 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 8.652285e-01 | 0.063 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 8.666198e-01 | 0.062 | 0 | 0 |
| Plasma lipoprotein assembly | R-HSA-8963898 | 8.667616e-01 | 0.062 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 8.667616e-01 | 0.062 | 0 | 0 |
| Assembly of active LPL and LIPC lipase complexes | R-HSA-8963889 | 8.667616e-01 | 0.062 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 8.698492e-01 | 0.061 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 8.698492e-01 | 0.061 | 0 | 0 |
| Acyl chain remodelling of PE | R-HSA-1482839 | 8.698492e-01 | 0.061 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 8.698492e-01 | 0.061 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 8.698492e-01 | 0.061 | 0 | 0 |
| Defects in vitamin and cofactor metabolism | R-HSA-3296482 | 8.698492e-01 | 0.061 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 8.766494e-01 | 0.057 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 8.771731e-01 | 0.057 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 8.771731e-01 | 0.057 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 8.778454e-01 | 0.057 | 0 | 0 |
| PI-3K cascade:FGFR2 | R-HSA-5654695 | 8.784681e-01 | 0.056 | 0 | 0 |
| Hyaluronan degradation | R-HSA-2160916 | 8.784681e-01 | 0.056 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 8.784681e-01 | 0.056 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 8.784681e-01 | 0.056 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR3 | R-HSA-5654227 | 8.793607e-01 | 0.056 | 0 | 0 |
| Retrograde neurotrophin signalling | R-HSA-177504 | 8.793607e-01 | 0.056 | 0 | 0 |
| HDL assembly | R-HSA-8963896 | 8.793607e-01 | 0.056 | 0 | 0 |
| Transport of fatty acids | R-HSA-804914 | 8.793607e-01 | 0.056 | 0 | 0 |
| YAP1- and WWTR1 (TAZ)-stimulated gene expression | R-HSA-2032785 | 8.793607e-01 | 0.056 | 0 | 0 |
| TP53 Regulates Transcription of Death Receptors and Ligands | R-HSA-6803211 | 8.793607e-01 | 0.056 | 0 | 0 |
| Physiological factors | R-HSA-5578768 | 8.793607e-01 | 0.056 | 0 | 0 |
| Malate-aspartate shuttle | R-HSA-9856872 | 8.793607e-01 | 0.056 | 0 | 0 |
| Respiratory syncytial virus genome transcription | R-HSA-9828642 | 8.793607e-01 | 0.056 | 0 | 0 |
| Glycerophospholipid catabolism | R-HSA-6814848 | 8.793607e-01 | 0.056 | 0 | 0 |
| Acyl chain remodeling of CL | R-HSA-1482798 | 8.793607e-01 | 0.056 | 0 | 0 |
| Formation of Fibrin Clot (Clotting Cascade) | R-HSA-140877 | 8.797933e-01 | 0.056 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 8.846960e-01 | 0.053 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 8.892178e-01 | 0.051 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 8.892178e-01 | 0.051 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 8.892178e-01 | 0.051 | 0 | 0 |
| Caspase activation via extrinsic apoptotic signalling pathway | R-HSA-5357769 | 8.892178e-01 | 0.051 | 0 | 0 |
| Sphingolipid catabolism | R-HSA-9845614 | 8.892178e-01 | 0.051 | 0 | 0 |
| Diseases of branched-chain amino acid catabolism | R-HSA-9865118 | 8.892178e-01 | 0.051 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 8.895407e-01 | 0.051 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 8.919540e-01 | 0.050 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 8.927418e-01 | 0.049 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 8.927418e-01 | 0.049 | 0 | 0 |
| Protein lipoylation | R-HSA-9857492 | 8.927418e-01 | 0.049 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR4 | R-HSA-5654228 | 8.927418e-01 | 0.049 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 8.927418e-01 | 0.049 | 0 | 0 |
| DNA Damage Reversal | R-HSA-73942 | 8.927418e-01 | 0.049 | 0 | 0 |
| Transport and metabolism of PAPS | R-HSA-174362 | 8.927418e-01 | 0.049 | 0 | 0 |
| p38MAPK events | R-HSA-171007 | 8.927418e-01 | 0.049 | 0 | 0 |
| Signaling by Activin | R-HSA-1502540 | 8.927418e-01 | 0.049 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 8.949448e-01 | 0.048 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 8.976734e-01 | 0.047 | 0 | 0 |
| Triglyceride biosynthesis | R-HSA-75109 | 8.990789e-01 | 0.046 | 0 | 0 |
| Insulin processing | R-HSA-264876 | 8.990789e-01 | 0.046 | 0 | 0 |
| Synthesis of PE | R-HSA-1483213 | 8.990789e-01 | 0.046 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 8.994514e-01 | 0.046 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 9.000111e-01 | 0.046 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 9.012013e-01 | 0.045 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 9.046395e-01 | 0.044 | 0 | 0 |
| Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion | R-HSA-434316 | 9.046395e-01 | 0.044 | 0 | 0 |
| Activation of the phototransduction cascade | R-HSA-2485179 | 9.046395e-01 | 0.044 | 0 | 0 |
| Regulation of glycolysis by fructose 2,6-bisphosphate metabolism | R-HSA-9634600 | 9.046395e-01 | 0.044 | 0 | 0 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | R-HSA-210744 | 9.046395e-01 | 0.044 | 0 | 0 |
| Induction of Cell-Cell Fusion | R-HSA-9733458 | 9.046395e-01 | 0.044 | 0 | 0 |
| Synthesis of wybutosine at G37 of tRNA(Phe) | R-HSA-6782861 | 9.046395e-01 | 0.044 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 9.046395e-01 | 0.044 | 0 | 0 |
| TP53 Regulates Transcription of Caspase Activators and Caspases | R-HSA-6803207 | 9.046395e-01 | 0.044 | 0 | 0 |
| Attachment and Entry | R-HSA-9678110 | 9.046395e-01 | 0.044 | 0 | 0 |
| Virus Assembly and Release | R-HSA-168268 | 9.046395e-01 | 0.044 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 9.065807e-01 | 0.043 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 9.081163e-01 | 0.042 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 9.081669e-01 | 0.042 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 9.089774e-01 | 0.041 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 9.127699e-01 | 0.040 | 0 | 0 |
| Defective B3GALT6 causes EDSP2 and SEMDJL1 | R-HSA-4420332 | 9.152180e-01 | 0.038 | 0 | 0 |
| Defective B4GALT7 causes EDS, progeroid type | R-HSA-3560783 | 9.152180e-01 | 0.038 | 0 | 0 |
| Scavenging by Class B Receptors | R-HSA-3000471 | 9.152180e-01 | 0.038 | 0 | 0 |
| Phase 2 - plateau phase | R-HSA-5576893 | 9.152180e-01 | 0.038 | 0 | 0 |
| STAT5 activation downstream of FLT3 ITD mutants | R-HSA-9702518 | 9.152180e-01 | 0.038 | 0 | 0 |
| Passive transport by Aquaporins | R-HSA-432047 | 9.152180e-01 | 0.038 | 0 | 0 |
| Synthesis of PG | R-HSA-1483148 | 9.152180e-01 | 0.038 | 0 | 0 |
| tRNA modification in the mitochondrion | R-HSA-6787450 | 9.152180e-01 | 0.038 | 0 | 0 |
| Regulation of innate immune responses to cytosolic DNA | R-HSA-3134975 | 9.152180e-01 | 0.038 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 9.152180e-01 | 0.038 | 0 | 0 |
| Defects of contact activation system (CAS) and kallikrein/kinin system (KKS) | R-HSA-9651496 | 9.152180e-01 | 0.038 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 9.159474e-01 | 0.038 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 9.163440e-01 | 0.038 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 9.200224e-01 | 0.036 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 9.209786e-01 | 0.036 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 9.239617e-01 | 0.034 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 9.239617e-01 | 0.034 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 9.240754e-01 | 0.034 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 9.240754e-01 | 0.034 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 9.240754e-01 | 0.034 | 0 | 0 |
| Phospholipase C-mediated cascade: FGFR1 | R-HSA-5654219 | 9.246235e-01 | 0.034 | 0 | 0 |
| Defective B3GAT3 causes JDSSDHD | R-HSA-3560801 | 9.246235e-01 | 0.034 | 0 | 0 |
| Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | R-HSA-164938 | 9.246235e-01 | 0.034 | 0 | 0 |
| Synthesis of 15-eicosatetraenoic acid derivatives | R-HSA-2142770 | 9.246235e-01 | 0.034 | 0 | 0 |
| Catecholamine biosynthesis | R-HSA-209905 | 9.246235e-01 | 0.034 | 0 | 0 |
| Sulfide oxidation to sulfate | R-HSA-1614517 | 9.246235e-01 | 0.034 | 0 | 0 |
| Scavenging by Class A Receptors | R-HSA-3000480 | 9.264185e-01 | 0.033 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 9.264185e-01 | 0.033 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 9.264185e-01 | 0.033 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 9.292251e-01 | 0.032 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 9.292251e-01 | 0.032 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 9.308820e-01 | 0.031 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 9.308820e-01 | 0.031 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 9.323418e-01 | 0.030 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 9.329862e-01 | 0.030 | 0 | 0 |
| PKA activation | R-HSA-163615 | 9.329862e-01 | 0.030 | 0 | 0 |
| PKA activation in glucagon signalling | R-HSA-164378 | 9.329862e-01 | 0.030 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 9.329862e-01 | 0.030 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 9.330735e-01 | 0.030 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 9.372033e-01 | 0.028 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 9.385133e-01 | 0.028 | 1 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 9.385133e-01 | 0.028 | 1 | 0 |
| Germ layer formation at gastrulation | R-HSA-9754189 | 9.404214e-01 | 0.027 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 9.404214e-01 | 0.027 | 0 | 0 |
| Pre-NOTCH Processing in Golgi | R-HSA-1912420 | 9.404214e-01 | 0.027 | 0 | 0 |
| Strand-asynchronous mitochondrial DNA replication | R-HSA-9913635 | 9.404214e-01 | 0.027 | 0 | 0 |
| Diseases of hemostasis | R-HSA-9671793 | 9.404214e-01 | 0.027 | 0 | 0 |
| Transport of nucleotide sugars | R-HSA-727802 | 9.404214e-01 | 0.027 | 0 | 0 |
| Other interleukin signaling | R-HSA-449836 | 9.404214e-01 | 0.027 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 9.428544e-01 | 0.026 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR2 | R-HSA-5654221 | 9.470321e-01 | 0.024 | 0 | 0 |
| Creatine metabolism | R-HSA-71288 | 9.470321e-01 | 0.024 | 0 | 0 |
| Common Pathway of Fibrin Clot Formation | R-HSA-140875 | 9.470321e-01 | 0.024 | 0 | 0 |
| Signaling by NODAL | R-HSA-1181150 | 9.470321e-01 | 0.024 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 9.482364e-01 | 0.023 | 0 | 0 |
| Glutamate and glutamine metabolism | R-HSA-8964539 | 9.482364e-01 | 0.023 | 0 | 0 |
| Vitamin B5 (pantothenate) metabolism | R-HSA-199220 | 9.482364e-01 | 0.023 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 9.485454e-01 | 0.023 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 9.502192e-01 | 0.022 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 9.503121e-01 | 0.022 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 9.508798e-01 | 0.022 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 9.518954e-01 | 0.021 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 9.518954e-01 | 0.021 | 0 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 9.529097e-01 | 0.021 | 0 | 0 |
| NOTCH2 Activation and Transmission of Signal to the Nucleus | R-HSA-2979096 | 9.529097e-01 | 0.021 | 0 | 0 |
| PD-L1(CD274) glycosylation and translocation to plasma membrane | R-HSA-9931295 | 9.529097e-01 | 0.021 | 0 | 0 |
| Vitamin C (ascorbate) metabolism | R-HSA-196836 | 9.529097e-01 | 0.021 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 9.529097e-01 | 0.021 | 0 | 0 |
| Acyl chain remodelling of PG | R-HSA-1482925 | 9.529097e-01 | 0.021 | 0 | 0 |
| Prevention of phagosomal-lysosomal fusion | R-HSA-9636383 | 9.529097e-01 | 0.021 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 9.530341e-01 | 0.021 | 0 | 0 |
| Regulation of TLR by endogenous ligand | R-HSA-5686938 | 9.530341e-01 | 0.021 | 0 | 0 |
| Hyaluronan metabolism | R-HSA-2142845 | 9.530341e-01 | 0.021 | 0 | 0 |
| Phosphate bond hydrolysis by NUDT proteins | R-HSA-2393930 | 9.530341e-01 | 0.021 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 9.530341e-01 | 0.021 | 1 | 1 |
| Triglyceride metabolism | R-HSA-8979227 | 9.539935e-01 | 0.020 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 9.539935e-01 | 0.020 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 9.541020e-01 | 0.020 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 9.552421e-01 | 0.020 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 9.556994e-01 | 0.020 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 9.556994e-01 | 0.020 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 9.556994e-01 | 0.020 | 0 | 0 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 9.558833e-01 | 0.020 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 9.572779e-01 | 0.019 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 9.575024e-01 | 0.019 | 0 | 0 |
| CS-GAG biosynthesis | R-HSA-2022870 | 9.581353e-01 | 0.019 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 9.581353e-01 | 0.019 | 0 | 0 |
| FRS-mediated FGFR3 signaling | R-HSA-5654706 | 9.581353e-01 | 0.019 | 0 | 0 |
| Mitochondrial calcium ion transport | R-HSA-8949215 | 9.581353e-01 | 0.019 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 9.581353e-01 | 0.019 | 0 | 0 |
| Glutathione synthesis and recycling | R-HSA-174403 | 9.581353e-01 | 0.019 | 0 | 0 |
| Metabolism of Angiotensinogen to Angiotensins | R-HSA-2022377 | 9.581353e-01 | 0.019 | 0 | 0 |
| Assembly Of The HIV Virion | R-HSA-175474 | 9.581353e-01 | 0.019 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 9.584238e-01 | 0.018 | 0 | 0 |
| Plasma lipoprotein remodeling | R-HSA-8963899 | 9.595599e-01 | 0.018 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 9.596435e-01 | 0.018 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 9.613842e-01 | 0.017 | 0 | 0 |
| Triglyceride catabolism | R-HSA-163560 | 9.613842e-01 | 0.017 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 9.613842e-01 | 0.017 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 9.620271e-01 | 0.017 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 9.624433e-01 | 0.017 | 0 | 0 |
| FRS-mediated FGFR4 signaling | R-HSA-5654712 | 9.627813e-01 | 0.016 | 0 | 0 |
| Cellular hexose transport | R-HSA-189200 | 9.627813e-01 | 0.016 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 9.627813e-01 | 0.016 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 9.627813e-01 | 0.016 | 0 | 0 |
| Neurotoxicity of clostridium toxins | R-HSA-168799 | 9.627813e-01 | 0.016 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 9.637894e-01 | 0.016 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 9.645354e-01 | 0.016 | 0 | 0 |
| Voltage gated Potassium channels | R-HSA-1296072 | 9.650052e-01 | 0.015 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 9.650052e-01 | 0.015 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 9.659028e-01 | 0.015 | 0 | 0 |
| Iron uptake and transport | R-HSA-917937 | 9.659028e-01 | 0.015 | 0 | 0 |
| Response of EIF2AK1 (HRI) to heme deficiency | R-HSA-9648895 | 9.669120e-01 | 0.015 | 0 | 0 |
| Free fatty acids regulate insulin secretion | R-HSA-400451 | 9.669120e-01 | 0.015 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 9.669120e-01 | 0.015 | 0 | 0 |
| Carnitine shuttle | R-HSA-200425 | 9.669120e-01 | 0.015 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 9.671137e-01 | 0.015 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 9.682984e-01 | 0.014 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 9.682984e-01 | 0.014 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 9.689362e-01 | 0.014 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 9.705844e-01 | 0.013 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 9.705844e-01 | 0.013 | 0 | 0 |
| TNFs bind their physiological receptors | R-HSA-5669034 | 9.705844e-01 | 0.013 | 0 | 0 |
| Interleukin-6 family signaling | R-HSA-6783589 | 9.705844e-01 | 0.013 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 9.706762e-01 | 0.013 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 9.707005e-01 | 0.013 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | R-HSA-381771 | 9.712920e-01 | 0.013 | 0 | 0 |
| FRS-mediated FGFR1 signaling | R-HSA-5654693 | 9.738495e-01 | 0.012 | 0 | 0 |
| Biosynthesis of electrophilic ω-3 PUFA oxo-derivatives | R-HSA-9027604 | 9.738495e-01 | 0.012 | 0 | 0 |
| Glycogen breakdown (glycogenolysis) | R-HSA-70221 | 9.738495e-01 | 0.012 | 0 | 0 |
| Formation of the nephric duct | R-HSA-9830364 | 9.738495e-01 | 0.012 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 9.740118e-01 | 0.011 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 9.746560e-01 | 0.011 | 0 | 0 |
| Class B/2 (Secretin family receptors) | R-HSA-373080 | 9.746560e-01 | 0.011 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 9.746815e-01 | 0.011 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 9.759223e-01 | 0.011 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 9.764817e-01 | 0.010 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 9.767523e-01 | 0.010 | 0 | 0 |
| Synthesis of IP2, IP, and Ins in the cytosol | R-HSA-1855183 | 9.767523e-01 | 0.010 | 0 | 0 |
| Urea cycle | R-HSA-70635 | 9.767523e-01 | 0.010 | 0 | 0 |
| Suppression of phagosomal maturation | R-HSA-9637687 | 9.767523e-01 | 0.010 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 9.787238e-01 | 0.009 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 9.791762e-01 | 0.009 | 0 | 0 |
| Signaling by BMP | R-HSA-201451 | 9.793330e-01 | 0.009 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 9.793330e-01 | 0.009 | 0 | 0 |
| ER Quality Control Compartment (ERQC) | R-HSA-901032 | 9.793330e-01 | 0.009 | 0 | 0 |
| Synthesis of bile acids and bile salts via 27-hydroxycholesterol | R-HSA-193807 | 9.793330e-01 | 0.009 | 0 | 0 |
| Biosynthesis of DPAn-3 SPMs | R-HSA-9025094 | 9.793330e-01 | 0.009 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 9.796081e-01 | 0.009 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 9.796617e-01 | 0.009 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 9.796617e-01 | 0.009 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 9.807328e-01 | 0.008 | 0 | 0 |
| Incretin synthesis, secretion, and inactivation | R-HSA-400508 | 9.807580e-01 | 0.008 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 9.811145e-01 | 0.008 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 9.812448e-01 | 0.008 | 0 | 0 |
| FRS-mediated FGFR2 signaling | R-HSA-5654700 | 9.816274e-01 | 0.008 | 0 | 0 |
| Insulin receptor recycling | R-HSA-77387 | 9.816274e-01 | 0.008 | 0 | 0 |
| ATF4 activates genes in response to endoplasmic reticulum stress | R-HSA-380994 | 9.816274e-01 | 0.008 | 0 | 0 |
| Pyrimidine salvage | R-HSA-73614 | 9.816274e-01 | 0.008 | 0 | 0 |
| Pyrimidine catabolism | R-HSA-73621 | 9.826030e-01 | 0.008 | 0 | 0 |
| Endosomal Sorting Complex Required For Transport (ESCRT) | R-HSA-917729 | 9.836672e-01 | 0.007 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 9.836672e-01 | 0.007 | 0 | 0 |
| Activation of Matrix Metalloproteinases | R-HSA-1592389 | 9.836672e-01 | 0.007 | 0 | 0 |
| Biosynthesis of EPA-derived SPMs | R-HSA-9018679 | 9.836672e-01 | 0.007 | 0 | 0 |
| Purine catabolism | R-HSA-74259 | 9.841527e-01 | 0.007 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 9.849000e-01 | 0.007 | 0 | 0 |
| Amino acid transport across the plasma membrane | R-HSA-352230 | 9.849000e-01 | 0.007 | 0 | 0 |
| Neurotransmitter clearance | R-HSA-112311 | 9.854806e-01 | 0.006 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 9.862247e-01 | 0.006 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 9.870928e-01 | 0.006 | 0 | 0 |
| Molecules associated with elastic fibres | R-HSA-2129379 | 9.870928e-01 | 0.006 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 9.870928e-01 | 0.006 | 0 | 0 |
| Biosynthesis of DPA-derived SPMs | R-HSA-9018683 | 9.870928e-01 | 0.006 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 9.888679e-01 | 0.005 | 1 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 9.888679e-01 | 0.005 | 1 | 0 |
| Diseases associated with glycosylation precursor biosynthesis | R-HSA-5609975 | 9.898002e-01 | 0.004 | 0 | 0 |
| Recycling of bile acids and salts | R-HSA-159418 | 9.898002e-01 | 0.004 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 9.898002e-01 | 0.004 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 9.905218e-01 | 0.004 | 0 | 0 |
| Interleukin-10 signaling | R-HSA-6783783 | 9.905218e-01 | 0.004 | 0 | 0 |
| Glyoxylate metabolism and glycine degradation | R-HSA-389661 | 9.905524e-01 | 0.004 | 0 | 0 |
| CS/DS degradation | R-HSA-2024101 | 9.909329e-01 | 0.004 | 0 | 0 |
| Heme degradation | R-HSA-189483 | 9.909329e-01 | 0.004 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 9.910176e-01 | 0.004 | 0 | 0 |
| Synthesis of Prostaglandins (PG) and Thromboxanes (TX) | R-HSA-2162123 | 9.914740e-01 | 0.004 | 0 | 0 |
| Glycosaminoglycan-protein linkage region biosynthesis | R-HSA-1971475 | 9.919399e-01 | 0.004 | 0 | 0 |
| Branched-chain amino acid catabolism | R-HSA-70895 | 9.923076e-01 | 0.003 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 9.928210e-01 | 0.003 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 9.930212e-01 | 0.003 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 9.934279e-01 | 0.003 | 1 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 9.935745e-01 | 0.003 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 9.937801e-01 | 0.003 | 0 | 0 |
| NCAM1 interactions | R-HSA-419037 | 9.943385e-01 | 0.002 | 0 | 0 |
| SLC-mediated transport of organic cations | R-HSA-549127 | 9.943385e-01 | 0.002 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 9.944309e-01 | 0.002 | 0 | 0 |
| Immune System | R-HSA-168256 | 9.947273e-01 | 0.002 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 9.949184e-01 | 0.002 | 0 | 0 |
| Purine salvage | R-HSA-74217 | 9.949674e-01 | 0.002 | 0 | 0 |
| Mitochondrial translation elongation | R-HSA-5389840 | 9.949988e-01 | 0.002 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 9.950849e-01 | 0.002 | 0 | 0 |
| Pentose phosphate pathway | R-HSA-71336 | 9.955265e-01 | 0.002 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 9.957096e-01 | 0.002 | 0 | 0 |
| Mitochondrial translation initiation | R-HSA-5368286 | 9.957745e-01 | 0.002 | 0 | 0 |
| Maturation of TCA enzymes and regulation of TCA cycle | R-HSA-9854311 | 9.960235e-01 | 0.002 | 0 | 0 |
| Tryptophan catabolism | R-HSA-71240 | 9.960235e-01 | 0.002 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 9.960235e-01 | 0.002 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 9.960770e-01 | 0.002 | 0 | 0 |
| Purine ribonucleoside monophosphate biosynthesis | R-HSA-73817 | 9.964653e-01 | 0.002 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 9.966480e-01 | 0.001 | 0 | 0 |
| Citric acid cycle (TCA cycle) | R-HSA-71403 | 9.966489e-01 | 0.001 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 9.971624e-01 | 0.001 | 0 | 0 |
| Mitochondrial ribosome-associated quality control | R-HSA-9937383 | 9.972407e-01 | 0.001 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 9.972818e-01 | 0.001 | 0 | 0 |
| Nucleotide salvage | R-HSA-8956321 | 9.972818e-01 | 0.001 | 0 | 0 |
| SLC-mediated transport of organic anions | R-HSA-9955298 | 9.974920e-01 | 0.001 | 0 | 0 |
| Synthesis of very long-chain fatty acyl-CoAs | R-HSA-75876 | 9.975176e-01 | 0.001 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.975522e-01 | 0.001 | 0 | 0 |
| Surfactant metabolism | R-HSA-5683826 | 9.977934e-01 | 0.001 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 9.977934e-01 | 0.001 | 0 | 0 |
| Complex I biogenesis | R-HSA-6799198 | 9.977973e-01 | 0.001 | 0 | 0 |
| Diseases associated with glycosaminoglycan metabolism | R-HSA-3560782 | 9.980387e-01 | 0.001 | 0 | 0 |
| Degradation of cysteine and homocysteine | R-HSA-1614558 | 9.980387e-01 | 0.001 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 9.983596e-01 | 0.001 | 0 | 0 |
| Mitochondrial translation termination | R-HSA-5419276 | 9.984969e-01 | 0.001 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 9.985888e-01 | 0.001 | 0 | 0 |
| Chemokine receptors bind chemokines | R-HSA-380108 | 9.987758e-01 | 0.001 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 9.989119e-01 | 0.000 | 0 | 0 |
| Complex IV assembly | R-HSA-9864848 | 9.990329e-01 | 0.000 | 0 | 0 |
| Cytosolic sulfonation of small molecules | R-HSA-156584 | 9.990329e-01 | 0.000 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 9.992105e-01 | 0.000 | 0 | 0 |
| Nucleotide biosynthesis | R-HSA-8956320 | 9.992360e-01 | 0.000 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 9.992598e-01 | 0.000 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 9.992957e-01 | 0.000 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.992957e-01 | 0.000 | 0 | 0 |
| Nucleotide catabolism | R-HSA-8956319 | 9.993075e-01 | 0.000 | 0 | 0 |
| Transport of vitamins, nucleosides, and related molecules | R-HSA-425397 | 9.993148e-01 | 0.000 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.993813e-01 | 0.000 | 0 | 0 |
| Chondroitin sulfate/dermatan sulfate metabolism | R-HSA-1793185 | 9.993965e-01 | 0.000 | 0 | 0 |
| Paracetamol ADME | R-HSA-9753281 | 9.993965e-01 | 0.000 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 9.994242e-01 | 0.000 | 0 | 0 |
| Metabolism of amine-derived hormones | R-HSA-209776 | 9.994636e-01 | 0.000 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 9.994636e-01 | 0.000 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.995096e-01 | 0.000 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 9.995232e-01 | 0.000 | 0 | 0 |
| Synthesis of PA | R-HSA-1483166 | 9.995232e-01 | 0.000 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 9.995761e-01 | 0.000 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 9.996133e-01 | 0.000 | 0 | 0 |
| Sialic acid metabolism | R-HSA-4085001 | 9.996234e-01 | 0.000 | 0 | 0 |
| RAB geranylgeranylation | R-HSA-8873719 | 9.996653e-01 | 0.000 | 0 | 0 |
| Glutathione conjugation | R-HSA-156590 | 9.996653e-01 | 0.000 | 0 | 0 |
| Endogenous sterols | R-HSA-211976 | 9.997025e-01 | 0.000 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 9.997190e-01 | 0.000 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 9.997505e-01 | 0.000 | 0 | 0 |
| Disease | R-HSA-1643685 | 9.998073e-01 | 0.000 | 1 | 0 |
| Nicotinate metabolism | R-HSA-196807 | 9.998534e-01 | 0.000 | 0 | 0 |
| Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol | R-HSA-193368 | 9.998534e-01 | 0.000 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 9.998570e-01 | 0.000 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 9.998697e-01 | 0.000 | 0 | 0 |
| Post-translational modification: synthesis of GPI-anchored proteins | R-HSA-163125 | 9.998743e-01 | 0.000 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 9.998995e-01 | 0.000 | 0 | 0 |
| Retinoid metabolism and transport | R-HSA-975634 | 9.999086e-01 | 0.000 | 0 | 0 |
| Metabolism of porphyrins | R-HSA-189445 | 9.999086e-01 | 0.000 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 9.999215e-01 | 0.000 | 0 | 0 |
| Aspirin ADME | R-HSA-9749641 | 9.999278e-01 | 0.000 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 9.999304e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation | R-HSA-5368287 | 9.999321e-01 | 0.000 | 0 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 9.999387e-01 | 0.000 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 9.999447e-01 | 0.000 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 9.999671e-01 | 0.000 | 0 | 0 |
| Metabolism of fat-soluble vitamins | R-HSA-6806667 | 9.999719e-01 | 0.000 | 0 | 0 |
| Biosynthesis of DHA-derived SPMs | R-HSA-9018677 | 9.999719e-01 | 0.000 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.999752e-01 | 0.000 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 9.999768e-01 | 0.000 | 0 | 0 |
| Sensory perception of sweet, bitter, and umami (glutamate) taste | R-HSA-9717207 | 9.999857e-01 | 0.000 | 0 | 0 |
| Sulfur amino acid metabolism | R-HSA-1614635 | 9.999862e-01 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 9.999902e-01 | 0.000 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 9.999912e-01 | 0.000 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 9.999945e-01 | 0.000 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 9.999946e-01 | 0.000 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 9.999949e-01 | 0.000 | 0 | 0 |
| Sensory perception of taste | R-HSA-9717189 | 9.999950e-01 | 0.000 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 9.999963e-01 | 0.000 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 9.999973e-01 | 0.000 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 9.999978e-01 | 0.000 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 9.999987e-01 | 0.000 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 9.999988e-01 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 9.999992e-01 | 0.000 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 9.999994e-01 | 0.000 | 0 | 0 |
| Synthesis of substrates in N-glycan biosythesis | R-HSA-446219 | 9.999995e-01 | 0.000 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 9.999996e-01 | 0.000 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 9.999996e-01 | 0.000 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 9.999997e-01 | 0.000 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 9.999999e-01 | 0.000 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 9.999999e-01 | 0.000 | 0 | 0 |
| Regulation of Complement cascade | R-HSA-977606 | 9.999999e-01 | 0.000 | 0 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 1.000000e+00 | 0.000 | 0 | 0 |
| Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein | R-HSA-446193 | 1.000000e+00 | 0.000 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 1.000000e+00 | 0.000 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 1.000000e+00 | 0.000 | 0 | 0 |
| Biosynthesis of specialized proresolving mediators (SPMs) | R-HSA-9018678 | 1.000000e+00 | 0.000 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 1.000000e+00 | 0.000 | 0 | 0 |
| Complement cascade | R-HSA-166658 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 1.000000e+00 | 0.000 | 0 | 0 |
| Cytochrome P450 - arranged by substrate type | R-HSA-211897 | 1.000000e+00 | 0.000 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 1.000000e+00 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase II - Conjugation of compounds | R-HSA-156580 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 1.000000e+00 | 0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 1.000000e+00 | 0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 1.000000e+00 | 0.000 | 0 | 0 |
| Expression and translocation of olfactory receptors | R-HSA-9752946 | 1.000000e+00 | -0.000 | 0 | 0 |
| Olfactory Signaling Pathway | R-HSA-381753 | 1.000000e+00 | -0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 1.000000e+00 | -0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000e+00 | -0.000 | 0 | 0 |